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General Introduction 
Cell adhesion in the immune system 
The human body needs a defence mechanism that protects it from intruding foreign 
organisms and tissue damage. The immune system, with its main actors the leukocytes, 
protects the body against these invading micro-organisms and supports wound healing. To 
perform this function, leukocytes should be able to circulate as non-adherent cells in blood 
and lymph and to migrate as adherent cells throughout the tissues. Therefore these cells are 
equipped with many adhesion receptors that, based on their structure, belong to different 
families of adhesion receptors: Cadherins, selectins, members of the immunoglobulin (Ig)-
superfamily and integrins (Figure 1). Integrins form a large group of adhesion receptors 
that mediate adhesion between leukocytes and antigen-bearing cells, between leukocytes 
and endothelium, as well as between leukocytes and extracellular matrix (ECM) 
components. A prototype interaction between leukocytes and endothelium will be 
described in detail (Figure 2). 
Cadherins Selectins Ig-superfamily Integrins 
Figure 1. Structure of adhesion receptor families. General structure and representative 
examples are shown schematically. Cadherins contain in their extracellular domain five 
tandem repeats, of which the N-terminal contains the adhesive recognition site, while the 
other repeats include putative calcium binding sites. Selectins have an amino-lerminal 
domain which is homologous to calcium-dependent animal lectins, followed by an EGF-
like domain, 2 to 9 repeats of a complement regulatory protein domain, and a short 
cytoplasmic tail. The immunoglobulin (Ig)-superfamily consists of many members, that all 
contain the Ig-like domains. Integrins are heterodimeric receptors that contain α and β 
subunits, which are non-covalently associated and have short cytoplasmic tails (except β4) 
[1]. 
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Integrili families 
Integrine are heterodimenc transmembrane molecules composed of an α subunit, 
which is non-covalently associated with a β subunit [15] Integnns are adhesion molecules 
and the term integrin was coined to indicate that these molecules integrate the activities of 
the extracellular matrix and the cytoskeleton This has been confirmed by the observation 
that disruption of the cytoskeleton can inhibit integrin mediated adhesion [16-19] 
According to the differences in their β subunit, various integrin subfamilies can be 
distinguished Thus far, eight different β and sixteen different α subunits have been 
identified [14], that can form 22 different integnns [13] 
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Rolling Arrest Strong adhesion Diapedesis 
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Rolling 
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Strong 
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L-Selectin 
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a4ßi 
α 4 β 7 
a4ß! 
α 4 β 7 
CD31 
LFA-1 
Mac-1 
LFA-1 
Mac-1 
CD31 
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Sialyated, sulfated sugar related 
to sLex and sLea, CD34, MAdCAM-1 
E-Selectin, P-selectin 
VCAM-1 
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VCAM-1 
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ICAM-1 
ICAM-1 
ICAM-1 
CD31 
Figure 2. The adhesion cascade: rolling, arrest, firm adhesion/spreading and 
transmigration (diapedesis) of leukocytes through the endothelium into the tissues at sites 
of inflammation [10-14]. 
ßl integrins 
β I integrins (CD49/CD29), also called 'very late activation antigens' (VLA's), are 
expressed on a variety of cell types, including cells of hematopoietic origin [54-56]. βι 
integrins function as cell surface receptors, mediating adhesive interactions between cells 
and between cells and extracellular matrix (ECM) [57-60]. Outside the immune system, 
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they are essential in embryogenesis, as shown by high lethality of embryonic or neonatal 
mice when expression of the integrin α (that associates with βι) or βι subunit is absent 
[61-65]. Interaction of leukocytes with ECM is regulated by the repertoire of integrin 
receptors for ECM components on leukocytes and by the ability of leukocytes to increase 
rapidly integrin-mediated adhesion to ECM in response to agonist stimulation [56,66]. 
ECM components that bind to βι integrins are laminin, collagen, fibronectin, epiligrin, 
entactin, tenascin and vitronectin. (Χ4βι is the only βι integrin that, besides the ECM 
component fibronectin, also binds to cellular ligands, such as the 0C4 subunit [27] and 
VCAM-1, a member of the Ig-superfamily [55]. During inflammation, expression of VCAM-
1 is increased on endothelium, suggesting a role for VLA-4 in rolling and arrest of 
leukocytes before transmigration across the endothelium [5,6,67]. 
Table I. Integrins expressed on leukocytes 
Subunit 
βι αϊ 
012 
« 3 
α4 
as 
0C6 
Name 
VLA-1 
VLA-2 
VLA-3 
VLA-4 
VLA-5 
VLA-6 
CD 
CD49a/CD49 
CD49b/CD49 
CD49C/CD49 
CD49d/CD49 
CD49e/CD49 
CD49f/CD49 
Ligands 
LM, Coll 
LM, Coll 
LM, Coll, FN, Epi, Ent 
FN, VCAM-1,04 
FN, LI 
LM 
References 
[20,21] 
[22-24] 
[25] 
[26-28] 
[29,30] 
[31,32] 
β2 OIL LFA-1 CDlla/CD18 
а м Mac-1, CDllb/CD18 
CR-3 
α χ ρ 150,95 CD 11 c/CD 18 
ad CDII0VCDI8 
ICAM-1,-2,-3 [33-38] 
ICAM-l,-2,FG,C3bi,CD23, [39-48] 
X, Hep, NIF, DP, HK 
FG, C3bi, DP, LPS, CD23 [40,45,49,50] 
ICAM-3 [51] 
ß7 0C4 LPAM-1 CD49d/CD-
ан alEL 
FN, VCAM-1, MAdCAM, 04 [6,27,52] 
E-Cadherin [53] 
Abbreviations used: LM, laminin; Coll, collagen; FN, fibronectin; Epi, epiligrin; Ent, 
entactin; FG, fibrinogen; DP, denatured proteins; CD23, low affinity receptor for 
immunoglobulin E; LPAM-1, lymphocyte Peyer's patch adhesion molecule 1; NIF, 
neutrophil inhibitory factor; HK, high molecular weight kininogen; Hep, heparin; X, factor 
X; VCAM-1, vascular cell adhesion molecule-]; ICAM, intercellular adhesion molecule; 
MAdCAM, mucosal addressin cell adhesion molecule; C3bi, complement factor 3bi; LPS, 
lipopolysaccharide; LI, 200 kD transmembrane glycoprotein, belonging to the Ig-
superfamily. 
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ß2 integrins 
ß2 integrins are leukocyte specific integrins. This integrin subfamily, also called the 
LeuCAM (leukocyte cell adhesion molecule) family, consists of four different members, 
LFA-1, CR3, ρ 150,95 and the recently discovered new member (Xdp2, all sharing the same 
95 kD β2 subunit [51,68-70]. The importance of p2 integrins in the immune system is 
clearly demonstrated by the so called 'leukocyte adhesion deficiency' (LAD) syndrome, a 
disease in which expression of the β2 molecules is lost [71-74]. Cause of the disease are 
either deletions or mutations of the ß2 subunit [75-77]. Patients suffering from this disease 
die at a very young age as a result of severe bacterial infections, since predominantly 
neutrophils but also monocytes cannot transmigrate across the endothelium in response to 
inflammatory stimuli [78]. 
LFA-1 and its ligands: LFA-1 (lymphocyte function-associated antigen 1; ат^2і 
CD 1 la/CD 18) is an adhesion receptor, with an α subunit of 180 kD that is expressed on all 
leukocytes. LFA-1 is implicated in a broad range of adhesive interactions and signaling 
events in the immune system, such as Τ cell mediated killing, Τ helper cell and В cell 
responses, natural killer cell activity, monocyte mediated antibody dependent cytotoxicity, 
triggering of the respiratory burst of polymorphonuclear cells upon binding of collagen I, 
and leukocyte adhesion to endothelial cells [2,79-82]. LFA-1 mediates adhesion through 
binding to one of its three cellular ligands, intercellular adhesion molecule (ICAM)-l [33], 
-2 [34] or -3 [35-38], that are all members of the Ig-superfamily. ICAM-1 and ICAM-3 are 
composed of five Ig-like domains, while ICAM-2 has two Ig-like domains. LFA-1 binds to 
the first two N-terminal domains of the ICAMs, which show the highest homology in 
amino-acid sequence amongst the different ICAMs (35% homology between ICAM-1 and 
-2; 48% homology between ICAM-1 and -3 and 31% homology between ICAM-2 and -3). 
The cytoplasmic tails of ICAM-1 and -2 show high homology in amino-acid sequence, 
which is not shared by the cytoplasmic tail of ICAM-3 [35,36]. ICAM-1 is significantly up-
regulated by inflammatory mediators (cytokines) on many cell types, including leukocytes, 
endothelial cells, keratinocytes and fibroblasts [83-85]. It has been demonstrated that 
ICAM-1 exists in a membrane-bound form and in a shed form (sICAM-1) in human serum 
[86]. Especially during pathogenesis, sICAM-1 levels are increased [87]. Recently, it has 
been demonstrated that ICAM-1 exists as a non-covalent dimer, what directly correlates 
with enhanced binding to LFA-1 [88]. ICAM-2 is constitutively expressed on all 
leukocytes and endothelial cells [34,89,90]. ICAM-3 expression is constitutively high on 
leukocytes and appears to be inducible on vascular endothelium of certain tumors, such as 
lymphomas and myelomas [91,92]. Furthermore, ICAM-3 provides со-stimulatory signals 
for cell proliferation [93]. Since ICAM-3 is highly expressed on resting Τ cells, it was 
thought to be the dominant ligand for LFA-1 on leukocytes [38]. However, in contrast to 
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LFA-1, that shows stronger binding to ICAM-1 than to ICAM-3, the novel <Xdß2 has been 
demonstrated to preferentially bind ICAM-3 over ICAM-1 [51] This suggests that ICAM-
3 is the dominant ligand for otdß2 In addition to adhesive functions, ICAM-3 can also 
function as a signal transducer Cross-linking of ICAM-3 by antibodies induces Ca2 + 
mobilization and association with tyrosine kinases [94] A consequence of this signaling is 
increased cell adhesion via ßi and ß2 pathways [95,96] Similar to ICAM-1, cellular ICAM-
3 can be shed, as shown in sera of patients with systemic lupus erythematosus [97] 
CR3 and its ligands CR3 (complement receptor 3, Mac-1, 0CMß2» CD lib/CD 18) with 
a 170 kD α subumt is primarily expressed on leukocytes of myeloid and monocytic lineage 
but also on natural killer cells [39,98-101] In resting granulocytes CR3 is stored in 
peroxidase-negative granules Upon addition of inflammatory mediators degranulation 
occurs leading to an increased surface expression of CR3 molecules [101-104] CR3 is the 
major leukocyte integrin expressed on neutrophil and mediates phagocytosis of opsonized 
particles [105], adherence to endothelium [43,106], homotypic aggregation of neutrophils, 
and Chemotaxis CR3 is also implicated in the initiation of a novel coagulation serine 
protease cascade, resulting in thrombin and fibrin formation on cell surfaces Counter-
structures for CR3 are fibrinogen [42], the complement factor C3bi [39], factor X [41], 
denatured proteins [45], high molecular weight kininogen [48], heparin [44] and 
neutrophil inhibitory factor (NIF) [46,47] Recently, it has been demonstrated that CR3 
can also bind the cellular ligands ICAM-1 (CR3 binds to the third domain of ICAM-1) 
[43,107,108], -2 [109,110] and CD23, which is a low affinity receptor for IgE [40] 
p!50.95 and its ligands Ρ150,95 (CR4, complement receptor 4, αχβ2 CDllc/CD18) 
with a 150 kD α subumt shows high homology with the α subumt of CR3 (67%)[111], 
whereas it is only 33% similar to the LFA-1 α subumt [112] It is expressed on a small 
subset of lymphocytes It is highly expressed by monocytes, macrophages, granulocytes, 
by most of the CD8+ Τ lymphocytes, dendritic cells and by either Τ or В cells of patients 
with hairy cell leukemia [100,113-117] In phagocytic cells, pi50,95 is stored in peroxidase-
negative granules and its expression can be up-regulated very rapidly by chemotactic 
agents such a N-formylated methionylleucylphenylalanine (fMLP) [101] P150,95 is 
implicated in adhesion, Chemotaxis and migration of monocytes through the endothelium 
[118] Until now, the only cellular ligand for pl50,95 is CD23 [40] P150.95 mediates 
adhesion upon binding to fibrinogen [50], complement factor C3bi [39,119], LPS [49] and 
binds strongly to denatured proteins [45] 
απβ2 and its ligand ctdß2 (CD1 lo7CD18) is recently discovered as the fourth member 
of the LeuCAM family and consists of a 155-160 kD α subumt which is non-covalently 
associated with the β2 subumt [70] otdß2 'S expressed at moderate levels on myelo-
monocytic cell lines and subsets of peripheral blood lymphocytes (PBL) [51] It is 
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predominantly expressed on macrophages and granulocytes in the red pulp of the spleen, 
in an overlapping but non-identical pattern with other integrine, and on foam cells, which 
are specialized macrophages implicated in the establishment of submtimal aortic fatty 
streaks that may develop into atherosclerotic lesions On granulocytes, expression of otdß2 
appears to increase rapidly after stimulation with fMLP or the phorbol ester PMA, 
consistent with recruitment of an intracellular pool of adß2 in these cells [51] <Xdß2 binds 
ICAM-3 but not ICAM-1, when expressed in chinese hamster ovary cells (CHO) The 
putative amino-acid sequence of ad shares greater identity to the α subunit of CR3 (60%) 
and ρ 150,95 (66%) than to that of LFA-1 (36%) Although the ad subunit is structurally 
similar to а ь а м and α χ , distinct regions present in the extracellular and intracellular 
domain of ad suggest that it may bind to unique hgands Alternatively, it may also bind to 
unique binding sites on hgands, shared by other ß2 integrine Because adß2 is expressed 
by foam cells and these are thought to be involved in the development of atherosclerosis 
[120], adß2 may contribute to macrophage-specific activities such as phagocytosis of 
modified lipoproteins in these lesions 
ß7 integrins 
Similar to ß2 integrins, βγ integrins are also leukocyte specific Thus far, only two 
members of this integrin subfamily are identified affi or LPAM-1 (lymphocyte Peyer's 
patches adhesion molecule 1) [121] and αΕβ7 caffi binds to the mucosal addressin 
MAdCAM-1, which is expressed on high endothelial venules (HEV) in Peyer's patches 
Three additional hgands for affi are VCAM-1, a4 and fibronectin [6,27,52] αΕβγ is only 
expressed on CD8+ Τ cells, within or immediately adjacent to mucosal epitheha [122-124], 
whereas E-Cadhenn, the only known counter-structure for αεβγ, is expressed on epithelial 
cells [53,125,126] Therefore, it has been suggested that αΕβ7 might retain CD8+ Τ 
lymphocytes within mucosal epitheha [126] 
Integrin structure 
Integrin α subunits (Figure 3) have 950-1100 amino-acid extracellular domains, 
containing three or four putative divalent cation binding sites, each about 60 amino-acids 
long These so called EF-hand like motifs share homology with motifs in classical C a 2 + 
binding proteins, like calmodulin [127,128] The cytoplasmic domains of α subunit are 
short, ranging from 15 to 77 amino-acids and are in general not strongly homologous to 
each other, with the exception of a highly conserved GFFKR motif at the N-terminal site of 
the cytoplasmic tail (near the transmembrane region) The α ι , a2, aL, а м , α χ and ad 
subunits contain a region of approximately 200 residues, designated the A or inserted (I) 
domain It shares structural homology to the hgand-binding domain in Von Willebrand 
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ßl 
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TM 
ι 
MIDAS 
cysteine 200 AA NH2 
Figure 3. Structure of the a- and β subunit of LFA-1. TM, transmembrane domain; EF 
hand, EF-hand like motifs involved in cation binding; I, 1 domain; MIDAS, metal ion 
dependent adhesion site; cysteine, cysleine-rich domain; 200 AA, a highly conserved 200 
amino-acid residue sequence. 
Integrin β subunits (Figure 3) have a 675-700 amino-acid extracellular domain, with 
a cysteine-rich domain in the carboxy-terminal half of the extracellular region. This domain 
has internal disulfide bonds that may contribute rigidity to the molecule. Amino-terminal of 
the cysteine-rich domain, a 200 amino-acid sequence is located that is highly conserved in 
β subunits. It shows homology to the I domain [136], which is also demonstrated by the 
presence of a MIDAS-like motif [137]. Mutations within this sequence also eliminate 
ligand binding [138,139]. It can be speculated that the MIDAS-containing I domain in the 
α subunit and the MIDAS-like motif in the β subunit, function cooperatively in ligand 
binding. 
The cytoplasmic tail of most β subunits is relatively short (40-60 amino-acids), except 
the cytoplasmic tail of βφ which is more than 100 amino-acids long [140]. The cytoplasmic 
domain of the β2 subunit consists of a C-terminal sequence that is conserved between βι, 
ß2, ß3 and βγ integrins. In particular a triplet of threonines and a phenylalanine in this 
sequence have been shown to be essential for LFA-1/ ICAM-1 binding (Figure 8) 
[141,142]. 
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Regulation of integrin function 
Leukocytes circulate through the bloodstream as non-adherent cells However 
during infection, tissue damage and wound healing, leukocytes must be recruited to sites 
of inflammation Therefore, leukocyte have been equipped with several mechanisms to 
regulate their adhesive properties (Table II) I) Variation in expression levels of adhesion 
receptor or hgand, and II) Activation of adhesion receptors by avidity and/or affinity 
changes In addition, adhesion receptors can also function as signaling molecules, 
transmitting signals into the cells III) Interaction of adhesion receptors with hgand can 
lead to intracellular signaling events that affect cellular functions such as proliferation and 
transcription of certain genes ('outside-in' signaling) In the following section these 
distinct levels of regulation will be discussed in detail 
Table Π. Mechanisms to regulate integrin function 
Γ) Expression levels of adhesion receptors and/or ligands 
Π) Modulation of the affinity and/or avidity of adhesion receptors 
1) 'Inside-out' signaling 
2) Conformational changes (affinity changes) 
3) Clustering (avidity changes) 
4) Adhesion cascade 
Ш) Post-hgand signaling through adhesion receptors 
1) 'Outside-in' signaling 
I) Expression levels of adhesion receptors or ligands to regulate adhesion 
Integrin expression can either be up- or down-regulated by chemotactic factors or 
cytokines Stimulation of neutrophils with fMLP results in a rapid increase of cell surface 
expression of both CR3 and pl50,95 [143-145] Similarly, a two-fold increase in LFA-1 
expression can be achieved upon cytokine treatment of leukocytes with IL-2 or IFNy 
[146] However, expression of the ligands of integrins is also affected by cytokines 
Stimulation of endothelium with IL-1, IL-4, IFNy or TNFa results in an enhanced 
expression of ICAM-1, VCAM-1, MAdCAM and E-selectin, although with different 
kinetics For example, stimulation of endothelium with TNFa results in a maximal 
expression of E-selectin at 4 hours, after which it declines In contrast, ICAM-1 is 
maximally expressed at 24 hours and remains at this expression level for at least 72 hours 
[83-85,147-149] Other ligands, such as ICAM-2 and ICAM-3 are less sensitive to 
inflammatory cytokines Furthermore, differences in glycosylation may also contribute to 
the capacity of adhesion receptors to bind their ligands It has been shown that de-
glycosylated ICAM-1 binds better to Mac-1 than to LFA-1 [107,150] Finally, expression 
19 
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Π) Modulation of affinity and/or avidity to regulate lymphocyte adhesion 
Four different processes can be distinguished in the modulation of the affinity and/or 
avidity of adhesion receptors 1) 'inside-out' signaling, 2) conformational changes, 3) 
clustering of the adhesion receptor and 4) adhesion cascades 
Figure 4. Activation and inactivation of integrins through 'inside-out' signaling activates 
the receptor by inducing a conformational change Clustering of the receptor results in 
strong hgand binding Occupation of the receptor by hgand can generate intracellular 
signals, called 'outside-in' signaling 
1) Affinity/avidity modulation of inte grim through 'iwide-out' signaling 
On most cells, integrins do not bind their hgands unless they become activated by 
intracellular signals, so called 'inside-out' signaling (Figure 4) In vitro, 'inside-out' signaling 
and LFA-1 mediated adhesion can be induced by triggering with the phorbol ester PMA, 
which activates protein kinase С (PKC) A number of leukocyte surface receptors can 
activate LFA-1 through G proteins or protein tyrosine kinases (PTKs) [152] These 
receptors activate PKC and increase intracellular calcium levels ([Ca2 +],) as a result of 
phosphohpase Cy (PLCyJ-mediated inositol breakdown Elevation of intracellular cAMP 
levels and influx of intracellular Ca 2 + , and lipids (e g íntegrin modulating factor, IMF) 
have been demonstrated to activate LFA-1[153,154] LFA-1 can also be activated by 
cross-linking of the Τ cell receptor/CD3 complex with antibodies directed against CD3 or 
20 
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by TCR ligation by peptides in the context of the major histocompatibility complex type I 
or II [155,156] Antibody cross-linking of CD2 [156], ICAM-3 [95,96,157], CD7 [158], 
CD28 [158], CD19 [159], CD43 [160], CD44 [161], CD45 [162,163], Τ cell activation 
antigen (TABS) [164], and many other leukocyte surface receptors have also shown to 
activate LFA-1 Most of the 'inside-out' signaling events, discussed above, are not specific 
for LFA-1 activation, but are also involved in activation of βι, βγ and other β2 ïntegnns 
2) Conformational changes of inte grins 
There is accumulating evidence that activation of ïntegnns coincidences with 
alterations in the conformation of the integrin First, divalent cations have been implicated 
in a change in conformation of ïntegnns, as demonstrated by alterations in ligand binding 
affinity of βι and ß2 ïntegnns when Mn2+ has bound extracellularly [165] Furthermore, 
several unique monoclonal antibodies have been described to report multiple 
conformations of ïntegnns on the cell surface These include (Figure 5) A) Activating 
antibodies that bind to the integrin and thereby activate the integrin, B) Reporter 
antibodies that recognize an active conformation of the integrin, and C) Ligand induced 
binding sites (LIBS), formed after binding of ligand 
A) Activating antibodies that bind to the extracellular domain of the integrin and 
thereby activate the integrin are known for βι, β2 and ββ ïntegnns Fab fragments of most 
of these antibodies induce adhesion as well, indicating that these antibodies do not 
activate ïntegnns by cross-linking, but rather stabilize an active conformation of the 
molecule Some of the integrin activating antibodies are KIM 185 [166], CBR LFA-1/2 
[167] directed against the β2 subunit, MEM83 directed against (XL subunit [130], LIBS6 
directed against anbß3 [168], D33C directed against the аць subunit [169] and 8A2 [170] 
and TS2/16 directed against the ßi subunit [171,172] 
B) Reporter antibodies that recognize an active conformation of the integrin and are 
non-reactive with low affinity integrin receptors, are for example 15/7 which recognizes a 
ligand-occupied conformation of βι ïntegnns [173] and the PAC-1 antibody which 
recognizes anbßi molecules that have a high affinity for their ligand fibnnogen [174] 
C) LIBS epitopes are only expressed after ligand has bound [29] Antibodies that 
recognize such neo-epitopes are D3, directed against аць [175,176], LIBS1 directed 
against ß3 [177] and the M24 antibody which recognizes a Mg2+ dependent epitope on 
the α subunit of LFA-1, after binding of ICAM-1 [178] One novel LIBS is recognized by 
the monoclonal antibody 9EG7, directed against the βι subunit [179] 9EG7 detects the 
ligand-bound conformation of β ι ïntegnns However, there is no expression of the 9EG7 
epitope when βι ïntegnns are activated by the βι activating antibody TS2/16, suggesting 
that expression does not always correlate with integrin activation 
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A) Activating antibodies 
"Ml 
B) Reporter antibodies that recognize 
an active conformation of the integrin 
Figure 5. Affinity modulation of 
integrins by conformational 
changes in the adhesion receptor 
These intramolecular alterations in 
the adhesion receptor are 
recognized by different types of 
antibodies 
C) Ligand induced binding sites (LIBS) 
1t-t 
3) Clustering of adhesion receptors 
Integnn-ligand interaction can also be regulated by changing the cell surface 
distribution (avidity) of the integrin Clustering of CR3 receptors has been reported to 
correlate with Us ability to bind ligand [180] Also clustering of LFA-1 adhesion receptors 
on the cell surface has been shown to facilitate ICAM-1 interaction C a 2 + has been 
implicated in clustering of LFA-1 Using the antibody NKI-L16 which reports binding of 
C a 2 + to LFA-1, evidence has been obtained that binding to LFA-1 is associated with 
multimerization of LFA-1 on the surface of activated Τ cells (Figure 6) [181] Cations have 
also been shown to affect the distribution of рз integrins, suggesting that the regulation of 
integnn clustering by cations is a general mechanism In addition, chemokines can regulate 
adhesion receptor redistribution on leukocytes interacting with endothelium and ECM 
[182] Clustering of integrin receptors results in an increased avidity of the integrin for 
IbV 
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binding its ligand extracellularly, as demonstrated in chapter 4 of this thesis Besides 
enhanced adhesion, clustering of integnns also results in intracellular signals, which will be 
discussed in section III) Post-hgand signaling through adhesion receptors, in this 
introduction 
Figure 6. Clustering of LFA-1 
depends on the presence of calcium 
and is characterized by expression 
of an unique epitope, which is 
detected by the antibody NKI-L16 
4) Adhesion cascade 
More evidence has been obtained that demonstrates that multiple adhesion receptor-
ligand pairs act in a sequential and overlapping manner For example leukocyte adhesion 
to endothelia in inflamed tissue is a multi-step process and is determined by series of 
sequential molecular events, rather than by a single molecular interaction [11,12,183,184] 
(also see section Cell adhesion in the immune system, and Figure 2) 
Ш) Post-ligand signaling through adhesion receptors 
Besides regulation of the adhesion receptor by signals generated inside the cell, 
increasing evidence has been obtained that adhesion receptors can also transmit signals 
into the cell This so called 'outside-in' signaling by integnns (Figure 4) has been identified 
by monoclonal antibodies or immobilized hgands to cross-link specific integnn receptors 
Cross-linking of LFA-1 by antibodies triggers phosphorylation of phosphohpase C-
γΐ (PLC-γΙ) and phosphorylation of an 80 kD protein [185] Furthermore, LFA-1 cross-
linking results in a rise in intracellular Ca 2 + levels and pH in lymphocytes, which is also 
observed when CR3 or осцьРт are clustered with antibodies [186-190] Plating of human 
endothelial cells on anti-βι antibodies or on fibronectin/vitronectin also enhances 
intracellular Ca 2 + levels, whereas clustering of ßi integnns with antibodies in solution has 
no such effect [191] A rise in intracellular Ca2+ seems to be regulated differentially by 
several integnns Adhesion to vitronectin or anti-ocvß3 antibodies, but not adhesion to 
collagen or ct2ß] antibodies, results in enhanced concentrations of intracellular Ca2+ [81] 
In contrast, integri η adhesion to collagen, laminin, fibronectin and vitronectin all induce 
elevation of intracellular pH [192,193] Clustering of ßi integnns on the surface of 
carcinoma cells seems also to induce phosphorylation of a complex of proteins of 
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The cytoskeleton and integrin function 
The cytoskeleton is a network composed of different filamentous proteins, extending 
throughout the cytoplasm It is present in all eukaryotic cells and facilitates changes in cell 
shape and coordinates and directs movements of the cell It provides the machinery for 
intracellular movements, such as segregation of chromosomes at mitosis, and play an 
important role in positioning membrane-bound organelles within the cytoplasm [213,214] 
The cytoskeleton is composed of three types of protein filaments 1) actin filaments, 2) 
microtubules and 3) intermediate filaments 
The actin filaments or microfilaments are two-stranded helical polymers of the protein 
actin Actin filaments are flexible structures, with a diameter of 5-9 nm, organized into a 
variety of linear bundles, two-dimensional networks and three-dimensional gels [215-218] 
Although expressed throughout the cell, actin filaments are most highly concentrated in 
the cortex, just beneath the plasma membrane 
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Microtubules are long, hollow cylinders made of tubulin, with a diameter of 25 nm. 
They are more rigid than actin filaments. Microtubules are long and straight and typically 
have one end attached to a single microtubule organizing center called a centrosome [219-
224]. 
Intermediate filaments are rope-like fibers with a diameter of around 10 nm, they are 
made of intermediate filament proteins, which constitute a large and heterogeneous family. 
Some of the intermediate filaments form a meshwork called the nuclear lamina just beneath 
the inner nuclear membrane. Other types extend across the cytoplasm, providing 
mechanical strength to cells and carrying the mechanical stresses in an epithelial tissue by 
spanning the cytoplasm from one cell-cell junction to another [225-230]. The actin 
cytoskeleton or cortical cytoskeleton will be discussed in more detail, since this comprises 
the cortical cytoskeleton to which integrins are linked in the cell membrane. 
Actin is important in movements of cells, in particular the leading edge of moving 
cells contain actin filaments that are continually polymerizing. For example, in culture, the 
leading edge of a crawling fibroblast regularly extends thin, sheet-like processes known as 
lamellipodia, which contain dense meshworks of actin filaments. Filopodia are thinner and 
longer protrusions formed by moving cells (especially in neuronal growth cones), and 
contain loose bundles of actin filaments [231]. Because the dynamic cortical meshwork of 
actin filaments rearranges rapidly in response to signals from outside the cell, the actin-
cytoskeleton can be considered to be an integral part of the cell's signal transduction 
system. For example, G proteins have also been implicated in the signaling processes that 
activate the actin cortex during cell locomotion, and distinct members of the rho subfamily 
of the Ras superfamily of GTP-binding proteins have been shown to differently affect the 
actin cytoskeleton organization in fibroblasts [232]. For example, cdc42 when micro-
injected has shown to induce filopodia, whereas Rac induces lamellipodia formation, and 
Rho leads to the appearance of large bundles of actin filaments known as stress fibers, and 
to the enhancement of focal adhesion complexes (Discussion, Figure 1) [233-235]. 
The cortical actin filaments are organized into three general types of arrays 
[236,237]: 1) in parallel bundles, as found in filopodia, where they have the same polarity 
and are closely spaced; 2) in contractile bundles, as in stress fibers; and 3) in the gel-like 
networks of the cell cortex, where they are arranged in a relatively loose, open array with 
many orthogonal interconnections. Actin filament cross-linking proteins play an important 
role in maintaining the architecture of the different organizations of the cortical actin 
filaments. For example fimbrin and a-actinin are widely distributed bundling proteins and 
oc-actinin (concentrated in stress fibers) and talin (another cytoskeletal protein) have been 
demonstrated to associate with the cytoplasmic domain of the integrin β subunits, 
coupling integrins to the actin cytoskeleton [238-243]. Since talin can also bind to 
vinculin and vinculin can bind a-actinin, this suggests that integrins are attached to the 
25 
Chapter 1 
actin cytoskeleton by distinct cytoskeletal proteins Other actin binding and bundling 
proteins are paxilhn, filamin and spectrin These proteins are also implicated in integrin 
function [244-246] Many of the cytoskeletal proteins discussed here can be found in 
structures called focal adhesion complexes (FACs), that are implicated in integnn function 
Accumulation of cytoskeletal proteins, such as α-actinin, F-actin, vincuhn, paxilhn, talin 
and filamin, into FACs requires a combination of both aggregation of the integnn receptor 
by antibodies and ligand binding [244] This demonstrates that redistribution of 
cytoskeletal components is important, during activation and ligand binding of integrine 
In conclusion, focal adhesion complexes are specialized structures in the cell 
membrane consisting of the cytoplasmic tail of integrins, different cytoskeletal proteins, 
protein tyrosine kinase (PTKs) and many other signaling molecules Binding of the 
extracellular domain of the integnn to its ligand results in association of the short integnn 
cytoplasmic domains with cytoplasmic proteins and the cytoskeleton Subsequently, 
cytoplasmic proteins interact with other cytoskeletal proteins and different protein 
tyrosine kinases, resulting in a cascade of intracellular signals 
The importance of the cortical cytoskeleton in integnn function will be discussed in 
chapter 6 
Regions in the α and β cytoplasmic tail important for integrin function 
The term integnn was coined to indicate that these molecules integrate the activities 
of the extracellular matrix and the cytoskeleton Therefore, integrins must be able to 
transmit signals from outside the cell to the inside The cytoplasmic tail of the integrin is the 
window through which these signals are transmitted It is the cytoplasmic tail that 
associates with different cytoskeletal proteins and triggers accumulation and activation of 
several signaling elements at the site where the integnn has bound ligand In addition, the 
altered association of the integnn with cytoskeletal proteins and signaling elements can 
influence the extracellular conformation ol the integnn 
To investigate the regulation of integnn function and the role of the cytoplasmic tail 
in this process many studies have been performed, in which parts of the cytoplasmic tail 
were deleted, or chimeric proteins were designed of which one part of the cytoplasmic tail 
of an integrin was replaced for another Also mutations of amino-acid residues in the 
cytoplasmic tail were performed to identify residues within the cytoplasmic tail that are 
involved in integrin binding, distribution and association with signaling components or 
cytoskeletal proteins (Table III) 
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Table Ш. Possible functions for the cytoplasmic tail of integrins 
1) Association with cytoskeletal proteins (e.g. tensin, talin, paxillin, vinculin and a-
actinin) 
2) Interaction or phosphorylation of signaling components such as protein kinases and 
phosphatases (e.g. p59 I L K, ppl25 F A K and CD45) 
3) Controling the avidity of integrins through the extracellular conformation of the 
integrin (clustering) 
4) Modulation of the ligand-binding affinity of integrins 
1) Role of the cytoplasmic domain of the α chain in integrin function 
Several deletion studies suggest that the N-terminal GFFKR sequence, which is 
highly conserved among different integrin α subunits, is important in the regulation of the 
affinity of integrins. Disruption of this sequence in аць by truncation, deletion, or 
substitution results in a high affinity receptor (Figure 8) [247]. Deletion of the GFFKR 
motif in <XLß2 results in lower levels of membrane expression, which is caused by increased 
retention of αβ complexes in the Golgi apparatus. It also results in reduced dimerization 
and stability of αι,β2 [248]. However, chimeric ccnbß3 complexes, containing the 
intracellular CCLß2 domain of which the GFFKR motif is disrupted or deleted, show high 
affinity ligand binding, despite low expression levels of the chimeric integrin complex 
[141]. Truncation of the α cytoplasmic domain directly after the conserved GFFKR 
sequence results in a low affinity state of the integrin receptor, as has been shown for the 
«2 [249], 0C4 [250], ció [251] and av [252] subunit, and is not sensitive to stimulation with 
PMA. 
Constructs that consist of the extracellular part of аць joined to the cytoplasmic tail 
of CC2, 0x5 or 0C6 resulted in a receptor that bound ligand constitutively [247]. In contrast, а 
chimera containing а , ам or OIL cytoplasmic sequences were inactive [253]. 
Recently, the nuclear protein calreticulin, a negative regulator of gene expression, 
was found to bind directly to the GFFKR motif [254-257]. Antisense oligonucleotide 
down-regulation of calreticulin led to a decrease in integrin-mediated cell attachment and 
spreading [258]. Treatment of cells with anti-calreticulin antibody resulted in a significant 
and specific inhibition of 0C2ß] -mediated adhesion to collagen I, indicating that 
translocation of calreticulin from the nucleus to the cell membrane might be involved in 
integrin activation and stabilizing the high affinity state of 0C2ßi [257]. 
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General Introduction 
Furthermore, studies with chimeric ai, containing either the 0:5 or 04 cytoplasmic tail, 
reveal that hgand avidity is not affected by the cytoplasmic domain of the α subunit, 
whereas it does affect the post-ligand binding function of integrins, suggesting different 
roles for integrin α subunit cytoplasmic domains in post-ligand binding events [259] 
In conclusion, the conserved GFFKR sequence is of most importance for the affinity 
modulation of integrins Deletion or destruction of the GFFKR sequence results in a high 
affinity integrin receptor, whereas truncations directly after this sequence result in a low 
affinity receptor How this affinity modulation is exactly regulated is not known, although 
calreticulin binding to the GFFKR sequence could have a possible role in this process 
2) Role of the cytoplasmic domain of the β chain in integrin function 
Similar to the cytoplasmic tail of the α chain, deletion and mutation studies have 
been performed to investigate the role of the cytoplasmic domain of the β subunit in 
integrin function In addition, peptides or chimeric proteins of integrin β subunits, 
containing either an irrelevant domain or a distinct extracellular β subunit, have been used 
to study the role of the cytoplasmic tail of the β subunit 
Overexpression of chimeric integrins containing the intracellular domain of either the 
ßl or ß3 subunit joined to the extracellular domain of the IL-2 cytokine, in cells that also 
express chimeric integrins that contain the extracellular domains of ocnbß3 and the 
cytoplasmic domains of α^βι, resulted in reduced binding of the PAC-1 antibody, which 
reports the activation state of ccnbß3> whereas IL-2 chimeras containing the cytoplasmic 
domain of as or аць lacked this inhibitory activity [260] Furthermore, the IL-2/as chimera 
was expressed diffusely on the plasma membrane, whereas the IL-2/βι chimera co-
localized with the endogenous fibronectin receptors at focal contacts, when cells were 
bound to fibronectin, indicating that these chimeras behave like ligand-occupied receptors, 
even though the IL-2/βι chimeras themselves cannot bind extracellular hgand [261] 
Comparison of chimeric integrin proteins containing the extracellular domain of ßi and the 
intracellular domain of ßs (ßj/ßs), with normal ßi (in α^βι) in CHO cells, has demonstrated 
that the ßi/ßs chimera is unable to localize into focal adhesion complexes (FAC) when 
CHO cells are spread on fibronectin Furthermore, only ßi-CHO cells showed increased 
proliferation, whereas ßi/ßs-CHO cells were notably more migratory, in response to 
fibronectin and an integrin-activating antibody These results indicate that distinct 
cytoplasmic ß-domains can translate similar adhesive information into highly contrasting 
subsequent events [262], creating an enormous diversity in integrin function 
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General Introduction 
The cytoplasmic domain of integrin β subunits can directly interact with the 
cytoskeleton and p p l 2 5 F A K Both talin and α-actinin have been demonstrated to 
associate with the cytoplasmic domain of β subunits [238-243] Peptides of the βι 
cytoplasmic tail reveal that paxillin and ppl25 F A K bind to the membrane proximal part of 
the βι integrin cytoplasmic tail (Figure 8 KLLMIIHDRREFA) [263] 
In vitro, LFA-1 mediated adhesion can be induced by triggering with the phorbol 
ester PMA, which activates protein kinase С (PKC), resulting in phosphorylation of serine 
at position 756 in the cytoplasmic tail of the ß2 subunit However, mutation of the serine 
residues in the cytoplasmic tail of ß2 have shown that phosphorylation is not crucial for 
the affinity modulation of LFA-1 [142] A conserved region (EYRRFEKE), N-terminal of 
the ß2 cytoplasmic tail, seems to be critical not only for interaction with the cytoskeleton 
(as shown by the diffuse cell distribution when this region is deleted), but also for 
endoplasmic reticulum retention, assembly, and transport to the cell membrane of LFA-1 
[248] Deletion of a stretch of five amino-acids containing the three threonines and 
phenylalanine in the C-terminal part of the ß2 cytoplasmic domain are obligatory for LFA-
1/ICAM-l binding (Figure 8) [142,264] Mutation of the threonines resulted also in 
impaired spreading, and decreased ability to form focal adhesion complexes (FACs) and to 
organize the cytoskeleton into stress fibers [265] Deletion of the C-terminal part of the ß7 
cytoplasmic tail abrogated hgand-binding activity, whereas truncation of the complete 
cytoplasmic tail resulted in constitutively active affi integrins [266] More or less the 
same was observed for ßi integrins Moderately long truncations of βι cytoplasmic 
domain abrogated localization into FACs, whereas complete truncations caused weak 
localizations into FACs [267-269] 
Point mutations in the βι cytoplasmic tail revealed three clusters of amino-acids 
which contribute to localization in FACs [270] One cluster, located near the plasma 
membrane, is a stretch of 11 amino-acids (DRREFAKFEKE) conserved between integrin β 
subunits (except β4) and affects heterodimer affinity and specificity, as already 
demonstrated for the β2 cytoplasmic tail (Figure 8) [248,270] Deletion of 7 amino-acids 
(LITIHDR) more N-terminal of this cluster (also containing the D and R of the first cluster) 
also specifies ligand binding affinity in the βι cytoplasmic tail [270] It has been proposed 
that both the conserved membrane-proximal region of the β (KLLvXIhDRRE less 
conserved amino-acids are in the lower case, X indicates a non-conserved residue) and of 
the α (GFFKR) cytoplasmic domains bind to each other, since there appear to be 
interactions between the two integrin subunits in synthetic neo-protein mimics of the 
integrin cytoplasmic face [271] Furthermore, deletion of these conserved regions has 
shown to result in increased ligand binding affinity, suggesting that the conserved 
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membrane-proximal region of the integrin cytoplasmic domains may serve to constrain 
these receptors into a default low affinity conformation [272]. 
Another cluster is a conserved NPXY motif and has also been implicated in 
regulation of integrin binding affinity and localization in FACs [270,273,274], whereas the 
third cluster is a non-conserved NPKY motif, implicated in regulation of integrin function 
[270]. 
In conclusion, FACs are specialized structures in the cell membrane consisting of the 
cytoplasmic tail of integrins, different cytoskeletal proteins, protein tyrosine kinases (PTKs) 
and many other signaling molecules. The intracellular signals derived from integrin/ligand 
binding synergize with intracellular signals derived from other receptor systems (e.g. 
growth factor receptors) to regulate cell proliferation, motility, secretion and other cellular 
events [239,244,275-278]. 
Introduction to the chapters 
The aim of this thesis is to determine the role of the cytoskeleton and the cytoplasmic 
domains of integrins in the regulation of LFA-1 mediated adhesion in leukocytes and non-
leukocytes. Chapter 2 describes how two ß2 integrins (LFA-1 and Mac-1), that bind a 
similar ligand (ICAM-1), communicate with each other and allow the cell to preferentially 
use LFA-1 to adhere to ICAM-1. The function of LFA-1 as signaling molecule, transmitting 
extracellular signals into the cell and vice versa, in normal and malignant Τ cells is 
described in chapter 3. Chapter 4 discusses the role of the actin cytoskeleton in the cell 
surface distribution of LFA-1, and its implication in LFA-1 and βι mediated adhesion. In 
this chapter, data are integrated into a model that highlights the role of the cytoskeleton in 
the regulation of LFA-1. The role of the cytoplasmic domain of the β subunit of LFA-1 in 
LFA-1 mediated adhesion to ICAM-1 is discussed in chapter 5. In this chapter, the 
signaling function of β2 integrins is compared to βι and ß7 integrins, and demonstrates 
that leukocyte specific regulatory elements may play an important role in ß2 adhesion 
mediated adhesion. 
32 
General Introduction 
REFERENCES 
1 Rosales, С , V Obrien, L Kornberg, and R Juliano 1995 Signal transduction by cell 
adhesion receptors Bba-Rev Cancer 1242 77-98 
2 Springer, Τ A 1990 Adhesion receptors of the immune system Nature 346 425-434 
3 McEver, R Ρ 1994 Selectins Curr Opin Immunol 6 75-84 
4 Nakajima, Η , Η Sano, Τ Nishimura, S Yoshida, and I Iwamoto 1994 Role of Vascular 
Cell Adhesion Molecule- 1/Very Late Activation Antigen-4 and Intercellular Adhesion 
Molecule-1/Lymphocyte Function-Associated Antigen-1 Interactions in Antigen-Induced 
Eosinophil and T-Cell Recruitment into the Tissue J Exp Med 179 1145-1154 
5 Alon, R , Ρ D Kassner, M W Carr, Ε В Finger, Μ E Hemler, and Τ Α Springer 
1995 The întegrin VLA-4 supports tethering and rolling in flow on VCAM-1 J Cell Biol 
128 1243-1253 
6 Berlin, С , R F Bargatze, J J Campbell, U H Vonandnan, M С Szabo, S R Hasslen, 
R D Nelson, E L Berg, S L Erlandsen, and E С Butcher 1995 alpha-4 Integrins 
mediate lymphocyte attachment and rolling under physiologic flow Cell 80 413-422 
7 Murphy, Ρ M 1994 The molecular biology of leukocyte chemoattractant receptors Annu 
Rev Immunol 12 593-633 
8 Butcher, E C 1991 Leukocyte-endothehal cell recognition three (or more) steps to 
specificity and diversity Cell 67 1033-1036 
9 Tanakd, Y , D H Adams, S Hubscher, H Hirano, U Siebenlist, and S Shaw 1993 T-
cell adhesion induced by proteoglycan-immobihzed cytokine МІР-1-beta Nature 361 79-82 
10 Imhoi", В A and D Dunon 1995 Leukocyte migration and adhesion Advances in 
Immunology Vol 5 58 345-416 
11 Hogg, N and С Berlin 1995 Structure and function of adhesion receptors in leukocyte 
trafficking Immunol Today 16 327 330 
12 Mackay, С 1995 Lymphocyte migration A new spin on lymphocyte homing Curr Biol 5 
733-736 
13 Rosales, С and R L Juliano 1995 Signal transduction by cell adhesion receptors in 
leukocytes J Leukocyte Biol 57 189-198 
14 Stewart, Μ , M Thiel, and N Hogg 1995 Leukocyte integrins Curr Opin Cell Biol 7 
690-696 
15 Hynes, R О 1987 Integrins A family of cell surface receptors Cell 48 549-554 
16 Wang, N, J Ρ Butler, and D E Ingber 1993 Mechanotransduction across the cell surface 
and through the cytoskeleton [see comments] Science 260 1124 1127 
17 Plow, E F , J С Loftus, E G Levin, D S Fair, D Dixon, J Forsyth, and M H 
Ginsberg 1986 Immunologic relationship between platelet membrane glycoprotein 
GPIIb/IIIa and cell surface molecules expressed by a variety of cells Prot Natl Acad Sci 
U S A S3 6002-6006 
18 Gurtner, G С , V Davis, Η Μ Li, Μ J Mccoy, A Sharpe, and M I Cybulsky 1995 
Targeted disruption of the murine VC AMI gene Essential role of VCAM-1 in chorioallantoic 
fusion and pldcentation Gene Develop 9 1-14 
19 Pyszmak, A M , C A Welder, and F Takei 1994 Cell surface distribution of high-avidity 
LFA 1 detected by soluble ICAM-1-coated microspheres J Immunol 152 5241-5249 
20 Goodman, S L , M Aumailley, and H von der Mark 1991 Multiple cell surface receptors 
for the short arms of laminin alpha 1 beta-1 integrin and RGD-dependent proteins mediate 
cell attachment only to domains III in murine tumor lammin J Cell Biol 113 931-941 
21 Lallier, Τ , R Deutzmann, R Perns, and M Bronnerfraser 1994 Neural Crest Cell 
Interactions with Laminin - Structural Requirements and Localization of the Binding Site for 
alpha 1 beta-1 lntegnn Dev Biol 162 451-464 
22 Elices, M J and Μ E Hemler 1989 The human integrin VLA 2 is a collagen receptor on 
some cells and a collagen/laminin receptor on others Prot Natl Acad Sci U S A 86 
9906 9910 
23 Yuan, Q , W M Jiang, D Hollander, E Leung, J D Watson, and G W Knssansen 
1991 Identity between the novel integrin beta 7 subunit and an antigen found highly 
33 
Chapter 1 
expressed on intraepithelial lymphocytes in the small intestine. Biochem. Biophys. Res. 
Commun. 176: 1443-1449. 
24. Kirchhofer, D., L. R. Languino, E. Ruoslahti, and M. D. Pierschbacher. 1990. Alpha-2 bela-
1 integrins from different cell types show different binding specificities. J. Biol. Chem. 265: 
615-618. 
25. Takada, Y., E. Murphy, P. Pil, С. Chen, M. H. Ginsberg, and M. E. Hemler. 1991. 
Molecular cloning and expression of the cDNA for alpha-3 subunit of human alpha-3 beta-1 
(VLA-3), an integrin receptor for fibronectin, laminin, and collagen. J. Cell Biol. 115: 257-
266. 
26. Ylanne, J., D. A. Cheresh, and I. Virtanen. 1990. Localization of beta-1, beta-3, alpha-5, 
alpha-v, and alpha-lib subunits of the integrin family in spreading human erythroleukemia 
cells. Blood 76: 570-577. 
27. Altevogt, P., M. Hubbe, M. Ruppert, J. Lohr, P. von Hoegen, M. Sammar, D. P. Andrew, 
L. McEvoy, M. J. Humphries, and E. С Butcher. 1995. The alpha-4 integrin chain is a 
ligand for alpha-4 beta-7 and alpha-4 beta-1. J. Exp. Med. 182: 345-355. 
28. Takada, Y., С Huang, and M. E. Hemler. 1987. Fibronectin receptor structures in the VLA 
family of heterodimers. Nature 326: 607-609. 
29. Diamond, M. S. and T. A. Springer. 1994. The dynamic regulation of integrin adhesiveness. 
Curr. Biol. 4: 506-517. 
30. Ruppert, M., S. Aigner, M. Hubbe, H. Yagita, and P. Altevogt. 1995. The LI adhesion 
molecule is a cellular ligand for VLA-5. J. Cell Biol. 131: 1881-1891. 
31. Sonnenberg, Α., P. W. Modderman, and F. Hogervorst. 1988. Laminin receptor on platelets 
is the integrin VLA-6. Nature 336: 487-489. 
32. Hall, D. E., L. F. Reichardt, E. Crowley, B. Holley, H. Moezzi, A. Sonnenberg, and С Η. 
Damsky. 1990. The alpha-1 beta-1 and alpha-6 beta-1 integrin heterodimers mediate cell 
attachment to distinct sites on laminin. J. Cell Biol. 110: 2175-2184. 
33. Marlin, S. D. and T. A. Springer. 1987 Purified intercellular adhesion molecule-1 (ICAM-1) 
is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51: 813-819. 
34. Staunton, D. E., M. L. Dustin, and T. A. Springer. 1989. Functional cloning of ICAM-2, a 
cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 339: 61-64. 
35. Vazeux, R., P. A. Hoffman, J. K. Tornita, E. S Dickinson, R. L. Jasman, T. Stjohn, and 
W. M. Gallatin. 1992. Cloning and characterization of a new intercellular adhesion molecule 
ICAM-R. Nature 360: 485-488. 
36. Fawcett, J., С L. Holness, L. A. Needham, H. Turley, К. С Gatter, D. Y. Mason, and D. 
L. Simmons. 1992. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively 
expressed on resting leukocytes. Nature 360: 481-484. 
37. de Fougerolles, A. R., L. B. Klickstein, and T. A. Springer. 1993. Cloning and expression 
of intercellular adhesion molecule 3 reveals strong homology to other immunoglobulin family 
counter- receptors for lymphocyte function-associated antigen 1. J. Exp. Med. ill: 1187-
1192 
38. de Fougerolles, A R. and Τ A. Springer. 1992. Intercellular adhesion molecule 3, a third 
adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting 
lymphocytes. J. Exp. Med. 175: 185-190. 
39. Wright, S. D., P. E. Rao, W. С Van Voorhis, L. S. Craigmyle, K. Iida, M. A. Talie, E. F. 
Westberg, G. Goldstein, and S. С. Silverstein. 1983. Identification of the C3bi receptor of 
human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. 
U S. Α. 80: 5699-5703 
40. Lecoanethenchoz, S., J. F. Gauchat, J Ρ Aubry, P. Graber, P. Life, N. Pauleugene, B. 
Ferma, Α. L. Corbi, В. Dugas, С. Platerzyberk, and J. Y. Bonnefoy. 1995. CD23 regulates 
monocyte activation through a novel interaction with the adhesion molecules CD1 lb/CD 18 
andCDllc/CD18 Immunity. 3: 119-125 
41. Altieri, D. C. and T. S. Edgington. 1988. The saturable high affinity association of factor X 
to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J. Biol. Chem 
263:7007-7015. 
34 
General Introduction 
42 Wright, S D , J I Weitz, A J Huang, S M Levin, S С Silverstein, and J D Loike 
1988 Complement receptor type three (CDllb/CD18) of human polymorphonuclear 
leukocytes recognizes fibrinogen Proc Natl Acad Sci USA 85 7734-7738 
43 Smith, С W , S D Marlin, R Rothlein, С Toman, and D С Anderson 1989 
Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in 
facilitating adherence and transendothehal migration of human neutrophils in vitro J Clin 
Inven 83 2008-2017 
44 Diamond, M S , R Alon, С A Parkos, Μ Τ Quinn, and Τ A Springer 1995 Heparin is 
an adhesive hgand for the leukocyte mtegnn Mac 1 (CD1 lb/CD18) J Cell Biol 130 1473-
1482 
45 Davis, D E 1992 The Mac-1 and pl50,95 beta-2 integrins bind denatured proteins to 
mediate leukocyte cell-substrate adhesion Exp Cell Rei 200 242-252 
46 Moyle, M , D L Foster, D E McGrath, S M Brown, Y Laroche, J De Meutter, Ρ 
Stanssens, С A Bogowitz, V A Fried, J A Ely, and et al 1994 A hookworm 
glycoprotein that inhibits neutrophil function is a hgand of the integrin CD1 lb/CD 18 J Biol 
Chem 269 10008-10015 
47 Rieu, Ρ , Τ Ueda, 1 Haruta, С Ρ Sharma, and M A Arnaout 1994 The Α-domain of 
beta-2 integrin CR3 (CDllb/CD18) is a receptor for the hookworm-derived neutrophil 
adhesion inhibitor NIF J Cell Biol 127 2081-2091 
48 Wachtfogel, Υ Τ , R A Delacadena, S Ρ Kunapuli, L Rick, M Miller, R L Schultze, 
D С Altieri, Τ S Edgington, and R W Colman 1994 High molecular weight kininogen 
binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5) J 
Biol Chem 269 19307-19312 
49 Ingdlls, R R and D Τ Golenbock 1995 CDllc/CD18, a transmembrane signaling 
receptor for lipopolysacchande J Exp Med 181 1473-1479 
50 DSouza, S E , M H Ginsberg, G R Matsueda, and E F Plow 1991 A discrete 
sequence in a platelet integrin is involved in hgand recognition Nature 350 66-68 
51 Vandervieren, M , H Letrong, С L Wood, Ρ F Moore, Τ Stjohn, D E Staunton, and 
W M Gallatin 1995 A novel leukointegnn, alpha-d beta-2, binds preferentially to ICAM-3 
Immunity 3 683-690 
52 Ruegg, С , A A Postigo, E E Sikorski, E С Butcher, R Pytela, and D J Erle 1992 
Role ot integrin alpha-4 beia-7/alpha-4 beta Ρ in lymphocyte adherence to fibronectin and 
VCAM-1 and in homotypic cell clustering J Cell Biol 117 179-189 
53 Cepek, К L , S К Shaw, С M Parker, G J Russell, J S Morrow, D L Rimm, and 
M В Brenner 1994 Adhesion between epithelial cells and Τ lymphocytes mediated by E-
cadherin and the alpha-Ε beta-7 integrin Nature 372 190 193 
54 Hemler, Μ E 1990 VLA proteins in the integrin family structures, functions, and their role 
on leukocytes Annu Rev Immunol 8 365-400 
55 Hemler, M E M J Elices, С Parker, and Y Takada 1990 Structure of the integrin VLA-
4 and its cell-cell and cell-matrix adhesion functions Immunol Rev 114 45-65 
56 Hemler, Μ E 1988 Adhesive protein receptors on hematopoietic cells Immunol Today 9 
109 113 
57 Hynes, R О 1992 Integrins Versatility, modulation, and signaling in cell adhesion Cell 69 
11-25 
58 Ruoslahti, E and M D Pierschbacher 1987 New perspectives in cell adhesion RGD and 
integrins Science 238 491-497 
59 Shimizu, Y , W Newman, Τ V Gopal, К J Horgan, N Graber, L D Beali, G A Van 
Seventer, and S Shaw 1991 Four molecular pathways of Τ cell adhesion to endothelial 
cells roles ot LFA-1, VCAM-I, and ELAM 1 and changes in pathway hierarchy under 
different activation conditions J Cell Biol 113 1203 1212 
60 Yamada, Κ M 1991 Adhesive recognition sequences J Biol Chem 266 12809-12812 
61 DeSimone, D W 1994 Adhesion and matrix in vertebrate development Curr Opin Cell 
Biol 6 747 751 
62 Yang, J T , H Rayburn, and R О Hynes 1995 Cell adhesion events mediated by alpha-4 
integrins are essential in placental and cardiac development Development 121 549-560 
35 
Chapter 1 
63 Yang, J Τ , H Rayburn, and R О Hynes 1993 Embryonic mesodermal defects in alpha-5 
integnn-deficient mice Development 119 1093-1105 
64 Stephens, L Ε , A E Sutherland, I V Khmanskaya, A Andneux, J Meneses, R A 
Pedersen, and С H Damsky 1995 Deletion of beta-1 integrins in mice results in inner cell 
mass failure and pen-implantation lethality Gene Develop 9 1883-1895 
65 Fassler, R and M Meyer 1995 Consequences of lack of beta-1 integrin gene expression in 
mice Gene Develop 9 1896-1908 
66 Hemler, M E , С Huang, and L Schwarz 1987 The VLA protein family Characterization 
of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta 
subunit J Biol Chem 262 3300-3309 
67 Jones, D A , L V Mclntire, С W Smith, and L J Picker 1994 A two-step adhesion 
cascade for Τ cell endothelial cell interactions under flow conditions J Clin invest 94 
2443-2450 
68 Sanchez-Madrid, F , A M Krensky, С F Ware, E Robbins, J L Strominger, S J 
Burakoff, and Τ A Springer 1982 Three distinct antigens associated with human T-
lymphocyte-mediated cytolysis LFA-1, LFA-2, and LFA-3 Proc Natl Acad Sci USA 
79 7489-7493 
69 Keizer, G D , J Borst, С G Figdor, H Spits, F Miedema, С Terhorst, and E De Vnes 
1985 Biochemical and functional characteristics of the human leukocyte membrane antigen 
family LFA-1, Mo-1 and ρ 150,95 Eur J Immunol 15 1142-1147 
70 Damlenko, D Μ , Ρ V Rossitto, M van der Vieren, H L Trong, S Ρ McDonough, V 
К Affolter, and Ρ F Moore 1995 A novel canine leukointegnn, alpha-d beta-2 is 
expressed by specific macrophage subpopulations in tissue and a minor CD8+ lymphocyte 
subpopulation in peripheral blood J Immunol 155 35 44 
71 Springer, Τ Α , W S Thompson, L J Miller, F С Schmalstieg, and D С Anderson 
1984 Inherited deficiency of the Mac-1, LFA-1, pl50,95 glycoprotein family and its 
molecular basis J Exp Med 160 1901-1918 
72 Anderson, D С and Τ A Springer 1987 Leukocyte adhesion deficiency an inherited 
defect in the Mac-1, LFA-1, and ρ 150,95 glycoproteins Annu Rev Med 38 175-194 
73 Kishimoto, Τ Κ , К O'Connor, A Lee, Τ Μ Roberts, and Τ A Springer 1987 Cloning 
of the beta subunit of the leukocyte adhesion proteins homology to an extracellular matrix 
receptor defines a novel supergene familiy Cell 48 681-690 
74 Todd, R F and D R Freyer 1988 The CD 11/CD 18 leukocyte glycoprotein deficiency 
Hematol Oncol Clin North Am 2 13 31 
75 Wardlaw, A J , M L Hibbs, S A Stacker, and Τ A Springer 1990 Distinct mutations in 
two patients with leukocyte adhesion deficiency and their functional correlates J Exp Med 
172 335-345 
76 DSouza, S E , M H Ginsberg, Τ A Burke, S С Lam, and E F Plow 1988 
Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor Science 
242 91-93 
77 Wright, Α Η , W A Douglass, G M Taylor, Y L Lau, D Higgins, К A Davies, and S 
К A Law 1995 Molecular characterization of leukocyte adhesion deficiency in six patients 
Eur J Immunol 25 717-722 
78 Fischer, A , R Seger, A Durandy, В Grospierre, J Virelizier, F Le Deist, С Griscelli, E 
Fischer, M Kazatchkine, M -C Bohler, В Descamps-Latscha, Ρ Trung, Τ A Springer, 
D Olive, and С Mawas 1985 Deficiency of the adhesive protein complex lymphocyte 
function antigen 1, complement receptor type 3, glycoprotein pl50,95 in a girl with recurrent 
bacterial infections J Clin Invest 76 2385-2392 
79 Kurzinger, Κ , Τ Reynolds, R N Germain, D Davignon, E Martz, and Τ A Springer 
1981 A novel lymphocyte function associated antigen (LFA-1) cellular distribution, 
quantitative expression, and structure J Immunol 127 596 602 
80 Marlz, E 1987 LFA-1 and other accessory molecules functioning in adhesions of Τ and В 
lymphocytes Hum Immunol 18 3 37 
81 Arnaout, M A 1990 Leukocyte adhesion molecules deficiency its structural basis, 
pathophysiology and implications for modulating the inflammatory response Immunol Rev 
114 145-180 
36 
General Introduction 
82 Gdrnotel, R,J С Monboisse, A Randoux, В Haye, and J Ρ Borei 1995 The binding of 
type I collagen to lymphocyte function- associated antigen (LFA)-l integrin triggers the 
respiratory burst of human polymorphonuclear neutrophils - Role of calcium signaling and 
tyrosine phosphorylation of LFA 1 J Biol Chem 270 27495-27503 
83 Dustin, M L, R Rothlein, А К Bhan, С A Dinarello, and Τ A Springer 1986 
Induction by IL 1 and interferon gamma tissue distribution, biochemistry, and function of a 
natural adherence molecule (1СAM-1) J Immunol 137 245-254 
84 Pober, J S , Μ Ρ Bevilacqua, D L Mendrick, L A Lapierre, W Fiers, and M A 
Gimbrone.Jr 1986 Two distinct monokines, ìnterleukin 1 and tumor necrosis factor, each 
independently induce biosynthesis and transient expression of the same antigen on the surface 
of cultured human vascular endothelial cells J Immunol 136 1680-1687 
85 Cotran, R S , M A Gimbronejr, Μ Ρ Bevilacqua, D L Mendrick, and J S Pober 
1986 Induction and detection of a human endothelial activation antigen in vivo J Exp Med 
164 661-666 
86 Rothlein, R , E A Mainolfi, M Czajkowski, and S D Marlin 1991 A form of circulating 
ICAM 1 in human serum J Immunol 147 3788-3793 
87 Seth, R , F D Raymond, and M W Makgoba 1991 Circulating ICAM-1 isoforms 
diagnostic prospects for inflammatory and immune disorders Lancet 338 83-84 
88 Miller, J , R Knorr, M Ferrone, R Houdei, С Ρ Carrón, and M L Dustin 1995 
Intercellular adhesion molecule 1 dimerization and its consequences for adhesion mediated by 
lymphocyte function associated-1 J Exp Med 182 1231-1241 
89 de Fougerolles, A R, S A Stacker, R Schwarting, and Τ A Springer 1991 
Characterization of ICAM-2 and evidence lor a third counter-receptor for LFA-1 J Exp 
Med 174 253-267 
90 Nortamo, Ρ , R Li, R Renkonen, Τ Timonen, J Prieto, M Patarroyo, and С G 
Gahmberg 1991 The expression of human intercellular adhesion molecule-2 is refractory to 
inflammatory cytokines Eur J Immunol 21 2629 2632 
91 Doussis-Anagnostopoulou, I, L Kaklamanis, J Cordell, M Jones, H Turley, К Pulford, 
D Simmons, D Mason, and К Gatter 1993 ICAM-3 expression on endothelium in 
lymphoid malignancy Am J Pathol 143 1040-1043 
92 Acevedo, A , M A del Pozo, A G Arroyo, Ρ Sánchez-Mateos, R Gonzales-Amaro, and 
F Sanchez-Madrid 1993 Distribution of ICAM-3 bearing cells in normal human tissues 
Am J Pathol 143 774-783 
93 Starling, G С , A D Mclellan, W Egner, R V Sorg, J Fawcett, D L Simmons, and D 
N J Hart 1995 Intercellular adhesion molecule-3 is the predominant со-stimulatory ligand 
for leukocyte function antigen I on human blood dendritic cells Eur J Immunol 25 2528-
2532 
94 Juan, M , O Vinas, M R Pinootin, L Places, E Martinezcaceres, J J Barcelo, A 
Miralles, R Vilella, M A Delafuente, J Vives, J Yague, and A Gaya 1994 CD50 
(intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine 
phosphorylation through p59(fyn) and p56(lck) in Jurkat Τ cell line J Exp Med 179 1747-
1756 
95 Campanero, M R , Ρ Sánchez-Mateos, M A Delpozo, and F Sanchez-Madrid 1994 
ICAM-3 regulates lymphocyte morphology and integrin- mediated Τ cell interaction with 
endothelial cell and extracellular matrix ligands J Cell Biol 127 867-878 
96 Cid, M С , J Esparza, M Juan, A Miralles, J Ordì, R Vilella, A Urbanomarquez, A 
Gaya, J Vives, and J Yague 1994 Signaling through CD50 (ICAM-3) stimulates Τ 
lymphocyte binding to human umbilical vein endothelial cells and extracellular matrix proteins 
via an increase in beta-1 and beta 2 integrin function Eur J Immunol 24 1377-1382 
97 Pinootin, M R , O Vinas, M A Delafuente, M Juan, J Font, M Torradeflot, L Pallares, 
F Lozano, J Alberolaila, J Martorell, J Yague, J Vives, and A Gaya 1995 Existence of 
a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte 
activation - Present in normal human serum and levels are increased in the serum of systemic 
lupus erythematosus patients J Immunol 154 3015-3024 
37 
Chapter 1 
98 Miller, L J , D F Bainton, N Borregaard, and Τ A Springer 1987 Stimulated 
mobilization of monocyte Mac-1 and ρ 150,95 adhesion proteins from an intracellular vesicular 
compartment to the cell surface J Clin Invest 80 535 544 
99 Rothlein, R and Τ A Springer 1985 Complement receptor type three-dependent 
degradation of opsonized erythrocytes by mouse macrophages J Immunol 135 2668-2672 
100 Miller, L J , R Schwarting, and Τ A Springer 1986 Regulated expression of the Mac-1, 
LFA-1, ρ 150,95 glycoprotein family during leukocyte differentiation J Immunol 137 
2891-2900 
101 Bainton, D F , L J Miller, Τ К Kishimoto, and Τ A Springer 1987 Leukocyte 
adhesion receptors are stored in peroxidase-negative granules of human neutrophils J Exp 
Med 166 1641-1653 
102 Hughes, В J , J С Hollers, E Crockett-Torabi, and С W Smith 1992 Recruitment of 
CD1 lb/CD 18 to the neutrophil surface and adherence-dependent cell locomotion J Clin 
Invest 90 1687-1696 
103 Berger, M , J J O'Shea, A S Cross, Τ M Folks, Τ M Chused, E J Brown, and M 
M Frank 1984 Human neutrophils increase expression of C3bi as well as C3b receptor 
upon activation J Clin Invest 74 1566-1571 
104 Todd, R F , M A Arnaout, R E Rosin, С A Crowley, W A Peters, and В M Babior 
1984 Subcellular localization of the large subunit of Mol (Mol, formerly gpl 10), a surface 
glycoprotein associated with neutrophil adhesion J Clin Invest 74 1280-1290 
105 Beller, D I , Τ A Springer, and R D Schreiber 1982 Anti-Mac-1 selectively inhibits the 
mouse and human type three complement receptor J Exp Med 156 1000-1009 
106 Anderson, D C , R Rothlein, S D Marlin, S S Krater, and С W Smith 1990 Impaired 
transendothehal migration by neonatal neutrophils abnormalities of Mac-1 (CD1 lb/CD18)-
dependent adherence reactions Bloodlb 2613-2621 
107 Diamond, M S , D E Staunton, S D Marlin, and Τ A Springer 1991 Binding of the 
integnn Mac-1 (CD1 lb/CDI8) to the third immunoglobulin-like domain of ICAM-1 (CD54) 
and its regulation by glycosylation Cell 65 961-971 
108 Diamond, M S , D E Staunton, A R de Fougerolles, S A Stacker, J Garcia Aguilar, M 
L Hibbs, and Τ A Springer 1990 ICAM-1 (CD54) a counter-receptor for Mac-1 
(CD lib/CD 18) J Cell Biol 111 3129-3139 
109 Xie, J L , R Li, Ρ Kotovuon, С Vermotdesroches, J Wijdenes, M A Arnaout, Ρ 
Nortamo, and С G Gahmberg 1995 Intercellular adhesion molecule-2 (CD 102) binds to 
the leukocyte inlegnn CD lib/CD 18 through the A domain J Immunol 155 3619-3628 
110 Stockl, J , О Majdic, W F Pickl, A Rosenkranz, E Präger, E Gschwantler, and W 
Knapp 1995 Granulocyte activation via a binding site near the С- terminal region of 
complement receptor type 3 alpha-chain (CDlib) potentially involved in ìntramembrane 
complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) 
molecules J Immunol 154 5452-5463 
111 Corbi, A L , L J Miller, К О Connor, R S Larson, and Τ A Springer 1987 cDNA 
cloning and complete primary structure of the alpha subunit of a leukocyte adhesion 
glycoprotein, ρ 150,95 EMBO J 6 4023-4028 
112 Sastre, L , J M Roman, D В Teplow, W J Dreyer, С E Gee, R S Larson, Τ M 
Roberts, and Τ A Springer 1986 A partial genomic DNA clone for the alpha subunit of the 
mouse complement receptor type 3 and cellular adhesion molecule Mac-1 Proc Natl Acad 
Sci U S A 83 5644-5648 
113 Yavorkovsky, L L , N M Gipsh, N M Karminskaya, О Y Udris, S V Nikushin, and 
L I Yavorkovsky 1990 Hairy cell leukemia and other "hairy-cell" lymphoproliferative 
disorders (LPD-HC) the significance of morphologic, histologic and immunologic studies 
Neoplasma 37 430-444 
114 Crowley, Μ Τ , К Inaba, M D Witmer-Pack, and R M Stemman 1989 The cell surface 
of mouse dendritic cells FACS analyses of dendritic cells from different cell tissues including 
Thymus Cell Immunol 118 108 125 
115 Chadburn, A , G Inghirami, and D M Knowles 1992 Hairy cell leukemia-associated 
antigen LeuM5 (CD1 lc) is preferentially expressed by benign activated and neoplastic CD8 Τ 
cells Am J Pathol 136 29-37 
38 
General Introduction 
116 Lamer, L L , M A Arnaout, R Schwarting, N L Warner, and G Ross 1985 ρ 150,95, 
third member of the LFA- 1/CR3 polypeptide family identified by anti-Leu M5 monoclonal 
antibody Eur J Immunol 15 713-718 
117 Keizer, G D , J Borst, W Visser, R Schwarting, J E de Vries, and С G Figdor 1987 
Membrane glycoprotein ρ 150,95 of human cytotoxic Τ cell clone is involved in conjugate 
formation with target cells J Immunol 138 3130-3136 
118 Keizer, G D , A A te Velde, R Schwarting, С G Figdor, and J E de Vries 1987 Role 
of ρ 150,95 in adhesion, migration, Chemotaxis and phagocytosis of human monocytes Eur 
J Immunol 17 1317-1322 
119 Myones, В L , J G Dalzell, N Hogg, and G D Ross 1988 Neutrophil and monocyte 
cell surface ρ 150,95 has іСЗЬ-receptor (CR4) activity resembling CR3 J Clin Invest 82 
640 651 
120 Ross, R 1993 The pathogenesis of atherosclerosis a perspective for the 1990s Nature 362 
801-809 
121 Holzmann, Β , В W Mclntyre, and I L Weissman 1989 Identification of a murine 
Peyers patch—specific lymphocyte homing receptor as an integrin molecule with an alpha 
chain homologous to human VLA-4 alpha Cell 56 37-46 
122 Kilshaw, Ρ J and S J Mutant 1990 A new surface antigen on intraepithelial lymphocytes 
in the intestine Eur J Immunol 20 2201-2207 
123 Kilshaw, Ρ J and К С Baker 1988 A unique surface antigen on intraepithelial 
lymphocytes in the mouse Immunol Lett 18 149-154 
124 Cerf" Bensussan, N , A Jarry, N Brousse, В Lisowska Grospierre, D Guy Grand, and С 
Griscelli 1987 A monoclonal antibody (HML-1) defining a novel membrane molecule 
present on human intestinal lymphocytes Eur J Immunol 17 1279-1285 
125 Cepek, К L , C M Parker, J L Madara, and Μ В Brenner 1993 Integrin alpha-Ε beta-7 
mediates adhesion of Τ lymphocytes to epithelial cells J Immunol 150 3459-3470 
126 Karecla, Ρ I , S J Bowden, S J Green, and Ρ J Kilshaw 1995 Recognition of E 
Cadherin on epithelial cells by the mucosal Τ cell integrin alpha-M290 beta-7 (alpha-Ε beta-7) 
Eur J Immunol 25 852-856 
127 Tuckwell, D S , A Brass, and M J Humphries 1992 Homology modelling of integrin 
EF hands Biochem J 285 325-331 
128 Kirchhofer, D , J Grzesiak, and M D Pierschbacher 1991 Calcium as a potential 
physiological regulator of integnn-mediated cell adhesion J Biol Chem 266 4471-4477 
129 Larson, R S , A L Corbi, L Berman, and Τ Springer 1989 Primary structure of the 
leukocyte function-associated molecule-1 alpha subunit an integrin with an embedded domain 
defining a protein superfamily J Cell Biol 108 703-712 
130 Landis, R C , R I Bennett, and N Hogg 1993 A novel LFA-1 activation epitope maps to 
the I domain J Cell Biol 120 1519-1527 
131 Randi, A M and N Hogg 1994 I domain of beta-2 integrin lymphocyte function-
associated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1 J 
Biol Chem 269 12395-12398 
132 Kamata, Τ , R Wright, and Y Takada 1995 Critical threonine and aspartic acid residues 
within the I domains of beta-2 integnns for interactions with intercellular adhesion molecule 1 
(ICAM l)andC3bi J Biol Chem 270 12531 12535 
133 Michishita, M , V Videm, and M A Arnaout 1993 A novel divalent cation-binding site in 
the A domain of the beta-2 integrin CR3 (CD1 lb/CD 18) is essential for ligand binding Cell 
72 857 867 
134 Kamata, Τ , W Puzon, and Y Takada 1994 Identification of putative ligand binding sites 
within I domain of integrin alpha-2 beta-1 (VLA-2, CD49b/CD29) J Biol Chem 269 
9659-9663 
135 Fuortes, M , W W Jin, and С Nathan 1994 beta-2 integrin-dependent tyrosine 
phosphorylation of paxillin in human neutrophils treated with tumor necrosis factor J Cell 
Biol 127 1477-1483 
136 Lee, J Ο , Ρ Rieu, M A Arnaout, and R Liddington 1995 Crystal structure of the A 
domain from the alpha subunit of integrin CR3 (CDllb/CD18) Cell 80 631-638 
39 
Chapter 1 
137 Loftus, J C,J W Smith, and M H Ginsberg 1994 Integnn-mediated cell adhesion The 
extracellular face J Biol Chem 269 25235-25238 
138 Bajt, M L , T Goodman, and S L Mcguire 1995 Beta-2 (CD 18) mutations abolish hgand 
recognition by I domain integnns LFA-1 (alpha-L beta-2), CD1 la/CD 18) and Mac-1 (alpha-M 
beta-2), CD lib/CD 18) J Biol Chem 270 94-98 
139 Bajt, M L and J С Loftus 1994 Mutation of a hgand binding domain of beta-3 integnn 
Integral role of oxygenated residues in alpha-lib beta-3 (GPIIb-IIIa) receptor function J 
Biol Chem 269 20913-20919 
140 Tamura, R N , С Rozzo, L Starr, J Chambers, L F Reichardt, H M Cooper, and V 
Quaranta 1990 Epithelial integnn alpha-6 beta-4 complete primary structure of alpha-6 and 
variant forms of beta-4 J Cell Biol 111 1593-1604 
141 Peter, К and Τ E O'Toole 1995 Modulation of cell adhesion by changes in alpha-L beta-2 
(LFA-1, CD1 la/CDI8) cytoplasmic domain/cytoskeleton interaction J Exp Med 181 315-
326 
142 Hibbs, M L, S Jakes, S A Stacker, R W Wallace, and Τ A Springer 1991 The 
cytoplasmic domain of the integnn lymphocyte function-associated antigen 1 beta subunit 
sites required for binding to intercellular adhesion molecule 1 and the phorbol ester-stimulated 
phosphorylation site J Exp Med 174 1227-1238 
143 Arnaout, M A , H Spits, С Terhorsl, J Pitt, and R F Todd 1984 Deficiency of a 
leukocyte surface glycoprotein (LFA 1) in two patients with Mol deficiency Effects of cell 
activation on Mol/LFA-1 surface expression in normal and deficient leukocytes J Clin 
Invest 74 1291-1300 
144 Arnaout, Μ A, E A Wang, S С Clark, and С A Sieff 1986 Human recombinant 
granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface 
expression of adhesion-promoting surface glycoproteins on mature granulocytes J Clin 
Invest 78 597-601 
145 Gamble, J R , J M Harlan, S J Klebanoff, and M A Vadas 1985 Stimulation of the 
adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis 
factor Proc Natl Acad Sci U S A 82 8667-8671 
146 Shimizu, Y , G A Van Seventer, К J Horgan, and S Shaw 1990 Regulated expression 
and binding of three VLA (beta-1) integnn receptors on Τ cells Nature 345 250-253 
147 Thornhill, M H , S M Wellicome, D L Mahiouz, J S Lanchbury, U Kyan Aung, and 
D О Haskard 1991 Tumor necrosis factor combines with IL 4 or IFN-gamma to 
selectively enhance endothelial cell adhesiveness for Τ cells The contribution of vascular cell 
adhesion molecule 1 dependent and -independent binding mechanisms J Immunol 146 
592-598 
148 Shimizu, Y , S Shaw, N Graber, Τ V Gopal, Κ J Horgan, G A Van Seventer, and W 
Newman 1991 Activation-independent binding of human memory Τ cells to adhesion 
molecule ELAM 1 [see comments] Nature 349 799-802 
149 Picker, L J , Τ К Kishimoio, С W Smith, R A Warnock, and E С Butcher 1991 
ELAM-1 is an adhesion molecule for skin-homing Τ cells [see comments] Nature 349 796 
799 
150 Snramarao, Ρ, E J Berger, D Chambers, K-Ε Arfors, and К R Gehlsen 1993 High 
mannose type Гм-linked oligosaccharides on endothelial cells may influence beta-2 integnn 
mediated neutrophil adherence in vitro J Cell Biothem 51 360-368 
151 Dalton, S L , E Scharf, R Briesewitz, E E Marcantonio, and R К Assoian 1995 Cell 
adhesion to extracellular matrix regulates the life cycle of integnns Mol Biol Cell 6 1781 
1791 
152 Pardi, R , L Inverardi, and J R Bender 1992 Regulatory mechanisms in leukocyte 
adhesion flexible receptors for sophisticated travelers Immunol Today 13 224-230 
153 van Kooyk, Y , P Weder, К Heye, R de Waal Malefijt, and С G Figdor 1993 Role of 
intracellular Ca2+ levels in the regulation of CD1 la/CD18 mediated cell adhesion Cell Adhes 
Commun 1 21-32 
154 Hermanowski-Vosatka, A , J A Van Stnjp, W J Swiggard, and S D Wright 1992 
Integnn modulating factor-1 a lipid that altéis the function of leukocyte integnns Cell 68 
341-352 
40 
General Introduction 
155 Alexander, J , К Snoke, J Ruppert, J Sidney, M Wall, S Southwood, С Oseroff, Τ 
Arrhenius, F С Gaeta, S M Colon, and et al 1993 Functional consequences of 
engagement of the Τ cell receptor by low affinity ligands J Immunol 150 1-7 
156 van Kooyk, Υ , Ρ van de Wiel-van Kemenade, Ρ Weder, Τ W Kuijpers, and С G 
Figdor 1989 Enhancement of LFA-1 mediated cell adhesion by triggering through CD2 or 
CD3 on Τ lymphocytes Nature 342 811-813 
157 Campanero, M R , M A del Pozo, A G Arroyo, Ρ Sánchez-Mateos, Τ Hemandez-
Caselles, A Craig, R Pulido, and F Sanchez-Madrid 1993 ICAM-3 interacts with LFA-1 
and regulates the LFA-l/lCAM-1 cell adhesion pathway J Cell Biol 123 1007-1016 
158 Shimizu, Y , G A Van Seventer, E Ennis, W Newman, К J Horgan, and S Shaw 
1992 Crosslinking of the Τ cell-specific accessory molecules CD7 and CD28 modulates Τ 
cell adhesion J Exp Med 175 577-582 
159 Smith, S Η , Κ Ρ Rigley, and R E Callard 1991 Activation of human В cells through 
the CD 19 surface antigen results in homotypic adhesion by LFA-1-dependent and 
-independent mechanisms Immunol 73 293-297 
160 Axelsson, В , R Youseffi-Etemad, S Hammerstrom, and Ρ Perlmann 1988 Induction of 
aggregation and enhancement of proliferation and IL-2 secretion in human Τ cells by 
antibodies to CD43 J Immunol 141 2912-2917k 
161 Vermotdesroches, С , J Wijdenes, L Valmu, С Roy, R Pigott, Ρ Nortamo, and С G 
Gahmberg 1995 A CD44 monoclonal antibody differentially regulates CD 11a/ CD 18 
binding to intercellular adhesion molecules CD54, CD102 and CD50 Eur J Immunol 25 
2460-2464 
162 Bernard, G , D Zoccola, M Ticchioni, J Ρ Breittmayer, С Aussei, and A Bernard 1994 
Engagement of the CD45 molecule induces homotypic adhesion of human thymocytes 
through a LFA-1/1СAM-3-Dependent pathway J Immunol 152 5161-5170 
163 Zapata, J M , M R Campanero, M Marazuela, F Sanchez-Madrid, and Μ О 
Delandazun 1995 В-cell homotypic adhesion through exon-A restricted epitopes of CD45 
involves LFA-l/ICAM-1, ICAM-3 interactions, and induces coclustenng of CD45 and LFA-
1 Blood ЪЬ 1861-1872 
164 Andrew, D Ρ , Τ Yoshino, L Guh, Μ Τ G Martinsimonet, and E С Butcher 1995 
TABS, a Τ cell activation antigen that induces LFA-1- dependent aggregation J Immunol 
155 1671-1684 
165 Dransfield, I , С Cabanas, A Craig, and N Hogg 1992 Divalent cation regulation of the 
function of the leukocyte integnn LFA-1 J Cell Biol 116 219-226 
166 Ortlepp, S , Ρ E Stephens, N Hogg, С G Figdor, and M К Robinson 1995 
Antibodies that activate beta-2 integnns can generate different ligand binding states Eur J 
Immunol 25 637-643 
167 Petruzzelh, L , L Maduzid, and Τ A Springer 1995 Activation of lymphocyte function-
associated molecule-1 (CD1 la/CD18) and Mac-1 (CDllb/CD18) mimicked by an antibody 
directed against CD 18 J Immunol 155 854-866 
168 Frelinger, A L , X Ρ Du, E F Plow, and M H Ginsberg 1991 Monoclonal antibodies 
to ligand-otcupied conformers of integnn alpha-lib beta-3 (glycoprotein iTb-IIIa) alter 
receptor affinity, specificity, and function J Biol Chem 266 17106-17111 
169 Guhno, D , J J Ryckewaert, A Andneux, M J Rabiet, and G Marguene 1990 
Identification of a monoclonal antibody against platelet GPIIb that interacts with a calcium-
binding site and induces aggregation J Biol Chem 265 9575-9581 
170 Kovach, N L , Τ M Carlos, E Yee, and J M Harlan 1992 A monoclonal antibody to 
beta-1 integnn (CD29) stimulates VLA dependent adherence of leukocytes to human umbilical 
vein endothelial cells and matrix components J Cell Biol 116 499-509 
171 Hemler, M E , F Sanchez-Madrid, Τ J Flotte, A M Krensky, S J Burakoff, A К 
Bhan, Τ A Springer, and J L Strominger 1984 Glycoproteins of 210,000 and 130,000 
m w on activated Τ cells cell distribution and antigenic relation to components on resting 
cells and Τ cell lines J Immunol 132 3011 3018 
172 van de Wiel-van Kemenade, E , Y van Kooyk, A J De Boer, R J F Hu'jbens, Ρ Weder, 
W Van de Kasteele, С J M Melief, and С G Figdor 1992 Adhesion of Τ and В 
41 
Chapter 1 
lymphocytes to extracellular matrix and endothelial cells can be regulated through the beta 
subunitofVLA J Cell Biol 117 461-470 
173 Yednock, Τ A , С Cannon, С Vandevert, E G Goldbach, G Shaw, D R Ellis, С Liaw, 
L С Fritz, and L I Tanner 1995 Alpha 4 beta 1 întegnn-dependent cell adhesion is 
regulated by a low affinity receptor pool that is conformationally responsive to ligand J Biol 
Chem 270 28740-28750 
174 Shattil, S J , J A Hoxie, M Cunningham, and L F Brass 1985 Changes in the platelet 
membrane glycoprotein lib Ilia complex during platelet activation J Biol Chem 260 
11107-11114 
175 Kouns, W С , С D Wall, M M White, С F Fox, and L К Jennings 1990 A 
conformation-dependent epitope of human platelet glycoprotein Illa J Biol Chem 265 
20594-20601 
176 Kouns, W С , Ρ J Newman, К J Puckett, A A Miller, С D Wall, С F Fox, J M 
Seyer, and L К Jennings 1991 Further characterization of the loop structure of platelet 
glycoprotein Ilia partial mapping of functionally significant glycoprotein Ша epitopes Blood 
78 3215-3223 
177 Lundberg, С and S D Wright 1990 Relation of the CD 11/CD 18 family of leukocyte 
antigens to the transient neutropenia caused by chemoattractants Blood 76 1240-1245 
178 Dransfield, I and N Hogg 1989 Regulated expression of Mg2+ binding epitope on 
leukocyte integrin alpha subunits EMBO J 8 3759-3765 
179 Bazzoni, G , D Τ Shih, С A Buck, and M E Hemler 1995 Monoclonal antibody 9EG7 
defines a novel beta 1 integrin epitope induced by soluble ligand and manganese, but inhibited 
by calcium J Biol Chem 270 25570-25577 
180 Detmers, Ρ A , S D Wright, E Olsen, В Kimball, and Ζ A Cohn 1987 Aggregation of 
complement receptors on human neutrophils in the absence of ligand J Cell Biol 105 1137-
1145 
181 van Kooyk, Υ , Ρ Weder, К Heije, and С G Figdor 1994 Extracellular Ca2+ modulates 
leukocyte function-associated antigen-1 cell surface distribution on Τ lymphocytes and 
consequently affects cell adhesion J Cell Biol 124 1061-1070 
182 Delpozo, Μ Α , Ρ Sanchez Mateos, M Nieto, and F Sanchez-Madrid 1995 Chemokines 
regulate cellular polarization and adhesion receptor redistribution during lymphocyte 
interaction with endothelium and extracellular matrix Involvement of cAMP signaling 
pathway J Cell Biol 131 495 508 
183 Hynes, R О 1994 The impact of molecular biology on models for cell adhesion Bioessays 
16 663 669 
184 Luscinskas, F W , G S Kansas, H Ding, Ρ Pizcueta, В E Schleiffenbaum, Τ F 
Tedder, and M A Gimbrone 1994 Monocyte rolling, arrest and spreading on IL-4-activated 
vascular endothelium under flow is mediated via sequential action of L selectin, beta-1 
integnns, and beta-2 integrins J Cell Biol 125 1417-1427 
185 Kanner, S В , L S Grosmaire, J A Ledbetter, and Ν К Damle 1993 Beta 2-integnn 
LFA-1 signaling through phospholipase C-gamma-1 activation Ρ roc Natl Acad Sa U S 
A 90 7099-7103 
186 Pardi, R , J R Bender, С Dettori, E Giannazza, and E G Engleman 1989 
Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-
associated antigen (LFA-1) in human lymphocyte subsets J Immunol 143 3157-3166 
187 Richter, J , J Ng Sikorski, I Olsson, and Τ Andersson 1990 Tumor necrosis factor 
induced degranulation in adherent human neutrophils is dependent on CD1 lb/CD18-integnn 
triggered oscillations of cytosolic free Ca2+ Proc Natl Acad Sci USA 87 9472-9476 
188 Ng Sikorski, J , R Andersson, M Patarroyo, and Τ Andersson 1991 Calcium signaling 
capacity of the CDllb/CD18 integrin on human neutrophils Exp Cell Res 195 504 508 
189 Jaconi, M E , J M Théier, W Schlegel, R D Appel, S D Wright, and Ρ D Lew 1991 
Multiple elevations of cytosolic free Ca2+ in human neutrophils initiation by adherence 
receptors of the integrin family J Cell Biol 112 1249 1257 
190 Leavesley, D I , J M Oliver, В W Swart, M С Berndt, D N Haylock, and Ρ J 
Simmons 1994 Signals from platelet/endothelial cell adhesion molecule enhance the adhesive 
42 
General Introduction 
activity of the very late antigen-4 integrin of human CD34(+) hemopoietic progenitor cells J 
Immunol 153 4673-4683 
191 Iwdshimd, Μ , В A Irving, N S С Vanoers, А С Chan, and A Weiss 1994 Sequential 
Interactions of the TCR with 2 Distinct Cytoplasmic Tyrosine Kinases Science 263 1136-
1139 
192 Schwartz, M A , D E Ingber, M Lawrence, Τ A Springer, and С Lechene 1991 
Multiple integnns share the ability to induce elevation of intracellular pH Exp Cell Res 195 
533-535 
193 Schwartz, M А , С Lechene, and D E Ingber 1991 Insoluble fibronectin activates the 
Na/H antiporter by clustering and immobilizing integrin alpha 5 beta-1, independent of cell 
shape Proc Natl Acad Sa U S A 88 7849-7853 
194 Kornberg, L J , H S Earp, С E Turner, С Prockop, and R L Juliano 1991 Signal 
transduction by integnns increased protein tyrosine phosphorylation caused by clustering of 
beta-1 integnns Proc Natl Acad Sci U S A 88 8392 8396 
195 Guan, J , J E Trevithick, and R O Hynes 1991 Fibronectin/integrm interaction induces 
tyrosine phosphorylation of a 120-kDa protein Cell Regul 2 951 964 
196 Cobb, В S , M D Schaller, Τ H Leu, and J Τ Parsons 1994 Stable association of 
pp60(src) and pp59(fyn) with the focal adhesion-associated protein tyrosine kinase, 
ppl25FAK Mol Cell Biol 14 147 155 
197 Schaller, M D , J D Hildebrand, J D Shannon, J W Fox, R R Vines, and J Τ 
Parsons 1994 Autophosphorylation of the Focal Adhesion Kinase, ppl25(FAK), Directs 
SH2 Dependent Binding of pp60(src) Mol Cell Biol 14 1680-1688 
198 Miyamoto, S , S К Akiyama, and К M Yamada 1995 Synergistic roles for receptor 
occupancy and aggregation in integrin transmembrane function Science 267 883-885 
199 Schlaepfer, D D , S К Hanks, Τ Hunter, and Ρ van der Geer 1994 Integrin-mediated 
signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase Nature 
372 786-791 
200 Miyamoto, S , H Teramoto, О A Coso, J S Gutkind, Ρ D Burbelo, S К Akiyama, and 
Κ M Yamada 1995 Integrin function Molecular hierarchies of cytoskeletal and signaling 
molecules J Cell Biol 131 791 805 
201 Burbelo, Ρ D , S Miyamoto, A Utani, S Brill, К M Yamada, A Hall, and Y Yamada 
1995 pl90 B, a new member of the Rho GAP family, and Rho are induced to cluster after 
integrin cross-linking J Biol Chem 270 30919-30926 
202 Hannigan, G E , С Leunghagesteijn, L Fitzgibbon, M G Coppolmo, G Radeva, J 
Filmus, J С Bell, and S Dedhar 1996 Regulation of cell adhesion and anchorage-
dependent growth by a new beta 1 integrin-linked protein kinase Nature 379 91-96 
203 Roberts, K , W M Yokoyama, Ρ J Kehn, and E M Shevach 1991 The vitronectin 
receptor serves as an accessory molecule for the activation of a subset of gamma/delta Τ cells 
J Exp Med 173 231-240 
204 Yamada, A , Τ Nikaido, Y Nojima, S F Schlossman, and С Monmoto 1991 Activation 
of human CD4 Τ lymphocytes Interaction of fibronectin with VLA 5 receptor on CD4 cells 
induces the AP-1 transcription factor J Immunol 146 53-56 
205 Koopman, G , R M J Keehnen, E Lindhout, W Newman, Y Shimizu, G A van 
Seventer, С de Groot, and S Τ Pals 1994 Adhesion Through the LFA-1 (CDl 1 a/CD 18)-
ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-l (CD 106) Pathways Prevents Apoptosis 
of Germinal Center В Cells J Immunol 152 3760 3767 
206 Figdor, С G , Y van Kooyk, and G D Keizer 1990 On the mode of action of LFA-1 
Immunol Today 11 277-280 
207 Moy, V Τ and A A Brian 1992 Signaling by lymphocyte function-associated antigen 1 
(LFA 1 ) in В cells enhanced antigen presentation after stimulation through LFA-1 J Exp 
Med 175 1-7 
208 van Seventer, G A , Y Shimizu, and S Shaw 1991 Roles of multiple accessory molecules 
in T-cell activation Curr Opin Immunol 3 294-303 
209 Collins, Τ L , Ρ D Kassner, Β E Eierer, and S J Burakoff 1994 Adhesion receptors in 
lymphocyte activation Curr Opm Immunol 6 385-393 
43 
Chapter 1 
210. Haskill, S., A. A. Beg, S. M. Tompkins, J S Morris, A D. Yurochko, A. Sampson 
Johannes, К Mondai, P. Ralph, and A. S. J. Baldwin. 1991. Characterization of an 
immediate-early gene induced in adherent monocytes that encodes 1 kappa B-like activity. Cell 
65: 1281-1289. 
211. Fan, S. T., A. A. Brian, B. A. Lollo, N Mackman, N. L. Shen, and T. S. Edgington. 1993. 
CD 11 a/CD 18 (LFA-1) integrin engagement enhances biosynthesis of early cytokines by 
activated Τ cells. Cell Immunol. 148: 48-59. 
212. Yurochko, A. D., D. Y. Liu, D. Eierman, and S. Haskill. 1992. Integrins as a primary signal 
transduction molecule regulating monocyte immediate-early gene induction. Proc. Natl. Acad. 
Sci. U. S. Α. 89: 9034-9038 
213. Elson, E. L. 1988. Cellular mechanics as an indicator of cytoskeletal structure and function. 
Annu. Rev. Biophys. Biophys. Chem. 17: 397-430 
214. Ingber, D. E. 1993. Cellular tensegnty: defining new rules of biological design that govern 
the cytoskeleton J. Cell Sa. 104· 613-627. 
215. Kabsch, W. and J. van de Kerckhove 1992. Structure and function of actin. Annu. Rev. 
Biophys. Biomol. Struct. 21: 49-76. 
216. Bonder, E. M., D. J. Fishkind, and M. S. Mooseker. 1983. Direct measurement of critical 
concentrations and assembly rate constants at the two ends of an actin filament. Cell 34: 491-
501. 
217. Janmey, P. A. 1991. Mechanical properties of cytoskeletal polymers. Curr. Opin. Cell Biol. 
3:4-11. 
218. Kabsch, W , H. G. Mannherz, D. Suck, E. F. Pai, and К. С Holmes. 1990. Atomic 
structure of the actin:DNase I complex [see comments]. Nature 347: 37-44. 
219. Dustin, P. 1984. Microtubules. Springer-Verlag, New York. 
220. Hyams, J. F. 1993. Microtubules. Wiley-Liss, New York. 
221. Amos, L. A. and T. S. Baker. 1979. The three-dimensional structure of tubulin 
proto filaments. Nature 279: 607-612. 
222. Luduena, R. F. 1993. Are tubulin isotypes functionally significant. Mol. Biol. Cell 4: 445-
457. 
223. Sullivan, K. F. 1988. Structure and utilization of tubulin isotypes. Annu. Rev Cell Biol. 4: 
687-716. 
224. Wade, R. H. and D. Chretien. 1993 Cryoelectron microscopy of microtubules. J. Struct. 
Biol. 110: 1-27. 
225. Albers, K. and E. Fuchs. 1992. The molecular biology of intermediate filament proteins. Int. 
Rev. Cytol. 134: 243-279. 
226. Cary, R. B. 1992. Finding filament function. Curr. Biol. 2: 43-45. 
227. Steinert, P. M. and D. R. Roop 1988. Molecular and cellular biology of intermediate 
filaments. Annu. Rev. Biochem. 57: 593-625. 
228. Chou, Y. H., J. R. Bischoff, D. Beach, and R. D. Goldman. 1990. Intermediate filament 
reorganization during mitosis is mediated by p34cdc2 phosphorylation of vimentin. Cell 62: 
1063-1071. 
229. Stewart, M. 1993. Intermediate filament structure and assembly. Curr. Opm. Cell Biol. 5: 3-
11. 
230. Okabe, S., H. Miyasaka, and N. Hirokawa. 1993. Dynamics of the neuronal intermediate 
filaments./ Cell Biol. 121: 375-386. 
231. Schmidt, С E., J. W. Dai, D. A. Lauffenburger, M. P. Sheetz, and A. F. Horwitz. 1995. 
Integrin-cytoskeletal interactions in neuronal growth cones. J. Neurosci. 15: 3400-3407. 
232. Ridley, A. J. and A. Hall. 1992. The small GTP-binding protein rho regulates the assembly 
of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399. 
233. Huttenlocher, Α., R. R. Sandborg, and A. F. Horwitz. 1995. Adhesion in cell migration. 
Curr. Opin. Cell Biol. 7: 697-706. 
234. Parsons, J. T. 1996. Integnn-mediated signalling: regulation by protein tyrosine kinases and 
small GTP-binding proteins. Curr. Opin Cell Biol. 8: 146-152. 
235. Zigmond, S. H. 1996. Signal transduction and filament organization. Curr. Opin. Cell Biol. 
8: 66-73. 
44 
General Introduction 
236. Bretscher, Α. 1991. Microfilament structure and function in the cortical cytoskeleton. Annu. 
Rev. Cell Biol. 7- 337-374. 
237. Hartwig, J H. and D. J. Kwiatkowski. 1991. Actin-binding proteins. Curr. Opin. Cell Biol. 
3: 87-97. 
238. Horwitz, Α., К. Duggan, С. Buck, M. С. Beckerle, and К. Burridge. 1986. Interaction of 
plasma membrane fibronectin receptor with talin -a transmembrane linkage. Nature 320: 531-
533. 
239. Otey, С Α., G. В. Vasquez, К. Burridge, and В. W. Erickson. 1993. Mapping of the alpha-
actinin binding site within the beta-1 integrin cytoplasmic domain. J. Biol. Chem. 268: 
21193-21197. 
240. Burn, P., A. Kupfer, and S J. Singer. 1988. Dynamic membrane-cytoskeletal interactions: 
specific association of înlegrin and lalin arises in vivo after phorbol ester treatment of 
peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 85: 497-501. 
241. Pavalko, F. M. and S. M. LaRoche. 1993. Activation of human neutrophils induces an 
interaction between the integrin beta-2 subunit (CD 18) and the actin binding protein alpha-
actimn. J. Immunol. 151 • 3795-3807. 
242. Otey, C. Α., F M. Pavalko, and К. Burridge. 1990. An interaction between alpha-actinin 
and the beta-1 integrin subunit in vitro. J. Cell Biol. I l l : 721-729. 
243. Krauss, J. C , A. J. Ping, L. Mayo Bond, С E. Rogers, D. С Anderson, R. F. Todd, and 
J. M. Wilson. 1990. Complementation of genetic and functional defects in CD18-deficient 
lymphocytes by retrovirus-mediated gene transfer. Trans. Assoc. Am. Physicians. 103: 263-
270. 
244. Yamada, K. M. and S. Miyamoto. 1995. Integrin transmembrane signaling and cytoskeletal 
control. Curr. Opin. Cell Biol. 7: 681-689. 
245 Bennett, V. and D. M. Gilligan. 1993. The spectrin-based membrane skeleton and micron-
scale organization of the plasma membrane. Annu. Rev. Cell Biol. 9: 27-66. 
246. Carraway, K. L. and C. A Carraway. 1989. Membrane-cytoskeleton interactions in animal 
cells. Biochim. Biophys. Acta 988: 147-171. 
247. O'Toole, T. E., Y. Katagin, R. J. Faull, K. Peter, R. Tamura, V. Quaranta, J. С Loftus, S. 
J. Shattil, and M. H. Ginsberg. 1994. Integrin Cytoplasmic Domains Mediate Inside-Out 
Signal Transduction. J. Cell Biol. 124: 1047-1059. 
248. Pardi, R., G. Bossi, L. Inverardi, E. Rovida, and J. R. Bender. 1995. Conserved regions in 
the cytoplasmic domains of the leukocyte integrin alpha-L beta-2 are involved in endoplasmic 
reticulum retention, dimerization, and cytoskeletal association. J. Immunol. 155: 1252-1263. 
249. Kawaguchi, S. and M. E. Hemler. 1993. Role of the alpha subunit cytoplasmic domain in 
regulation of adhesive activity mediated by the integrin VLA-2. J. Biol. Chem. 268: 16279-
16285 
250. Kassner, P. D. and M. E. Hemler. 1993. Interchangeable alpha chain cytoplasmic domains 
play a positive role in control of cell adhesion mediated by VLA-4, a beta-1 integrin. J. Exp. 
Med. 178: 649-660. 
251. Shaw, L. M. and A. M. Mercurio. 1993. Regulation of alpha-6 beta-1 integrin laminin 
receptor function by the cytoplasmic domain of the alpha-6 subunit. J. Cell Biol. 123: 1017-
1025. 
252. Filardo, E. J. and D. A. Cheresh. 1994. A beta Turn in the Cytoplasmic Tail of the Integrin 
alpha-v Subunit Influences Conformation and Ligand Binding of alpha-v beta-3. J. Biol. 
Chem. 269: 4641-4647. 
253. Stuiver, I. and Т. E. O'Toole. 1995. Regulation of integrin function and cellular adhesion. 
Stem Cells 13: 250-262. 
254. Dedhar, S., P. S. Renme, M. Shago, C. Y. Hagesteijn, H. Yang, J. Filmus, R. G. Hawley, 
N. Bruchovsky, H. Cheng, R. J. Matusik, and V. Giguère. 1994. Inhibition of nuclear 
hormone receptor activity by calreticulin. Nature 367: 480-483. 
255. Rojiani, M. V., B. B. Finlay, V. Gray, and S. Dedhar. 1991. In vitro interaction of a 
polypeptide homologous to human Ro/SS- A antigen (calreticulin) with a highly conserved 
amino acid sequence in the cytoplasmic domain of integrin alpha subunits. Biochemistry 30: 
9859-9866 
45 
Chapter 1 
256. Dedhar, S. 1994. Novel functions for calreticulm: interaction with integnns and modulation of 
gene expression9 Trends. Biochem. Sci. 19: 269-271 
257. Coppolino, M , С Leung Hagesteijn, S Dedhar, and J. Wilkins. 1995. Inducible interaction 
of integnn alpha-2 beta-1 with calreticulin - Dependence on the activation state of the integnn. 
J. Biol. Chem. 270: 23132-23138. 
258. Leung Hagesteijn, С Υ., К. Milankov, M. Michalak, J. Wilkins, and S. Dedhar. 1994. Cell 
attachment to extracellular matrix substrates is inhibited upon downregulation of expression of 
calreticulin, an intracellular integnn alpha subunit-binding protein. J. Cell Sci. 107: 589-600. 
259. Chan, B. M., P. D. Kassner, J. A. Schiro, H R. Byers, T. S. Küpper, and M. E. Hemler. 
1992. Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic 
domains. Cell 68: 1051-1060. 
260. Chen, Y. P., T. E. O'Toole, T. Shipley, J. Forsyth, S. E. LaFlamme, K. M. Yamada, S. J. 
Shattil, and M. H. Ginsberg. 1994. "Inside-out" signal transduction inhibited by isolated 
integrin cytoplasmic domains. J. Biol. Chem. 269: 18307-18310. 
261. LaFlamme, S. E., S. K. Akiyama, and Κ. M Yamada. 1992. Regulation of fibronectin 
receptor distribution. J. Cell Biol. 117: 437-447 
262. Pasqualini, R. and M. E. Hemler. 1994. Contrasting roles for integnn beta-1 and Integrin 
beta-5 cytoplasmic domains in subcellular localization, cell proliferation, and cell migration. J. 
Cell Biol. 125: 447-460. 
263. Schaller, M. D., С A. Otey, J D. Hildebrand, and J. T. Parsons 1995. Focal adhesion 
kinase and paxillin bind to peptides mimicking beta integnn cytoplasmic domains. J. Cell 
Biol. 130: 1181-1187. 
264. Hibbs, M. L., H. Xu, S. A. Stacker, and T. A. Springer. 1991. Regulation of adhesion of 
ICAM-1 by the cytoplasmic domain of LFA-1 integrin beta subunit. Science 251: 1611-1613. 
265. Nathan, С F. 1987. Secretory products of macrophages. J. Clin. Invest. 79: 319-326. 
266. Crowe, D. T., H. Chiù, S. Fong, and I. L. Weissman. 1994. Regulation of the avidity of 
integrin alpha-4 beta-7 by the beta-7 cytoplasmic domain. J. Biol. Chem. 269: 14411-14418. 
267. Marcantonio, E. E , J. L. Guan, J. E. Trevithick, and R. O. Hynes. 1990. Mapping of the 
functional determinants of the integnn beta-1 cytoplasmic domain by site-directed 
mutagenesis. CellRegul. 1: 597-604. 
268. Hayashi, Y., B. Haimovich, A. Reszka, D Boettiger, and A. Horwitz. 1990. Expression and 
function of chicken integrin beta-1 subunit and its cytoplasmic domain mutants in mouse NIH 
3T3 cells. J. Cell Biol. 110: 175-184. 
269. Solowska, J., J. L. Guan, E. E. Marcantonio, J E. Trevithick, С A Buck, and R. O. 
Hynes. 1989. Expression of normal and mutant avian integnn subunits in rodent cells 
[published erratum appears in J Cell Biol 1989 Oct; 109(4 Pt 1):1187].7. Cell Biol. 109.853-
861. 
270. Reszka, A. A , Y. Hayashi, and A. F. Horwitz. 1992. Identification of amino acid sequences 
in the integrin beta-1 cytoplasmic domain implicated in cytoskeletal association. J. Cell Biol. 
117: 1321-1330. 
271. Muir, T. W., M. J. Williams, M H. Ginsberg, and S. В. H. Kent. 1994. Design and 
chemical synthesis of a neoprotein structural model for the cytoplasmic domain of a 
multisubunit cell- surface receptor: Integrin alpha-lib beta-3 (platelet GPIIb-IIIa). 
Biochemistry 33: 7701-7708. 
272. Du, X., M. Gu, I. W. Weisel, С. Nagaswami, J. S. Bennett, R. Bowditch, and M. H. 
Ginsberg. 1993. Long range propagation of conformational changes in integrin alpha-lib 
beta-3. J. Biol. Chem. 268: 23087-23092. 
273. O'Toole, T. E., J. Ylanne, and В. M. Culley. 1995. Regulation of integrin affinity states 
through an NPXY motif in the beta subunit cytoplasmic domain. J. Biol. Chem. 270: 8553-
8558. 
274. Filardo, E. J., P. С Brooks, S. L. Deming, С Damsky, and D. A. Cheresh. 1995. 
Requirement of the NPXY motif in the integnn beta-3 subunit cytoplasmic tail for melanoma 
cell migration in vitro and in vivo. J. Cell Biol. 130: 441-450. 
275. Clark, E. A. and J S. Brugge. 1995. Integnns and signal transduction pathways: the road 
taken. Science 268: 233-239. 
4 6 
General Introduction 
276 Craig, S W and R Ρ Johnson 1996 Assembly of focal adhesions progress, paradigms, 
and potents Curr Opm Cell Biol 8 74-85 
277 Parsons, J Τ , M D Schaller, J Hildebrand, Τ Η Leu, A Richardson, and С Otey 
1994 Focal adhesion kinase Structure and signalling J Cell Sci 109-113 
278 Yamamoto, Ν , Η Kitagawa, Κ Yamamoto, К Tanoue, and H Yamazaki 1989 Calcium 
ions and the conformation of glycoprotein Ilia that is essential fibrinogen binding to platelets 
analysis by a new monoclonal anti-GP Ilia antibody, TM83 Blood 73 1552-1560 
47 

Chapter 2 
Competition between lymphocyte function-associated antigen 1 
(CDlla/CD18) and Mac-1 (CDllb/CD18) for binding to 
intercellular adhesion molecule-1 (CD54) 
Marijke Lub, Yvette van Kooyk and Carl G. Figdor 

Dominance ofLFA-1 over Mac-J for binding ¡CAM-J 
ABSTRACT 
Both human integrin receptors Mac-1 (CD1 lb/CD18, CR3) and lymphocyte function-
associated antigen (LFA)-l (CD 11 a/CD 18) have been demonstrated to bind human 
intercellular adhesion molecule (ICAM)-l (CD54) Here we show that also in the mouse 
LFA-1 and Mac-1 can bind to ICAM-1 Interestingly, we observed that binding of murine 
LFA-1 dominates over Mac-1 for binding to ICAM-1 Using three different murine 
macrophage cell lines that express distinct levels of LFA-1 and Mac-1 on their cell surface, 
we could only detect Mac-1 dependent adhesion to ICAM-1 when little or no LFA-1 is 
expressed on the cell surface When LFA-1 and Mac-1 are expressed at similar levels, the 
LFA-l/ICAM-1 interaction dominates over Mac-l/ICAM-1 interaction, indicating that 
there is a competition of LFA-1 and Mac-1 for ICAM-1 binding 
INTRODUCTION 
Both lymphocyte function-associated antigen-1 (LFA-1, CD 11 a/CD 18) and Mac-1 
(CDllb/CD18, CR3) are members of the leukocyte restricted ß2 integnns This group 
consists of following three structurally related glycoproteins LFA-1, Mac-1 and ρ 150,95 
(CD1 lc/CD18) [1,2] The ßa ìntegrins are heterodimers composed of an unique α subunit 
with a molecular mass ot 170, 165 and 150 kD (for LFA-1, Mac-1 and pl50,95 
respectively) and a common β subunit ot 95 kD [3] 
Whereas LFA-1 is expressed on all leukocytes [4], Mac-1 is predominantly expressed 
by cells of the monocytic lineage [4-8] In resting granulocytes Mac-1 is stored in 
peroxidase-negative granules Upon addition of inflammatory mediators degranulation 
occurs, leading to an increased surface expression of Mac-1 molecules [8-11] In addition, 
intracellular signals can activate ß2 ìntegrins at the cell surface, which can be mimicked by 
Mn2+ [12,13] or by stimulating antibodies, that activate ß2 integrin molecules by altering 
the molecular conformation [14-17] 
LFA-1 is involved in distinct adhesion-dependent functions such as Τ cell mediated 
killing, Τ helper cell and В cell responses, natural killer cell activity, monocyte-mediated 
antibody-dependent cytotoxicity and leukocyte adhesion to endothelial cells [18,19] Mac-1 
acts as a complement receptor but also mediates phagocytosis by activated macrophages 
and plays a role in adherence-dependent locomotion of neutrophils in the presence of 
chemoattractants [7,20-22] 
Intercellular adhesion molecule-1 (ICAM-1) is a cell surface glycoprotein of 90-110 
kD and belongs to the immunoglobulin superfamily [23,24] It consists of five 
immunoglobuhn-like domains [24] Both human LFA-1 and Mac-1 have been described to 
bind ICAM-1 (CD54) [25-28] LFA-1 binds to the first immunoglobulin (Ig)-like domain of 
ICAM-1 [29,30], whereas Mac-1 binds to a distinct site on the ICAM-1 molecule, the third 
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MATERIAL AND METHODS 
Monoclonal antibodies 
Monoclonal antibodies directed against different murine adhesion molecules were 
used M17 4 (anti-CDl la, IgG2a) [47], H154 163 (anti-CDl la, IgG2a, kindly provided by 
Dr Pierres) [48], Ml/70 15 (anti-CDllb, IgG2b) [43], 5C6 (anti-CDllb, IgG2b, kindly 
provided by Marty η Robinson, Celltech) [49], Ml 8 2 (anti-CD18, IgG2a) [50], YN1/1 7 
(anti-CD54, IgG2b) [51] and Rl-2 (anti-CD29d, VLA-4, IgG2b, kindly provided by Dr 
Holzmann) [52] 
Fab fragments and F(ab')2 fragments of YN1/1 7 and 5C6 were prepared as 
previously described [53], and analyzed by SDS-PAGE [54] 
Cells and culture conditions 
The following three different cell lines were used the murine macrophage cell lines 
CA5 (fusion product of J774 macrophage cells with spleen macrophage cells), 293 and 298 
(BM12 bone marrow cells immortalized with Mic-virus and selected on their adhesive 
properties 293 cells adhere, 298 cells grow in suspension) All cells were grown in Iscove's 
medium (GIBCO) supplemented with 5% FCS and 1% antibiotics/antimycotics (GIBCO) 
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Isolation and purification of the antigens by affinity chromatography 
Murine Mac-1 and ICAM-1 were purified by lysing 10 χ IO9 CA5 cells, which 
expressed both Mac-1 and ICAM-1 at high levels Isolation of the antigens was performed 
at 4 °C Cells were lysed in lysis buffer, containing 0,5% Triton X-100, 150 mM NaCl and 
10 mM tnethanolamine All buffers used, were supplemented with 1 mM phenyl-methyl-
sulfonyl-fluonde (PMSF), 2 mM MgCb, 1 mM СаСІг and 50 μΜ sodiumvanadate 
For isolation of murine ICAM-1, purified YN1/1 7 mAb was covalently linked to 
CNBr-activated sepharose beads (Pharmacia, 5 mg/ml) For isolation of murine Mac-1 
purified Ml/70 15 mAb was covalently coupled to CNBr-activated sepharose beads (5 
mg/ml) The affinity columns were sequentially washed with 5 volumes (corresponding to 
the volume of the column) ot elution buffer (containing 1% ß-D-octylglucoside, 400 mM 
NaCl, and 50 mM tnethanolamine) pH 11 (1 ml/min) and 5 volumes of equilibration buffer 
(0 5% tnton-X 100, 150 mM NaCl and 50 mM tnethanolamine) pH 7 8 (1 ml/min) The 
lysate was pre-cleared by overnight incubation with rat IgG coupled to CNBr-activated 
sepharose beads and loaded onto the column (flowrate = 1 ml/min) After loading, the 
column was sequentially washed with 5 volumes of the equilibration buffer pH 7 8 (1 
ml/min), 5 volumes of washing buffer (containing 0 1% Triton X 100, 150 mM NaCl and 
50 mM tnethanolamine) pH 7 8 (1 ml/min), and with 5 volumes of glycin buffer (1% ß-D-
octylglucoside, 150 mM NaCl and 100 mM glycin) pH 10 (1 ml/min). Elution of the 
antigen was carried out by 5 volumes of elution buffer pH 11 (for YN1/1 7) or pH 12 5 (for 
Ml/70 15) (1 ml/3 mm) Fractions (0 5 ml) were immediately neutralized by adding 0.16% 
IM Tris HCl/1% ß-D-octylglucoside pH 6 7, and were snap-frozen in liquid nitrogen and 
stored at -70 °C 
Silver staining of the antigens 
To determine the presence of antigens and its purity 25 μΐ of each fraction was 
analyzed by SDS-PAGE, using a 5-15% reducing gel The gel was silver stained as 
described previously [55] Purity of the isolated Mac-1 and ICAM-1 proteins was 
determined by enzyme-linked immunosorbent assay (ELISA) in which the proteins were 
stained with either 10 μg/ml anti-Mac-1 (5C6) or anti-ICAM-1 (YN1/1 7) mAb or anti-
LFA-1 (M17 4) mAb as a control for contamination Peroxidase-labeled rabbit anti-rat IgG 
was used as second antibody and 3,3\5,5'-Tetra-methyl-benzidine (Sigma Chemical Co , 
St Louis, MO) as substrate The optical density (OD) was measured at 450 nm 
Immunofluorescence 
Cells were incubated (30 min, 4 °C) in phosphate-buffered saline, containing 0 5% 
wt/vol bovine serum albumin (BSA) and 0 01% sodium azide, with appropnate dilutions of 
the different mAb, followed by incubation with fluorescence isothiocyanate (FITC)-labeled 
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Radiolabeling and immunoprecipitation 
Cells were surface labeled with N a , 2 5 I (Amersham, Buckinghamshire, UK) through 
the lactoperoxidase method [56] For immunoprecipitation, CA5 cells (1 χ IO7) were lysed 
for 1 hr at 4 °C in immunoprecipitation buffer (IPB), which contained 1 % NP-40, 50 mM 
triethanolamine (pH 7 8), 150 mM NaCl, 5 mM EDTA and as protease inhibitors, 1 mM 
PMSF, ovomucoid trypsin inhibitor (0 02 mg/ml, Sigma), 0,02 mg/ml leupeptin and 1 mM 
Nd-P-tosyl-L-lysine chloromethyl ketone were added Nuclear debris was removed from the 
lysates by centnfugation at 13,000 g for 15 min at 4 °C Lysates were pre-cleared by 
successive incubation with rat IgG coupled via rabbit-anti-rat IgG to protein A-sepharose 
CL-4B beads (Pharmacia Fine Chemicals, Piscataway, NJ) Pre-cleared lysates were 
incubated for 2-3 h with a specific mAb coupled via rabbit-anti-rat IgG to protein A-
sepharose CL-4B The immunoprecipitates were removed from the lysates by centnfugation 
at 13,000 f> Subsequently, immunoprecipitates were washed extensively in IPB 
Electrophoresis and autoradiography 
SDS-PAGE was carried out on vertical slab gels (5-15%) according to a modification 
of the Laemh procedure [54] Samples were analyzed under reducing conditions, with 5% 
2-ß-mercaptoethanol in SDS sample buffer Kodak XAR-film was used in combination 
with intensifier screens (Cronex Lightning Plus, Dupont Chemical Co , Newton, CT) for 
autoradiography of l25I-labeled materials 
Cell binding to purified antigens 
Purified murine ICAM-1 and Mac-1 (10-30 ng) was coated overnight at 4 °C in TMS 
(20 mM Tns HCl pH 8, 150 mM NaCl, 1 mM СаСІг, 2 mM MgCh), on 96-well microtiter 
plates (Costar, Cambridge, MA) As protein control 100 μΐ of 40 μg/ml collagen type I 
(Sigma) was coated 1 hr at 37 °C Fibrinogen type I (Sigma Chemical) and BSA (Fraction 
V, Boehnnger-Mannheim) was coated (100 μΐ) in a concentration of 40 μg/ml or 20 mg/ml 
respectively Antigen coated and control wells were blocked with 0 01% wt/vol gelatine in 
TMS for 30 min 37 CC, after which they were washed twice with Iscove's medium 
supplemented with 0 5% wt/vol BSA and 1% antibiotics/antimycotics After labeling of the 
cells with Na2 5 l Cr04 for 45-60 mm at 37 °C, cells were pre-incubated with 10% normal rat 
serum (for the murine cell lines) for 15 mm at room temperature (RT) and subsequently 
washed twice with medium Radiolabeled (2 χ 104) cells were allowed to adhere for 20-30 
mm at 37 °C Unbound cells were removed by washing with Iscove's medium The adherent 
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cells were lysed with 100 μΐ of 2% Triton X-100 and radioactivity was quantified in a 
gamma counter Results are expressed as the mean percent of cell binding from duplicate 
wells or as relative inhibition of total adhesion of duplicate wells 
When mentioned EDTA was added in a final concentration of 5 mM Antibodies were 
added in a final concentration of 10-50 μg/ml 
RESULTS 
control H154 163 5C6 M 1 8 2 
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Figure 1. Expression of LFA-1 and Mac-1 on murine macrophage cell lines Cells were 
stained with control m Ab, anti-LFA-1 (H 154 163), anti-Mac-1 (5C6) and anti-ß2 (M 18 2) 
followed by incubation with FITC-labeled mouse anti-rat-κ IgG (Α-C) Expression of LFA-
1 and Mac-1 on 298, 293 and CA5 cells, respectively One representative experiment out of 
six is shown 
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Mr 
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Figure 2. Immunoprecipitation of LFA-1 and Mac-1 from the macrophage cell lines 298 
(Lanes A-C), 293 (lanes D-F) and CA5 (Lanes G-J) with anti-LFA-1 (M17.4; lanes A, D 
and G), anti-Mac-1 (Ml/70.15; lanes B, E and H), anti-ß2 (M18.2) mAb (lanes C, F and I) 
or with normal rat serum (lane J). The proteins precipitated were analyzed on a 5-15% SDS-
PAGE under reducing conditions. The migration of the molecular weight markers is 
indicated on the left. Similar results were obtained in two other experiments. 
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Isolation of murine Mac-1 and ICAM-1 
To investigate the interaction of Mac-1 with ICAM-1 in the mouse, we isolated both 
murine ICAM-1 and Mac-1 from the murine macrophage cell line CA5 (see Materials and 
Methods). Fractions collected after elution from the ICAM-1 (YN1/1.7) and the Mac-1 
(Ml/70.15) affinity column were analyzed by SDS-PAGE and silver staining (Figure 3). 
The fractions eluted from the Mac-1 column contained the complete α/β complex, with an 
α chain of 165 kD and a β chain of 95 kD (lane A), whereas the ICAM-1 antigen with a 
mass of 105 kD was eluted from the ICAM-1 column (lane B). In an ELISA detection 
system no contamination of LFA-1 in the purified Mac-1 fraction was observed (Table 1 ; 
OD450 with anti-LFA-1 mAb is < than 0.065). The purity of both Mac-1 and ICAM-1 
proteins was >95%. 
Mr 
(x103) 
2 0 0 -
9 7 -
6 8 -
4 3 -
2 5 -
1 8 -
• 
• 
Figure 3. SDS-PAGE of purified 
murine Mac-1 and ICAM-1. 25 μΐ of 
purified murine Mac-1 and ICAM-1 
was electrophoresed on a 5-15% 
gradient SDS-PAGE under reducing 
conditions and subjected to silver 
staining. Migration of the molecular 
weight markers is represented on the 
left. Lane A: purified murine Mac-1 
(165/95 kD). Lane B: purified murine 
ICAM-1 (105 kD). One representative 
experiment out of three is shown. 
A В 
Mac-1 and LFA-1 mediated adhesion to murine ICAM-1 
Human Mac-1 has been described to bind human ICAM-1 [27,30]. To test whether 
also murine Mac-1 binds murine ICAM-1, we allowed Mac-1 expressing cells to bind to 
coated purified murine ICAM-1. For this purpose we used the murine macrophage cell 
lines: CA5, 293 and 298, expressing distinct levels of Mac-1 on their cell surfaces (Figure 1 
and 2). Because these cell lines expressed variable levels of LFA-1 and Mac-1, we could 
investigate whether LFA-1 and Mac-1 compete for binding to ICAM-1. 
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Table I. Purity 
Dilution of purified 
protein 
1:25 
1-50 
1 100 
1:200 
1.400 
1 800 
1. 1600 
of isolated Mac-1 
Mac-1 
protein as measured 
OD450 with anti-Mac-1 
mAb (5C6) 
1 161 
1 176 
1 191 
1 106 
0 757 
0 377 
0 204 
by an antigen specific ELISA. 
OD450 with anti-LFA-1 mAb 
(M17.4) 
0 045 
0 038 
0 025 
0.032 
0 050 
0 065 
0 028 
All three macrophage cell lines bound to ICAM-1 equally well (15-35%, Figure 4A-
C)). Pre-incubation of the cells with EDTA resulted in a complete inhibition of adhesion of 
the different cell lines to ICAM-1. which indicates that the adhesion to ICAM-1 is integnn 
dependent (data not shown) Binding was specific, since no binding of control protein 
collagen type I was observed (<5%) The adhesion of the cells to ICAM-1 was not further 
increased upon addition of Mn2+, which is known to stimulate integnn mediated adhesion 
This finding indicates that the integrins expressed by these cells were already in an 
activated state (data not shown) 
Adhesion of 298 cells to ICAM-1 was completely LFA-1 dependent (Figure 4A and 
D), which corresponds with the observation that 298 cells express only LFA-1 No block of 
adhesion was observed when 298 cells were incubated with an anti-Mac-1 (5C6) mAb, or a 
control mAb (Rl-2) directed against VLA-4 In contrast, 293 cells (Figure 4C and D) 
adhered predominantly via Mac-1 to ICAM-1 (82% block with the anti-Mac-1 mAb 5C6), 
which corresponds with the high expression of Mac-1 and a low expression of LFA-1 on 
these cells Adhesion of CA5 cells, which express as much LFA-1 as the 298 cells, and 
similar levels of Mac-1 as the 293 cells, could only be blocked by anti-LFA-1 mAb (57%) 
and not by anti-Mac-1 mAb alone (Figure 4B and D) A small Mac-1 dependent component 
of 14% was only observed when anti-Mac-1 and anti-LFA-1 mAb were combined (Figure 
4B and D). The inability of Mac-1 to bind ICAM-1 was not caused by a defective or 
inactive form of Mac-1 expressed by CA5 cells, since CA5 cells showed strong Mac-1 
mediated adhesion to fibrinogen (Figure 5A) and BSA (Figure 5B), two other ligands of 
Mac-1 These findings indicate that, when both LFA-1 and Mac-1 are equally expressed on 
the cell surface, LFA-1 dominates over Mac-1 for binding ICAM-1 (Figure 4D). 
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Figure 4. LFA 1 and Mac-1 dependent adhesion to purified murine ICAM-1 ^'Cr-labeled 
macrophage cells 298 (A), CA5 (B) and 293 (C) were incubated for 15 min at RT with either no 
mAb or 10 μg/ml anti LFA-1 (HI 54 163), 10 μ§/ηι1 anti Mac-1 (5C6) or both m Ab combined 
Cells were allowed to bind to purified murine ICAM-1 (10-30 ng) for 20 min at 37 °C The 
different cell lines bound for 15-35% to ICAM-1 (D) Relative LFA-1- and Mac-1-dependent 
adhesion The LFA 1-mediated adhesion was determined by incubating cells with 10 μg/ml anti-
LFA-1 mAb (HI54 163) The Mac-1 dependent binding was determined by the difference in 
inhibition between cells incubated with both 10 μg/ml anti-Mac 1 (5C6) and 10 μ§/πιΙ anti-LFA-1 
mAb and cells incubated with 10 μg/ml anti-LFA-1 mAb alone The relative percentage of 
adhesion observed when only anti-Mac 1 mAb was added, was 0, 0, and 82% for 298, CA5 and 
293 respectively (E) Actual percentage of adhesion of either 298, CA5 or 293 cells to ICAM-1 in 
the presence (filled bars) or absence (hatched bars) of 50 μg/ml Fab fragments of anti-ICAM 1 
mAb (YN1/1 7 Fab) (F) Relative percentage inhibition of adhesion of 298, CA5 and 293 to 
purified murine ICAM-1 Cells were incubated with 50 μg/ml Fab fragments of anti-ICAM-1 mAb 
(YN1/1 7 Fab) Experiments were carried out in duplicate (SD<4%) Adhesion to protein control 
was always less than 2% One representative experiment out of three is shown 
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To demonstrate that adhesion was specifically mediated by 1С AM-1, we blocked the 
interaction of the distinct cell lines using Fab fragments of the anti-ICAM-1 mAb YN1/1 7, 
which is known to block the LFA-l/ICAM-1 interaction [57] Fab fragments were used to 
prevent Fc-mediated binding of the macrophage cells to ICAM-1 (Figure 4E and F) Anti-
ICAM-1 mAb completely blocked the adhesion of 298 cells to ICAM-1, whereas it partially 
blocked the adhesion of 293 and CA5 cells to ICAM-1 EDTA completely blocked the 
interaction of all three cell lines to ICAM-1 (data not shown), indicating that the adhesion 
was specific for mtegrins (I igure 4) 
A 30 
* 20 
•a 10 
В 30 
£ 20 
=a 10 
II... 
control YN1/17 5C6 5C6-F(ab)2 EDTA 
II... 
control YN1/17 5C6 5C6 F(ab)., EDTA 
Figure 5. Functional activity of 
Mac-1 on CA5 cells Adhesion of 
CA5 cells to purified fibrinogen 
(A) and BSA (B) 5lQ-labeled 
macrophage cells (CA5) were 
incubated with mAb for 15 min at 
RT and were allowed to bind to 
purified murine fibrinogen type I 
(40 μg/ml) for 20 min at 37 °C 
(A) or to BSA (20 mg/ml, B) 
Adhesion was inhibited by 
addition of 10 μg/ml anli-ICAM-1 
(YN1/1 7) mAb, 10 μ§/ηι1 anti-
Mac-1 (5C6) mAb, 50 μg/ml 
F(ab')2 fragments of the anti-Mac -
1 (5C6) mAb or EDTA (5 mM) 
Experiments were carried out in 
triplicate (SD<4%) and 20-25% of 
the CA5 cells bound purified 
fibrinogen and BSA One 
experiment out of three is shown 
ICAM-1 mediated adhesion to murine Mac-1 
To demonstrate thai the lack of Mac-1 mediated ICAM-1 binding by CA5 cells is not 
due to expression of an inactive form of Mac-1 by these cells, we isolated Mac-1 protein 
from these cells (Figure 3) and also tested the capacity of cell bound ICAM-1 to bind to this 
purified murine Mac-1 protein Purified murine Mac-1 antigen was functional, since CA5 
cells which express high levels of murine ICAM-1 readily bound to coated purified Mac-1 
antigen (Figure 6) Due to Fc receptor expression on the murine macrophage cell lines, 
F(ab')2 fragments of anti-Mac-1 mAb (5C6) were used to inhibit the binding Partial 
inhibition (50-60%) of CA5 cells to Mac-1 was observed, demonstrating that adhesion is 
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Mac-1 dependent (maximal inhibition obtained with 5C6-F(ab')2 is 50%, since F(ab')2 
fragments are less efficient than complete IgG [49]). As expected, EDTA completely 
abrogated binding, showing that adhesion of CA5 cells was integrin mediated (Figure 6) 
Figure 6. Binding of murine 1CAM-
1 to purified murine Mac-1 5 'Cr-
labeled CA5 cells were incubated 
with m Ab for 15 min at RT and were 
allowed to bind to purified murine 
Mac-1 (10-30 ng) for 30 min at 37 
°C The adhesion was inhibited by 
addition of 10 μg/ml anti-ICAM-1 
(YN1/1 7) mAb, 50 μg/ml anti-Mac -
1 (5C6-F(ab')2) mAb or EDTA (5 
mM). Experiments were carried out 
control YN1/1 7 5C6-F(ab'b EDTA m duplicate (SD<4%) and 20% of the 
СA5 cells bound purified Mac-1 One 
experiment out of three is shown. 
DISCUSSION 
In this study we investigated the interaction of Mac-1 with ICAM-1 in the mouse. The 
following two major conclusions can be drawn (1) we have shown that ICAM-1 is a hgand 
for Mac-1 in the mouse as well, (2) by comparing the Mac-l/ICAM-1 with the LFA-
1/ICAM-l interaction on cells expressing both LFA-1 and Mac-1, we observed that LFA-1 
and Mac-1 compete for binding to ICAM-1, and that LFA-1 dominates over Mac-1 
Although both 293 and CA5 cells express equal amounts of Mac-1, only 293 cells 
showed a Mac-1-dependent adhesion to ICAM-1. The observation that Mac-1 on CA5 cells 
was unable to bind to ICAM-1 was not the result of an inactive Mac-1 receptor, since the 
same cells showed Mac-1-dependent adhesion to solid-phase fibrinogen and BS A, two 
other hgands of Mac-1 (Figure 5) [40,41] These results suggest that when both LFA-1 and 
Mac-1 are present on the cell surface, ICAM-1 preferentially binds to LFA-1 Furthermore, 
preliminary data show a cross-species interaction of human Mac-1 with murine ICAM-1 
(data not shown) This cross-species interaction of Mac-1 with ICAM-1 is, similar to the 
LFA-l/ICAM-1 [58], unidirectional The cross-species interaction of Mac-1 to murine 
ICAM-1 was only detected when LFA-1 mediated adhesion was blocked This indicates 
that the preference of ICAM-1 to bind to LFA-1 rather than to Mac-1, also exists across the 
species barrier (data not shown) 
1 Ά Ш H 
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Until now, the mechanism underlying the preference for LFA-l/ICAM-1 interaction 
is not known However, the data presented in this article suggest that ligand occupation by 
LFA-1 may result in the generation oí intracellular signals that may lead to a selective 
inactivation of the Mac-1 receptor We cannot exclude that a higher affinity of LFA-1 
compared to Mac-1 may also account for the preference for LFA-1 to bind ICAM-1 
Although this is unlikely, since a lower percentage of LFA-1 expressing cells (in absolute 
numbers, Figure 4A), compared to Mac-1 expressing cells, bound to ICAM-1 (Figure 4C) 
Potential differences in affinity between LFA-1 and Mac-1 for binding ICAM-1 might be 
measured in a Biacore/surface plasmon resonance setting and more experiments are 
required to unravel the precise mechanism that may account for the preference for LFA-
l/ICAM-1 interaction The notion that integnn receptors are selectively used by a cell to 
bind ligand is further supported by our previous observation that LFA-1 can also dominate 
over VLA-4 in binding of activated Τ cells to endothelium In this particular case ligand 
binding by β2 integrins seem to down-regulate βι integnn mediated adhesion [59] 
Similar to ICAM-1 also the extracellular matrix components fibronectin and laminin 
can bind more than one integnn [60] Binding ol the same ligand by multiple integrins may 
be functionally important since attachment of that ligand by different integrins may result in 
distinct intracellular signals 
Several reports indicate that glycosylation of ICAM-1 may affect adhesion ot Mac-1 
to ICAM-1 [30,61] It has been shown that, when ICAM-1 transfectants are treated with an 
deoxymannojinmycin which disrupts Golgi-associated N-linked carbohydrate addition, 
adhesion to purified Mac-1, but not to LFA-1 is improved This enhanced adhesion is 
caused by the accumulation of N linked oligosaccharides in a high mannose form [61] 
Thus the level and type ot N-linked glycosylation on ICAM-1 may contribute to the 
regulation of integrin-mediated adhesion myeloid cells may accumulate if ICAM-1 is 
relatively deglycosylated, whereas lymphocytes may localize if ICAM-1 is more abundantly 
glycosylated [30] In our experiments we can detect both LFA-1 (298) and Mac-1 (293) 
dependent adhesion to punhed ICAM-1, indicating that ICAM-1 is properly glycosylated 
for both LFA-1 and Mac-1 interactions Adhesion assays of cells expressing both LFA-1 
and Mac-1 to deglycosylated ICAM-1 will determine whether this may affect the 
dominance of LFA-1 over Mac-1 for binding ICAM-1 
Because macrophage cells, express high levels of Fc receptors on their cell surface, 
F(ab')2 fragments of an anti-Mac-1 m Ab (5C6) were used to inhibit adhesion of the 
macrophage cells to purified Mac-1 Complete IgG of mAb 5C6 efficiently inhibited the 
interaction of Mac-1 with purified ICAM 1 (Figure 4D, cell line 293, 80% inhibition) 
However, binding of ICAM-1 expressing cells to purified Mac-1 was only partially blocked 
with F(ab')2 fragments of mAb 5C6 (60%), whereas Fab fragments of mAb 5C6 or mAb 
Ml/70 15 were ineffective The lower inhibition by F(ab')2 fragments of mAb 5C6 may be 
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due to a somewhat lower affinity of F(ab')2 fragments of mAb 5C6 for Mac-1 [49] Using 
the anti-ICAM-1 mAb YN1/1 7, we observed that this mAb was unable to block the Mac-
1ЛСАМ-1 interaction (Figure 4E, CA5 and 293), while it strongly inhibited LFA-1/ICAM-
1 interaction (Figure 4B, 298) Taking into account the high homology between mouse and 
human ICAM-1, it is most likely that YN1/1 7 bound to the first domain of ICAM-1 and 
therefore only inhibited LFA-1 mediated adhesion Until now no anti-ICAM-1 antibodies 
have been described that inhibit the Mac-l/ICAM-1 interaction in the mouse Such mAb 
would be useful to investigate the contribution of Mac-l/ICAM-1 in both in vitro as in vivo 
cell-cell interactions in more detail 
We have demonstrated by using purified murine ICAM-1 and Mac-1 as a substrate, 
that ICAM-1 is a hgand tor Mac-1 in the mouse Furthermore we have shown that LFA-1 
competes with Mac-1 for binding to ICAM-1, demonstrating a preference of ICAM-1/LFA-
1 binding, when both adhesion receptors are functionally expressed on the cell surface The 
importance of this preference remains to be established, in vivo 
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ABSTRACT 
Lymphocyte function-associated molecule 1 (LFA-1) is a leukocyte integrin that 
plays a major role in the immune system Recent findings demonstrate that LFA-1 has a 
two- way signaling function, mediating cell adhesion and stimulating intracellular 
processes at the same time Here, Marijke Lub, Yvette van Kooyk and Carl Figdor 
discuss the 'inside-out' and 'outside-in' signaling properties of LFA-1, as a prototype 
leukocyte integrin, in normal and malignant Τ cells They integrate data into a model 
that highlights the role of the cytoskeleton in the regulation of LFA-1 
Lymphocyte function-associated molecule 1 (LFA-1, CD 1 la/CD 18) is similar to other 
integrins in that it comprises an α and a β chain that are non-covalently associated [1] It is 
a member of the p2 group of integrins, which includes Mac-1 (CD1 lb/CD18) and pl50,95, 
these being exclusively expressed by leukocytes Activation of LFA-1 is a prerequisite for 
hgand binding [2,3] and, thus far, three hgands of LFA-1 have been identified· intercellular 
adhesion molecule 1 (ICAM-1), -2, and -3 [4] Circulating peripheral blood lymphocytes 
(PBLs) generally express an inactive form of LFA-1, this is crucial to maintain homeostasis, 
since constitutively active LFA-1 would cause instantaneous aggregation of circulating 
cells and clogging of the vessels Intracellular signals are generated only after activation of 
a lymphocyte, for instance through the T-cell receptor/CD3 complex (TCR/CD3) or by 
phorbol 12-mynstate 13-acetate (PMA), and these signals cause transient activation of 
LFA-1 [2,3] This process is referred to as 'inside-out' signaling (Figure 1) In addition to the 
TCR/CD3 complex, several other leukocyte surface receptors [5] can activate LFA-1 
through G proteins or protein tyrosine kinases (PTKs) These activate protein kinase С 
(PKC) and increase intracellular calcium levels ([Ca2+],) as a result of phosphohpase Cy 
(PLCy)-mediated inositol breakdown Influx of extracellular C a 2 + and lipids have been 
demonstrated to activate LFA-1 [6,7] 
Recent findings show that crosshnking of LFA-1 at the cell surface by antibodies can 
induce intracellular signals [8,9], suggesting that hgand binding can affect cellular 
functions such as apoptosis, cytotoxicity, proliferation, cytokine production and antigen 
presentation [10-12] This is referred to as 'outside-in' signaling (Figure 1) The relatively 
short cytoplasmic tails of leukocyte integrins do not contain any known catalytic domains, 
therefore any hgand-induced stimulation of PTKs or inhibition of protein tyrosine 
phosphatases (PTPs) must be indirect Although there is ample precedent for modulation of 
non-receptor PTKs and PTPs by ligation of the TCR/CD3 complex, it is not known which 
protein-protein interactions are responsible for integrin-mediated tyrosine phosphorylation 
[13,14] Ligand-induced oligomenzalion of surface receptors may initiate signaling by 
bringing together catalytic units of PTKs on the cytoplasmic tails of receptor subunits or 
on associated proteins [15] 
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Figure 1. Signaling pathways mediated by lymphocyte function-associated antigen 1 
(LFA-1). Ligation of the T-cell receptor (TCR)/CD3 complex by major histocompatibility 
complex (MHC) and peptide results in activation of LFA-1 through intracellular signals 
(termed 'inside-out' signaling). Subsequent binding of intercellular adhesion molecule 1 
(ICAM-1) by active LFA-1 results in cell adhesion, and generates intracellular signals 
(termed 'outside-in' signaling) that affect the functional activity of the cell. Molecules that 
are implicated in LFA-1 mediated signaling are: protein tyrosine kinase (PTK), protein 
tyrosine phosphatase (PTP), proteinkinase С (PKC), intracellular calcium levels [Ca2+]¡, 
intracellular pH and lipid. 
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Alternatively, oligomerization may organize cytoskeletal complexes that serve as 
frameworks for the association of PTKs Possible candidate PTKs in leukocytes include 
p724vA, ZAP-70, p56'^, ρ65Λ" and ρ 125™* [16] Indeed, recent information links ïntegrin-
mediated ρ 125™* phosphorylation to the Ras/mitogen-activated protein kinase (МАРК) 
signal transduction pathway [17] Furthermore, dephosphorylation by CD45 may 
negatively regulate LFA-1 -mediated signaling in lymphocytes [8,18], although, on 
thymocytes, CD45 is reported to stimulate LFA-1-mediated adhesion [19] 
The highly conserved GFFKR motif in the cytoplasmic domain of the α chain of 
integrins seems to play a major role in modulating integnn function The observation that 
the nuclear protein calreticuhn, a negative regulator of gene expression, can directly bind 
to the GFFKR region [20] suggests that sequestration of calreticuhn to the cell surface by 
binding to integrins [21] is involved in the activation process of integrins, and may disclose 
a new signaling pathway Furthermore, the observation that deletion of this region results 
in a constitutively active form of LFA-1 underscores the importance of this motif in LFA-1 
function [22] 
Conformational changes and multimerization of LFA-1 
Despite the wealth of information gathered, the precise mechanism that controls 
LFA-1-mediated hgand binding remains unknown The expression of integnn neo-epitopes 
upon activation or after hgand binding suggests that alterations in the conformation of 
integrins are important for ligand binding [11,23,24] This notion is supported by the 
observation that certain monoclonal antibodies raised against LFA-1 have the capacity to 
induce hgand binding rather than inhibit LFA-1-ICAM interactions (Table 1) Alterations in 
the conformation of integrins can also be achieved upon divalent cation binding, since 
integrin-mediated adhesion depends on the presence of Mg 2 + , C a 2 + and M n 2 + [25-27] 
Whereas binding of Mn 2 +directly activates LFA-1 by itself, M g 2 + supports LFA-1-
mediated adhesion only after additional stimuli (e g intracellular signals or activating 
antibodies) Although the role of C a 2 + has remained obscure, previous observations 
showing that integrins can aggregate at the cell surface [28] have implicated C a 2 + in the 
surface distribution of LFA-1 Using an antibody directed against a Ca 2 +-dependent 
activation epitope on LFA-1 (L16), direct evidence has been obtained that binding of Ca 2 + 
by LFA-1 is associated with multimerization of LFA-1 on the surface of activated Τ cells 
[27] This finding may explain why activated Τ cells (L16h l) readily bind ligand upon 
appropriate stimulation, whereas resting lymphocytes express less-clustered LFA-1 (L16'°) 
and bind ligand less avidly 
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Figure 2. Binding of lymphocyte 
function-associated antigen 1 
(LFA-1) to intercellular adhesion 
molecule 1 (ICAM-1) is regulated 
by two distinct mechanisms: 
Mg2 +-dependent alteration in the 
affinity of LFA-1; and C a 2 + -
dependent multimerization of LFA-
1. Maximal adhesion is observed 
on cells expressing LFA-1 in a 
high-affinity state, clustered on the 
cell surface. 
The importance of multimerization of integrin receptors has also been reported by 
others [29], and is essential to trigger 'outside-in' signaling. Indeed, it has been 
convincingly demonstrated that the induction of a high-affinity state by deleting the 
GFFKR motif is not sufficient for stable LFA-1-mediated cell adhesion; it still requires 
multimerization of LFA-1 [22]. Interestingly, divalent cations have been shown to exert 
distinct effects on integrin function. Multimerization of LFA-1 is exclusively mediated by 
Ca 2 + , while M g 2 + and M n 2 + have no such effect ([27]; Y. van Kooyk et al, unpublished). 
These findings demonstrate that divalent cations control LFA-1-mediated adhesion by two 
distinct mechanisms (Figure 2): (1) Mg 2 +- or Mn2+-dependent alterations in the ligand-
binding affinity of LFA-1; and (2) Ca2+-dependent multimerization of LFA-1, which 
enhances the avidity of LFA-1 ligand interactions. Because of these differences, Mn 2 + , 
M g 2 + and C a 2 + probably bind to distinct sites on integrins, and may have a cooperative 
effect on ligand binding [25-27]. 
Active and inactive forms of LFA-1 
As discussed above, LFA-1 is only transiently activated after stimulation by agonists 
(Figure 1). This holds true not only for freshly isolated lymphocytes, but also for a number 
of long-term T-cell cultures (Table 1). This observation, and the fact that ß2 integrins are 
exclusively expressed by leukocytes, raises the question as to how LFA-1 is regulated in 
non-leukocytic cells, which lack leukocyte-specific elements. 
When LFA-1 is expressed on non-leukocytic cells, distinct phenotypes are observed. 
Adherent mouse L-cell fibroblasts and monkey COS cells abundantly express the L16 
epitope, whereas non-adherent K562 cells are L16l0. Furthermore, as summarized in Table 
1, L or COS cells express a constitutively active form of LFA-1, whereas K562 cells express 
a form that is not responsive to PMA, suggesting that at least some regulatory elements are 
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Table 1. Ability of Τ cells to bind ICAM-1 after stimulation by PMA or 
activating anti-LFA-1 antibodies 
Stimulation 
Cell type none PMA Ab 
Normal Τ cells 
Resting PBL 
Activated PBL - + 
Τ cell clone - + 
Leukemic Τ cells 
СЕМ 
Jurkat 
LFA-1 transfectants 
COS-LFA-1 
Lcell-LFA-1 
K562-LFA-1 
Abbreviations Ab, activating antibody, ICAM-1, intercellular adhesion 
molecule 1, LFA-1, lymphocyte function-associated antigen 1 NT, not tested, 
PBL, peripheral blood leukocyte, PMA, phorbol 12-mynstate 13 acetate 
Regulation of LFA-1 ligand binding by the cytoskeleton 
Integnns can associate with cytoskeletal components (,α actinin, tahn), particularly 
through the β chain [32,33] Hibbs et al [34] identified a TTT motif in the β chain that is 
important for LFA-1-mediated ICAM-1 binding However, despite this information, 
molecular mechanisms involved in the association of LFA-1 with the cytoskeleton remain 
largely elusive According to the model proposed in Figure 3, transient release of LFA-1 
from the cytoskeleton, or cytoskeleton-associated molecules, modulates the affinity of 
+ 
+ 
+ 
+ 
+ 
NT 
+ 
+ 
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Figure 3. Model describing the interaction between lymphocyte function-associated 
antigen 1 (LFA-1) and the cytoskeleton. (a) The cell cortex (comprising short actin 
filaments, other cytoskeletal proteins and associated molecules) stabilizes LFA-1 at the 
surface of quiescent leukocytes and prevents it from becoming active (repression), (b) 
Intracellular signals released upon ligation of the T-cell receptor (TCR)/CD3 complex (not 
shown), and agonists, temporarily relieve constraints on the cytoplasmic domains of LFA-1, 
permitting the conformational dynamics required for recognition of intercellular adhesion 
molecule 1 (ICAM-1), and exposing the conserved GFFKR motif on the α chain. This 
results in binding of an unknown factor (X) (see text for details), (c) Binding of ICAM-1 
initiates a series of post-receptor signaling events - multimerization of LFA-1, actin 
polymerization, and protein tyrosine kinase (PTK) activity - which may result in initiation 
of transcription. The TTT motif on the β chain of LFA-1 plays an important role in post-
receptor events. 
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In leukocytes, actin polymers assemble into short filaments attached to the 
cytoplasmic face of the membrane [35] This membrane-associated actin network confers 
rigidity to the cell membrane, and may bind and stabilize the integrin subunits in quiescent 
cells (Figure 3a) In addition, because of the highly dynamic nature of leukocytes, 
membrane-anchored microfilaments may also directly control integrin function According 
to the model, intracellular signals from physiological agonists (ι e TCR engagement), or 
stimulation with PMA, cause a temporary dislodgement of LFA-1 from these short actin 
filaments, allowing LFA-1 to adapt to an active conformation (Figure 3b) Evidence in 
favor of this hypothesis comes from several recent findings First, enhanced motility of 
ligand-coated gold particles bound by integrins is observed upon stimulation with PMA 
(D Kucik and E Brown, personal communications) Furthermore, cytochalasins, that 
inhibit actin polymerization, were demonstrated to increase integrin motility [36], but also 
clearly enhance binding of ligand by Mac-1 on monocytes [35] Cytochalasin D was also 
demonstrated to enhance LFA-1 mediated adhesion to ICAM-1 of resting lymphocytes (M 
Lub et al, unpublished) Similarly, on U937 cells cultured with PMA, pl50,95-mediated 
rosetting of sheep erythrocytes opsonized with complement factor СЗЬі (ЕСЗЬі) could 
only be observed when these cells were treated with cytochalasin D [37] Together, these 
findings suggests that enhanced hgand-binding affinity of integrins is preceded by a 
temporary release from the cytoskeleton 
The release of LFA-1 from the cytoskeleton or associated molecules may expose the 
GFFKR motif, resulting in binding of an unknown factor (X) (Figure 3b) that is similar to 
calreticulin binding to the GFFKR sequence in β ι integrins [20] Subsequent ligand 
binding (Figure 3c) results in receptor multimerization, induction of PTK activity and actin 
polymerization, as well as other post-receptor binding events Multimers of LFA-1 would 
then allow firm adhesion to adjacent cells and support functional activity by intracellular 
signals Affinity modulation of LFA-1 has been shown to be an independent process [22] 
and precedes focal contact formation (multimers of LFA-1) Although the high affinity of 
LFA-1 is sufficient to bind ligand, strong cell-cell adhesion requires post-receptor 
reorganization of the cytoskeleton (ι e actin polymerization, receptor capping) 
РТР-mediated dephosphorylation of cytoskeletal- or cytoskeleton-associated 
proteins would ultimately revert LFA-1 into its inactive state [8] This inactivation does not 
necessarily lead to an immediate disruption of the multimers which may remain at the cell 
surface, thus favoring rapid binding of (previously) activated Τ cells as compared with 
naive resting Τ cells (Table 1 ) Interestingly, we observed that cytochalasin treatment of 
activated Τ cells that express clustered LFA-1 (Figure 3c) inhibits ligand binding (M Lub 
et al ), indicating that association of LFA-1 with the cytoskeleton of resting (Figure 3a) 
and activated lymphocytes (Figure 3C) is distinct These differences between cell types 
may also explain why inhibition of adhesion by cytochalasins has been reported [38-40] 
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Dual role of the actin cytoskeleton in regulating 
LFA-1 mediated cell adhesion 
Marijke Lub, Yvette van Kooyk, Sandra J. van Vliet and Carl G. Figdor 

Dual role of F-actin in regulating LFA-l function 
ABSTRACT 
Intracellular signals are required to activate the leukocyte specific adhesion 
receptor LFA-l (CD 1 la/CD 18) to bind its ligand, ICAM-1 In this study, we investigated 
the role of the cytoskeleton in LFA-l activation and demonstrate that filamentous actin (F-
actin) can both enhance and inhibit LFA-l mediated adhesion, depending on the 
distribution of LFA-l on the cell surface We observed that LFA-l is already clustered on 
the cell surface of IL-2/PHA activated lymphocytes These cells bind strongly ICAM-1 and 
disruption of the actin cytoskeleton inhibits adhesion In contrast to IL-2/PHA activated 
PBL, resting lymphocytes, which display a homogeneous cell surface distribution of LFA-
1, respond poorly to intracellular signals to bind ICAM-1, unless the actm cytoskeleton is 
disrupted On resting PBL, uncoupling of LFA-l from the actin cytoskeleton induces 
clustering of LFA-l and this, together with induction of a high affinity form of LFA-l, via 
'inside-out signaling, results in enhanced binding to ICAM-1, which is dependent on intact 
intermediate filaments, microtubules and metabolic energy We hypothesize that linkage of 
LFA-l to cytoskeletal elements prevents movement of LFA-l over the cell surface, thus 
inhibiting clustering and strong ligand binding Release from these cytoskeletal elements 
allows lateral movement and activation of LFA-l, resulting in ligand binding and Outside-
rn' signaling, that subsequently stimulates actin polymerization and stabilizes cell adhesion 
INTRODUCTION 
The lymphocyte function-associated molecule-1 (LFA-l) is an adhesion receptor that 
belongs to the ß2 family of integrins (CD11/CD18) It consists of an α chain and a β chain 
which are non-covalently linked [1] LFA-l is a leukocyte specific integrin expressed on 
the cell surface of most leukocytes and coordinates distinct adhesive and signaling 
interaction in the immune system, such as Τ cell mediated killing, Τ helper cell and В cell 
responses, natural killer cell activity, monocyte mediated antibody dependent cytotoxicity 
and leukocyte adhesion to endothelial cells [2,3] These highly dynamic interactions are 
accomplished by interaction of LFA-l with inter-cellular adhesion molecule-1 (ICAM-1) 
[4], -2 [5] and -3 [6-9] 
LFA-l expressed by leukocytes, is generally not functional and must be activated to 
bind its ligand Triggering of the T-cell receptor/CD3 complex (TCR/CD3) or stimulation of 
leukocytes with phorbol 12-mynstate 13-acetate (PMA) induces intracellular signals that 
activate LFA-l to bind to its ligand (often referred as 'inside-out' signaling) [3,10-12] As 
shown for PMA, these intracellular signals result in LFA-l adhesion receptors that have a 
200-fold higher affinity for binding of ICAM-1 than of the non-activated receptors [13] 
Consistent with this observation, PMA has shown to increase the diffusion rate of LFA-l, 
according to lack of cytoskeletal constraints on LFA-l [14], suggesting that PMA 
activation causes a temporarily dislodgement of LFA-l from the cytoskeleton, and thereby 
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induce an active conformation (high affinity state) of LFA-1 We previously demonstrated 
that LFA-1 can only significantly bind to ICAM-1, when it is expressed in clusters at the 
cell surface [15] Clustering of integnn molecules are thought to enhance the avidity of 
integrin-ligand interaction [15,16] It has recently been suggested for ацьРз, that ligand 
binding can induce clustering of integrins [17] We have demonstrated that an unique 
antibody NKI-L16, which recognizes a C a 2 + dependent epitope on LFA-1, is only 
expressed by clustered LFA-1, and can therefore report the distribution of LFA-1 at the cell 
surface [15,18] LFA-1 mediated adhesion to ICAM-1 can thus be regulated both by 
changes in avidity (clustering) and affinity (active conformation) of LFA-1 [13,15] 
Several antibodies have been described that bind the extracellular part of the α or β 
chain of LFA-1, and are capable of inducing an active conformation of LFA-1, resulting in 
increased ligand binding [18-21] It is thought that these anti-LFA-1 activating m Abs mimic 
ligand binding and stimulate post-ligand binding signaling ('outside-in' signaling) Outside­
rn signaling generates different intracellular signals, including phosphorylation of distinct 
tyrosine kinases and other proteins [22,23] 
Previous experiments have demonstrated that integrins can associate with 
cytoskeletal components (α-actinin, tahn) upon activation [24,25] Inhibitors such as 
cytochalasin В and D have been used to inhibit ß2 and ßi mediated adhesion to their 
ligands [26-28] In contrast, it has recently been reported that cytochalasins can also 
induce ß2 mediated function [14,29,30], whereas others showed no effect of these 
inhibitors [26,31] Peter et al showed that the ß2 cytoplasmic domain was involved in the 
localization of integrins to focal adhesions and to organize the actin cytoskeleton into 
stress fibers [32] Truncation of the cytoplasmic domain of the ß2 subunit eliminates LFA-1 
binding to ICAM-1, indicating that the cytoplasmic domain of ß2 controls adhesiveness 
[33,34] It has been suggested that the reduced adhesiveness of LFA-1 (by deletion of the 
TTT motif in the cytoplasmic domain of ß2) is due to the altered association/organization of 
the cytoskeleton rather than a change in the affinity of LFA-1 [32] Since the importance 
of the distribution (clustered/ dispersed) of LFA-1 at the cell surface and its attachment to 
the cytoskeleton became only recently apparent [15,35], we investigated the role of the 
cytoskeleton in the activation of LFA-1 when expressed in leukocytes and non-
leukocytes Therefore, we investigated the distribution and the adhesive capacity of LFA-1 
on different cell types, in the presence or absence of affinity modulators of LFA-1 (PMA) 
and cytoskeletal inhibitors Here, we demonstrate that disruption of the actin cytoskeleton 
can inhibit or induce LFA-1 mediated adhesion to ICAM-1, depending on the surface 
distribution of LFA-1 (clustered/dispersed), but independent of the cell type (leukocytes 
versus non-leukocytes) 
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MATERIAL AND METHODS 
Monoclonal antibodies and chemicals 
The mAbs SPV-L7 (IgGl), NKI-L15 (IgG2a), and NKI-L16 (IgG2a) reactive with the 
α chain of human LFA-1 (CD1 la) were raised as described previously [18,36] The non-
blocking mAb TS2/4 (IgGl) reactive with the α chain of human LFA-1 was kindly 
provided by Dr E Martz [37] The blocking mAb 60 3 against the β2 chain was kindly 
provided by Dr Harlan [38], and the anti-ß2 mAb KIM185 (IgGl) was used to activate 
LFA-1 [20] Other reagents used were PMA (50 nM, Calbiochem, La Jolla, CA), 
deoxyglucose (50 raM, Sigma Chemical Co , St Louis, MO) and sodiumazide (10 mM, 
Merck, Hohenbrunn, Germany) to deprive the cell from energy, acrylamide (4 mM, Bio-
Rad Laboratories, Hercules, CA) to block intermediate filaments and nocodazole (10 μg/ml, 
Sigma Chemical Co , St Louis, MO) to block microtubules 
Cells and cell lines 
A homogeneous population of highly purified resting Τ lymphocytes was isolated 
from buffy coats ot healthy donors by centrifugal elutnation, as described previously [39] 
Activated Τ lymphocytes were prepared by cultunng these cells with rIL-2 (400 U/ml, 
Cetus Corp , Emeryville, CA) and phytohemagglutinin (PHA, 0 2 μg/ml, Murex diagnostics 
ltd, Dartford, England) in Iscove's medium (Life Technologies ltd, Paisley, Scotland) 
supplemented with 5% FCS (Bio Whitaker, Verviers, Belgium) and 1% 
antibiotics/antimycotics (Life Technologies, Ine , Grand Island, NY) for 6 days 
L-LFA-1 and BLM-LFA-1 cells were obtained by transfection of the complete cDNA 
of (XL (in pCDM8) and p2 (in pRC-CMV containing a neomycin resistance gene, 
Invitrogen Corporation, San Diego, CA) into mouse fibroblast L cells and human melanoma 
cells (BLM) [40], by СагРОд precipitation (Calcium phosphate transfection system, Life 
Technologies, Ine , Gaithersburg, MD) After 24 hours (hrs), the cells were maintained in 
Iscove's medium containing 5% FCS, 1% antibiotics/antimycotics and the neomycin 
analogue, geneticin (2 mg/ml, Life Technologies ltd, Paisley, Scotland) The different 
transfectants were sorted three times to obtain a homogeneous population of cells 
expressing high levels of LFA-1 Positive cells were stained with directly FITC-labeled 
TS2/4 mAb Cells were sorted using the Coulter Epics Elite (Coulter, Hialeah, FL) For 
establishment of stable L16h l and L16'° L-LFA-1 transfectants, L cells, transfected with 
LFA-1, were incubated (30 min, 4 °C) in PBS, containing 0 5% BSA (Boehnnger, 
Mannheim, Germany) and 1% antibiotics/antimycotics, with mAb NKI-L16 (10 μg/ml), 
followed by incubation with FITC-labeled goat (Fab')2 anti-mouse IgG mAb (Zymed 
laboratories, San Francisco, CA) for 30 min at 4 °C Cells were positively and negatively 
selected on expression of the L16-epitope by sorting using the Coulter Epics Elite To 
83 
Chapter 4 
obtain a homogeneous population of L16'° and L16hl expressing L-LFA-1 cells the sorting 
procedure was repeated three times 
Immunofluorescence analysis 
Cells were incubated (30 mm, 4 °C) in PBS, containing 0 5% wt/vol BS A and 0 0 1 % 
sodiumazide, with appropriate dilutions of the different mAb, followed by incubation with 
FITC-labeled goat (Fab')2 anti-mouse IgG mAb for 30 min at 4 °C The relative 
fluorescence intensity was measured by FACScan analysis (Becton Dickinson & Co , 
Oxnard, CA) 
Cell adhesion assays 
Binding of LFA-1 positive cells to ICAM-1 was performed using ICAM-1 fusion 
proteins consisting of the five domains of ICAM-1 fused to a human IgGl Fc fragment 
(ICAM-1 Fc) Culture supernatant of mouse fibroblast cells (L-cells) transfected with 
pICAM-lFc cDNA [7] was tested for the presence of ICAM-1 Fc in a IgG-specific ELISA 
To coat ICAM-1 Fc, 50 μΐ of goat-anti-human Fc specific F(ab')2 (4 μg/ml, Jackson Immuno 
Research Laboratories, Ine , Westgrove, PA) was pre-coated on 96-wells flat bottom plates 
(MaxiSorp, Nunc, Roskilde, Denmark) for 1 hr 37 °C Subsequently, wells were blocked by 
1% BS A in TSM (20 mM Tns HCl pH 8, 150 mM NaCl, 1 mM СаС12, 2 mM MgCh) for 30 
min at 37 °C Culture supernatant of ICAM-1 Fc (approximately 40 ng/ml) was coated for 1 
hr at 37 °C After labeling of the cells with Na2^'Cr04 (Amersham International, England) 
for 1 hr at 37 °C, they were pre-incubated with cytochalasin D (5 μg/ml) in the presence or 
absence of either deoxyglucosc (50 mM) and sodiumazide (10 mM) or acrylamide (4 mM) 
and nocodazole (10 μg/ml) for 30 min at 37 °C Radiolabeled cells were pre-incubated for 
10 min at RT with different stimuli and/or blocking m Abs Cells were allowed to adhere for 
30-40 min at 37 °C Unbound cells were removed by washing with TSM, supplemented 
with 0 5% w/v BSA The adherent cells were lysed with 100 μΐ of 2% Triton X-100 and 
radioactivity was quantified in a gamma counter Results are expressed as the mean 
percentage of cells binding from triplicate wells Values are depicted as LFA-1 specific 
adhesion Percentage of cells binding - percentage of cells binding in the presence of an 
integnn blocking mAb (NKI-L15, 10 μg/ml) 
Confocal microscopy 
Adherent cells were grown o/n (adherent cells BLM and L cell transfectants) on 
glass slides and non-adherent cells (resting PBL and activated PBL) were immobilized on 
glass slides, pre-coated with Celltak adhesive (Collaborative biomedical products, Bedford, 
MA) Cells were pre-treated with cytochalasin D (5 μg/ml, 10 min at 37 °C) and activated 
with PMA (50 nM) for 20 min at 37 °C in the presence of cytochalasin D, followed by 
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fixation with 0 5% paraformaldehyde Fixed cells were stained with the mAb TS2/4 (10 
μg/ml) for 30 min at 37 °C, followed by incubation with FITC-labeled goat (Fab')2 anti-
mouse IgG mAb for 30 min at room temperature (RT) Cell surface distribution of integnns 
was determined by Confocal Laser Microscopy (CLSM) at 488 nm with a krypton/argon 
Laser (Bio-Rad, Hercules, CA) In all experiments, the same instrument settings of the 
CLSM were used 
RESULTS 
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Figure 1. Expression of LFA-1 and the LFA-1 activation epitope (L16) on distinct cells 
L-LFA-1, BLM-LFA-1, and resting and IL-2/PHA activated PBL were stained with either 
isotype-matched control antibodies, or specific antibodies directed against the α subunit of 
LFA-1 (SPV-L7) and (NKI-L16) or the β chain of LFA-1 (60 3) and GAM-(Fab')2-FITC 
second antibodies NKI-L16 SPV-L7 ratio is mentioned in the NKI-L16 histogram One 
out of five experiments is shown 
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Expression of LFA-1 by L cell fibroblasts and BLM-melanoma cells 
To compare the function of LFA-1 in leukocytes with that in non-leukocytes, we 
generated transfectants in which both the α and β subunit of LFA-1 were transfected We 
expressed LFA-1 in murine fibroblast cells (L cells) and human melanoma cells (BLM) 
Expression level of the α chain of LFA-1 was similar to that on resting and IL-2/PHA 
activated peripheral blood lymphocytes (PBL, Figure 1) Expression of the β chain of LFA-
1 was higher on activated PBL compared to resting PBL, which is caused by expression of 
Mac-1 and pi 50,95, other members of the β2 integri η subfamily, on activated PBL (Figure 
1) 
Since multimenzation or clustering of LFA-1 (high avidity) facilitates binding to 
ICAM-1, we investigated expression of the LI6 epitope, which reports the clustered status 
of LFA-1 on the cell surface of hematopoietic cells [15] Staining LFA-1 with m Ab NKI-
L16 reveals distinct expression patterns of this epitope, depending on the cell type Both 
BLM-LFA-1 and L-LFA-1 transfectants show a L16 expression, which equals the 
expression ot LFA-1 obtained with a regular mAb SPV-L7 (NKI-L16 SPV-L7 
peakchannel ratio=l, ranging from 0 9 to 1 2), and is comparable to activated PBL In 
contrast, LFA-1 on resting PBL expresses signilicantly less of the L16 epitope (NKI-L16 
SPV-L7 peakchannel ratio=0 2, ranging from 0 1 to 0 3) This indicates that LFA-1, on 
BLM, L cell transfectants and activated PBL, is constitutively expressed in clusters on the 
cell surface 
Figure 2. Surface distribution of LFA-1 expressed as determined by Confocal Laser 
Scanning Microscopy (CLSM), using a FITC-labeled anti-LFA-1 mAb TS2/4 LFA-1 is 
localized in large clusters on L-LFA-1 (A), BLM-LFA-1 (B) and on IL-2/PHA activated 
PBL (C), while it is dispersed on resting PBL (D) The instrument settings of the CLSM 
were the same for the distinct pictures 
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To prove that LI6 expression on these transfectants indeed correlates with LFA-1 
clustering as it does on leukocytes, we analyzed the surface distribution of LFA-1 on the 
L-LFA-1 and BLM-LFA-1 transfectants by confocal microscopy, and compared it with the 
distribution of LFA-1 on resting and IL-2/PHA activated Τ cells (Figure 2) The two LFA-1 
transfectants that express high levels of the LI6 epitope (Figure 2A, L-LFA-1, and B, 
BLM-LFA-1) show a clustered distribution of LFA-1 on the cell surface, similar to IL-
2/PHA activated PBL (Figure 2C) In contrast, resting PBL show a dispersed distribution 
of LFA-1 (Figure 2D), which corresponds with the low LI6 expression on these cells In 
conclusion, also in non-hematopoietic cells, expression of the L16-epitope correlates with a 
clustered distribution of LFA-1 
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Figure 3. Spontaneous LFA-1 
mediated adhesion to ICAM-1 
L-LFA-1, BLM-LFA-1, resting 
PBL and IL-2/PHA activated 
PBL were allowed to adhere to 
chimeric ICAM-1 Fc coated wells 
for 30 min at 37 °C Depicted is 
the mean percentage of LFA-1 
specific adhesion to ICAM-1 of 
triplicate wells Specific adhesion 
is percentage of cells binding -
percentage of cells binding in the 
presence of an LFA-1 blocking 
mAb (NKI-L15) Adhesion which 
could not be blocked by NKI-
L15 was always less than 5%, on 
activated PBL One represen­
tative experiment out of five is 
shown 
Clustering of LFA-1 facilitates ICAM-1 binding 
Since the various LFA-1 transfectants exhibited major differences in LFA-1 
distribution, we investigated the intrinsic activation state of the receptor, by measuring 
LFA-1 mediated adhesion to ICAM-1 without the addition of any activating stimuli The 
results in Figure 3 demonstrate that BLM-LFA-1, L-LFA-1 and IL-2/PHA activated PBL 
spontaneously bind to ICAM-1 In contrast, resting PBL that show a dispersed LFA-1 
distribution, hardly bind to ICAM-1 in the absence ot stimuli (Figure 3) The binding to 
ICAM-1 is LFA-1 specific and could not be attributed to Mac-1 or pl50,95 expression, 
since the depicted specific binding was determined in the presence of a blocking anti-LFA-
l a mAb The difference in the spontaneous adhesion of these cells to ICAM-1 is not due to 
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distinct levels of LFA-1 expression, since all cells have similar levels of LFA-1 expression 
(SPV-L7), but only differ in expression of the LI6 epitope (Figure 1) These data indicate 
that clustering of LFA-1 on the cell surface is required for significant LFA-l/ICAM-1 
binding [15] 
A 
Control 
ИМ 185 
ИМ 185 
20 30 40 50 0 10 20 30 
LFA-1 mediated adhesion to ICAM-1 (%) 
Figure 4. Induction of LFA-1 mediated adhesion to ICAM-1 of adherent transfectants 
and leukocytes by different LFA-1 activating stimuli Cells (resting PBL (A), IL-2/PHA 
activated PBL (B), BLM-LFA-1 (C), and L-LFA-1 (D) were pre-incubated in medium 
(control), PMA (50 nM) or the activating antibody KIM 185 (5 μg/ml) Depicted is the 
mean percentage of LFA-1 specific binding to ICAM-1 of three independent wells 
Specific adhesion is percentage of cells binding - percentage of cells binding in the 
presence of an LFA-1 blocking mAb (NKI-L15) Adhesion which could not be blocked by 
NKI-L15 was always less than 5%, on IL-2/PHA activated PBL Data are representative of 
three experiments 
Since binding to ICAM-1, which alters the affinity state of LFA-1, can also be 
enhanced upon activation of cells with PMA [131, we activate the cells with PMA and the 
activating anti-LFA-lß mAb KIM185, that both induce an active conformation (high 
affinity state) of LFA-1 The results in Figure 4A show that binding of resting PBL to 
ICAM-1, indeed requires additional stimuli, like KIM 185 or PMA In contrast, adhesion of 
IL-2/PHA activated PBL, BLM-LFA-1 and L-LFA-1 to ICAM-1, which bind already 
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spontaneously to ICAM-1 (Figure 3), can be further increased by PMA or the activating 
mAb KIM 185 (Figure 4B-D) However, PMA is significantly less effective in inducing 
LFA-l mediated adhesion to ICAM-1 of resting PBL (Figure 4A) when compared to IL-
2/PHA activated PBL (Figure 4B), which is in line with previous findings [15,41] Thus, 
both alteration in avidity (clustering) and affinity (induced by PMA or KIM185) of LFA-l 
is required for strong LFA-l/ligand interaction, when LFA-l is expressed on either 
hematopoietic or non-hematopoietic cells 
Dual role of F-actin in regulating LFA-l function 
The importance of association of cytoskeletal components (α-actinin and talin) with 
the p2 chain has been reported previously [24,25] However, it is not known, whether 
association with the cytoskeleton is important in modulating the affinity, the distribution of 
LFA-l, or both We therefore investigated the role of the actin cytoskeleton in LFA-l 
mediated adhesion to ICAM-1 by different cell types, that either show a dispersed (resting 
PBL) or a clustered LFA-l distribution (IL-2/PHA activated PBL) on the cell surface 
resting PBL activated PBL 
Control 
PMA 
20 30 0 20 40 
LFA-l mediated adhesion to ICAM 1(%) 
Figure 5. Role of F-actin in regulating LFA-l mediated adhesion LFA-l mediated 
adhesion to ICAM-1 ot cytochalasin D treated (•) or untreated cells (D) Resting PBL (A) 
and IL-2/PHA activated PBL (B) were first treated with cytochalasin D (5 μg/ml, 30 min at 
37 °C) or untreated as a control, followed by pre-incubation with PMA (50 nM) The mean 
percentage of LFA-l specific adhesion of triplicate wells is shown Specific adhesion is 
percentage of cells binding - percentage of cells binding in the presence of a LFA-l 
blocking mAb (NKI-L15) Adhesion which could not be blocked by NKI-L15 was always 
less than 5%, on IL-2/PHA activated PBL One representative experiment out of three is 
shown 
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Interestingly, when actin polymerization is inhibited in resting or in IL-2/PHA 
activated Τ cells, clear differences are observed Treatment of resting PBL (dispersed LFA-1 
distribution) with cytochalasin D or PMA, increases adhesion of LFA-1 to ICAM-1 
However, cytochalasin D treatment followed by activation of the cells with PMA, results in 
more than a twofold increase in LFA-1 mediated adhesion to ICAM-1 compared to 
untreated, PMA stimulated cells (Figure 5A), suggesting that both uncoupling of LFA-1 
from the cytoskeleton and induction of an active conformation are necessary to achieve 
strong adhesion In contrast, treatment of IL-2/PHA activated PBL (clustered LFA-1 
distribution) with cytochalasin D, results in a decreased LFA-1 mediated adhesion to 
ICAM-1, with or without the activation of LFA-1 with PMA (Figure 5B) 
Since on K562 cells, transfected with a β2 cytoplasmic deletion mutant of LFA-1, 
LFA-1 is localized in large clusters, and cytochalasin D uncouples actin from integrin 
molecules, the enhanced motility of LFA-1 at the cell surface may allow cluster formation 
that results in an increased adhesion to ICAM-1, we hypothesize that the cytoskeleton 
affects the distribution of LFA-1 To test this hypothesis, resting PBL were pre-treated with 
cytochalasin D and stained with an anti-LFA-la m Ab (Figure 6) Figure 6A shows the 
diffuse LFA-1 cell surface distribution on untreated resting PBL, whereas Figure 6C and D 
demonstrate that cytochalasin D treatment of these cells results in a clustered LFA-1 
distribution, more similar to the clustered LFA-1 distribution observed on IL-2/PHA 
activated PBL (Figure 2C and 7A) Together with the adhesion data, this suggests that 
cytochalasin D induces LFA-l/ICAM-1 adhesion by increasing the avidity (clustering) of 
LFA-1 on resting PBL PMA activation itself has no effect on the cell surface distribution 
of LFA-1 on untreated (Figure 6B), or on cytochalasin D treated cells (Figure 6D), 
indicating that PMA alters the affinity rather than the avidity of LFA-1 In contrast, 
treatment of IL-2/PHA activated PBL with cytochalasin D blocks the adhesion of these 
cells to ICAM-1 (Figure 5B) Cytochalasin D does not seem to affect the clustered 
distribution of LFA-1 on the cell surface (Figure 7C and D), as measured by CLSM 
However we can not exclude that also cytochalasin D affects to some extent the 
distribution of LFA-1 on IL-2/PHA activated PBL, since minor differences in pre-existing 
clusters can not be distinguished by CLSM PMA activation has no effect on the LFA-1 
distribution of IL-2/PHA activated PBL (Figure 7B and D), whereas it has shown to 
enhance adhesion of these cells to ICAM-1 (Figure 5B) Together with recent findings [14], 
this suggests that PMA alters the affinity of LFA-1, whereas cytochalasin D affects the 
avidity of LFA-1 
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Figure 6. LFA-1 distribution of cytochalasin D treated resting PBL shifts towards a 
clustered distribution of LFA-1 Resting PBL are pre-treated with cytochalasin D (5 μg/ml, 
С and D) or as a control untreated (A and B) and are either activated with PMA (B and D) 
or non-activated (A and C) All cells were stained for 30 mm with the anti-LFA-1 mAb 
TS2/4 (10 μg/ml) and (riTC)-labeled goat (Fab')2 anti-mouse IgG Fluorescence distribution 
was determined by Confocal Laser Scanning Microscopy at 488 nm The instrument 
settings of the CLSM were the same for the distinct panels 
Figure 7. Cytochalasin D does nol affect the LFA-1 distribution on IL-2/PHA activated 
PBL IL -2/PHA activated PBL are pie-lrcated with cytochalasin D (5 μg/ml, С and D) or as 
a control untreated (A and B) and are either activated with PMA (B and D) or non-
activated (A and C) All cells were stained ior 30 min with the anti-LFA-1 mAb TS2/4 (10 
μg/ml) and (FITC)-labeled goat (I ab )2 anti mouse IgG Fluorescence distribution was 
determined by Confocal Laser Scanning Microscopy at 488 nm The same instrument 
settings of the CLSM were used throughout the experiment 
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To summarize our findings (Figure 8) on resting PBL, LFA-1 is homogeneously 
distributed and hardly binds ICAM-1. Only the combination of PMA, to induce a high 
affinity receptor, and cytochalasin D treatment results in a clustered LFA-1 cell surface 
distribution and strong ICAM-1 binding (30%). On IL-2/PHA activated PBL, LFA-1 is 
already found in macro clusters and binds ICAM-1 in the absence of any stimulus (30%). 
PMA activation of IL-2/PHA activated PBL can increase the affinity of LFA-1 for ICAM-1 
binding (67%). Inhibition of the actin polymerization in these cells decreases adhesion to 
ICAM-1 to the level of the non-stimulated IL-2/PHA activated PBL, probably by 
decreasing the major clustering of LFA-1 on these cells, which we can not distinguish by 
CLSM (see discussion). These data suggest that the actin cytoskeleton is involved in two 
steps of the activation process of LFA-1: it maintains LFA-1 in a homogeneously 
distributed (low avidity) state on resting PBL, and the actin cytoskeleton maintains LFA-1 
in a high avidity state (clustered) on activated PBL. 
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Figure 8. The dual role of F-actin in regulating LFA-1 mediated adhesion and its 
correlation with the distribution of LFA-1 on both resting and IL-2/PHA activated PBL. 
This figure integrates the adhesion data presented in Figure 5 with the distribution data, 
shown in Figure 6 and 7. Cytochalasin D (CD) induces LFA-1 clustering and ICAM-1 
adhesion on resting PBL, whereas it does not affect the LFA-1 distribution, but inhibits the 
binding to ICAM-1 of IL-2/PHA activated PBL. Adhesion which could not be blocked by 
NKI-L15 was always less than 5%, on IL-2/PHA activated PBL. 
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L-LFA-1/L1610 L-LFA-1/L16hi 
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NKI-L16 
SPV-L7 
fluorescence intensity 
Figure 9. Expression of the LFA-1 activation epitope (L16) on L16h l and L16'° L-LFA-1 
transfectants. L16h l and L16'° L-LFA-1 transfectants were stained with either isotype-
matched control antibodies, or specific antibodies directed against the α subunit of LFA-1 
(SPV-L7 and NKI-L16) and GAM-(Fab')2-FITC second antibodies. The NKI-L16 : SPV-L7 
ratio of both transfectants is mentioned in the histograms. One out of five experiments is 
shown. 
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Figure 10. Distinct role of the actin cytoskeleton in LFA-1 mediated ICAM-1 binding of 
L16'° and L16h l L-LFA-1 transfectants. L-LFA-1 transfectants that show a high L16 
expression and L-LFA-1 cells that exhibit a low L16 expression were treated with 
cytochalasin D (•; 5 μg/ml; 30 min at 37 °C) or untreated (D). Depicted is the percentage 
of LFA-1 mediated adhesion to ICAM-1 of non-treated or cytochalasin D treated cells in 
triplicate wells. LFA-1 mediated adhesion is percentage of cells binding - percentage of 
cells binding in the presence of a LFA-1 blocking mAb (NKI-L15). Data are representative 
of three experiments. 
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Dual role of F-actin in LFA-1 mediated adhesion is not restricted to leukocytes 
To investigate whether the dual role of F-actin in regulating LFA-1 function is 
restricted to leukocytes, we determined the effect of cytochalasin D on the adhesion to 
ICAM-1 of two distinct L-LFA-1 transfectants. We therefore selected L-LFA-1 cells that 
have a low expression of the L16 epitope (Figure 9, NKI-L16 : SPV-L7 peakchannel ratio 
of approximately 0.1), in contrast to the normal L-LFA-1 transfectants that express high 
levels of the L16 epitope (Figure 9, NKI-L16 : SPV-L7 peakchannel ratio of approximately 
1). The L16'° ('resting') L-LFA-1 transfectants show increased adhesion to ICAM-1 upon 
pre-incubation with cytochalasin D and stimulation with PMA (Figure 10A), whereas the 
adhesion of L16hi ('activated') L-LFA-1 cells is inhibited, under the same conditions (Figure 
10B). This indicates that the dual role of F-actin in regulating LFA-1 function is 
independent on the cell type on which LFA-1 is expressed. 
Control 
PMA 
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Figure 11. Cytochalasin D dependent induction of adhesion of L16'° L-LFA-1 cells is 
dependent on intact intermediate filaments, microtubules and energy. L16'° L-LFA-1 cells 
are untreated (D) or treated with metabolic inhibitors: deoxyglucose and sodiumazide (50 
mM and 10 ltiM respectively; Ш), with inhibitors of the intermediate filaments and 
microtubules, like acrylamide and nocodazole (4 mM and 10 μg/ml respectively; Щ, 
cytochalasin D (5 μg/ml; •) alone, together with deoxyglucose and sodiumazide (Q), or 
together with acrylamide and nocodazole (D). Subsequently cells were activated with 
PMA with or without the blocking anti-LFA-1 mAb NKI-L15 and allowed to adhere to 
chimeric ICAM-lFc for 30 min at 37 °C. Depicted is the percentage of LFA-1 specific 
adhesion to ICAM-1 of non-treated or treated cells in triplicate wells. Specific adhesion is 
percentage of cells binding - percentage of cells binding in the presence of an LFA-1 
blocking mAb (NKI-L15). Data are representative of three experiments. 
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Intact intermediate filaments, microtubules and energy are essential in LFA-1/ICAM-
1 binding of cytochalasin D treated cells 
To determine whether induction of adhesion by cytochalasin D is an active, energy 
dependent process, we treated resting L16'° expressing L-LFA-1 cells with sodiumazide 
and deoxyglucose Sodiumazide or deoxyglucose alone was not effective in blocking the 
cytochalasin D induced adhesion (data not shown), whereas a combination of both 
inhibited adhesion, indicating that induction of adhesion caused by cytochalasin D is 
energy dependent (Figure 11) To analyze whether other cytoskeletal proteins participate 
in the cytochalasin D induced adhesion of L16 l 0 L-LFA-1 cells to ICAM-1, we treated the 
cells with acrylamide and nocodazole, disrupting the intermediate filaments and 
microtubules respectively Neither nocodazole nor acrylamide alone was effective in 
inhibiting adhesion, whereas Figure 11 demonstrates that the induced adhesion of 
cytochalasin D treated cells is inhibited by a combination of acrylamide and nocodazole 
This indicates that both intermediate filaments and microtubules are essential to mediate 
this adhesion to ICAM-1 Disruption of the intermediate filaments or microtubules in cells 
that are L16h l did not inhibit LFA-1 mediate adhesion to ICAM-1 (data not shown) 
DISCUSSION 
We have demonstrated that (1) On resting leukocytes, LFA-1 is homogeneously 
distributed, while on IL-2/PHA activated PBL LFA-1 is localized in clusters on the cell 
surface, (2) On cells with a clustered LFA-1 phenotype, association of LFA-1 with the actin 
cytoskeleton is essential for strong adhesion to ICAM-1, (3) Uncoupling F-actm from LFA-
1 (by cytochalasin D) induces LFA-1 mediated binding to ICAM-1 of cells that have a 
homogeneous LFA-1 surface distribution by facilitating lateral movement of LFA-I into 
clusters, and (4) This cytochalasin D induced adhesion to ICAM-1 is dependent on both 
intact intermediate filaments and microtubules and is energy dependent 
On resting PBL, LFA-1 is homogeneously distributed and hardly binds ICAM-1 In 
contrast, on IL-2/PHA activated PBL, L-LFA-1 and BLM-LFA-1 transfectants, LFA-1 is 
localized in huge clusters and spontaneously binds ICAM-1 (approximately 20-30%) In 
addition, adhesion of these cells can be increased by PMA or the activating mAb KIM 185, 
demonstrating that besides clustering of LFA-1 (avidity), affinity changes in the LFA-1 
molecule (active conformation) are still required for strong binding to ICAM-1 These 
findings, together with data that integnns can associate with cytoskeletal components (a-
actinin and tahn), in particular through the β chain [24,25], led us to hypothesize that 
certain cytoskeletal proteins are essential to maintain LFA-1 in a high avidity state on these 
cells The observation that cytochalasin D, which inhibits actin polymerization, blocks the 
adhesion (in the absence of an activator of LFA-1) of the L cell, BLM transfectants and IL-
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2/PHA activated PBL, supports this hypothesis, and demonstrates that this phenomenon is 
not leukocyte restricted. In contrast, on resting PBL and L-LFA-1/L16'0, detachment of the 
homogeneous distributed LFA-1 from the actin cytoskeleton, by cytochalasin D, may 
facilitate re-distribution of LFA-1 into clusters (Figure 6 and [35]). Cells with this high 
avidity form of LFA-1 (clustered) will bind better to ICAM-1, than cells on which LFA-1 is 
homogeneously distributed, thus explaining the enhanced adhesion when these cells are 
treated with cytochalasin D. On IL-2/PHA activated PBL, clustering of LFA-1 may be 
caused by culturing these cells with IL-2 and PHA, since it is possible that IL-2/PHA 
activates LFA-1 to interact with ICAM-1 on the opposite cell, thereby causing cytoskeletal 
reorganizations and clustering of LFA-1 on these cells, as recently has been suggested for 
the anbß3 integrin [17]. The observation that PMA is required, demonstrates that 
clustering of LFA-1 in itself is essential but not sufficient to stimulate strong adhesion. 
Both a high avidity (clustering) and affinity state (active conformation) of LFA-1 is 
necessary for strong adhesion. In contrast to LFA-1, on both resting and IL-2/PHA 
activated PBL, ßi integrin mediated adhesion is always inhibited when actin 
polymerization is inhibited, indicating that ßi and ß2 integrins differ in their coupling to 
the cytoskeleton (data not shown). 
Figure 12 explains the dual role of the actin cytoskeleton in the activation of LFA-1 
in leukocytes. In this model the correlation between adhesion capacity and cell surface 
distribution of LFA-1 on leukocytes is depicted. When LFA-1 is inactive, like on resting 
PBL, it has a dispersed distribution and actin filaments keep the LFA-1 molecules in a low 
avidity state ('repression'). Temporarily uncoupling of LFA-1 from the cytoskeleton by 
PMA is necessary to allow conformational changes in the LFA-1 molecule [14]. Together 
with lateral movement of the adhesion receptor by cytochalasin D, this results in the 
acquisition of clustered (high avidity) LFA-1 molecules with high ligand binding affinity 
[35]. Recently it has also been shown by others that release from cytoskeletal constraints 
is an important early step in activation of adhesion, and that the actin cytoskeleton is 
actively maintaining LFA-1 in its non-adhesive (low affinity and avidity) state [14]. 
Furthermore, other cytoskeletal proteins (e.g. intermediate filaments and microtubules) are 
essential for the induced LFA-1 mediated adhesion of cytochalasin D treated cells to 
ICAM-1. The association of LFA-1 with these cytoskeletal proteins may either, induce an 
active conformation of LFA-1, allow lateral movement of LFA-1 on the cell, or a 
combination of both. More evidence comes from K562 cells, transfected with a ß2 
cytoplasmic deletion mutant of LFA-1. On these transfectants, LFA-1 is localized in large 
clusters, suggesting that uncoupling of the ß2 from the cytoskeleton indeed facilitates 
redistribution of LFA-1 (M. Lub et al., submitted). These data suggest that F-actin is 
important in maintaining LFA-1 in its low avidity state on resting PBL (Figure 12-1), 
whereas it is important to maintain LFA-1 in its high avidity state (clustered) on IL-2/PHA 
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activated PBL (Figure 12-5) and L16h l transfectants However, we probably can not 
distinguish the minor difference in LFA-1 clustering on cytochalasin D treated resting PBL 
(clustering stage II, Figure 12-3 and 12-4) and LFA-1 clustering on unstimulated IL-2/PHA 
activated PBL (clustering stage III, Figure 12-5 and 12-6), since only major differences in 
clustering can be distinguished by CLSM (Figure 12, major differences in clustering 
between stage I and II can be observed by CLSM) The transition from inactive to active 
LFA-1 molecules is clearly dependent on intermediate filaments and microtubules In 
addition, cytochalasin D seems to lower the avidity of LFA-1 on IL-2/PHA activated PBL, 
whereas it increases the avidity of LFA-1 on resting PBL, suggesting that the association 
of LFA-1 with the cytoskeleton is different in resting PBL, compared to IL-2/PHA 
activated PBL 
The notion that cytochalasins induce, rather than inhibit adhesion is also supported 
by several recent findings It has been demonstrated that inhibition of actin polymerization 
by cytochalasins, increases integrin motility on endothelial cells [42] Furthermore, it has 
been shown [29], that inhibition of actin polymerization, enhances hgand binding by Mac-
1 on monocytic cells and by LFA-1 on В cells [14] In addition, inhibition of actin 
polymerization, increases the ability of macrophages to form ρ 150,95 dependent C3-
opsonized sheep erythrocytes (ЕСЗЬі) rosettes [30] The opposite effects of cytochalasins, 
e g inhibition [26-28], induction [14,29,30] or no effect [26,31], in integrai mediated 
adhesion can be explained by 1) The use of the more non-specific actin polymerization 
inhibitor cytochalasin В instead of the more specific cytochalasin D, 2) In a large number 
of the studies, cell aggregation assays were used rather than adhesion assays to purified 
ICAM-1, and most importantly, 3) the distribution state of the integrins on the cell surface 
was never investigated 
In conclusion, we have demonstrated that coupling of LFA-1 to the actin 
cytoskeleton is independent of the cell type (leukocytes compared to non-leukocytes) 
Furthermore, activation of LFA-1 and subsequent hgand binding depends both on the 
distribution and on the affinity state of the receptor F-actin has dual functions 1) to 
maintain LFA-I molecules in a clustered form (IL-2/PHA activated PBL, LFA-1/L16hl) and 
2) to act as a repressor to hold LFA-1 molecules in an inactive form, distributed over the 
cell surface (resting PBL, LFA-1/L16'°) We hypothesize that these LFA-1 molecules can 
only become sensitive to 'inside-out' activation when they are temporarily dislodged from 
the cytoskeleton Leukocytes require mechanisms to regulate LFA-1 adhesion, since they 
should be able to circulate as non-adherent cells in blood and lymph and to migrate as 
adherent cells throughout the tissues Detachment from and coupling to the actin 
cytoskeleton provides leukocytes with a mechanism to rapidly alter both the avidity and 
affinity of LFA-1 in order to respond to physiological stimuli occurring in vivo 
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Figure 12. A model, which explains the dual role of the actin cytoskeleton in the 
regulation of LFA-1 mediated adhesion. Depicted is the correlation between adhesion and 
distribution of LFA-1 on both resting and IL-2/PHA activated PBL, and the role of the 
actin cytoskeleton in these processes. On resting PBL, 'monomeric' LFA-1 receptors are 
inactive, due to connection to the actin cytoskeleton (1). LFA-1 adhesion can be increased 
by induction of a high affinity state (active conformation) of LFA-1, through 
conformational changes, by the phorbol ester PMA (2). On resting PBL, uncoupling of 
LFA-1 from the actin cytoskeleton by cytochalasin D (CD) induces clustering (high avidity 
state) of LFA-1 and thereby enhances LFA-l/ICAM-1 binding (3). Subsequent PMA 
stimulation enhances adhesion to ICAM-1 by induction of a high affinity state (active 
conformation) of LFA-1(4). In contrast, on activated PBL (5), LFA-1 is initially clustered 
and adhesion can be further increased by enhancing the binding affinity of LFA-1 by 
PMA (6). Cytochalasin D treatment of IL-2/PHA activated PBL partially reduces the 
avidity (clustering) of LFA-1 (3), resulting in a decreased adhesion to ICAM-1. Clustering 
of LFA-1 is depicted in different stages (I-III): stage I is no/micro clustering of LFA-1, stage 
III is macro clustering. Minor differences in clustering between stage II and III can not be 
measured by CLSM. Grey boxes indicate the initial state of LFA-1 on resting (1) and IL-
2/PHA activated PBL (5), prior to PMA or cytochalasin D treatment. 
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The cytoplasmic tails of ßi, ß2 and ß7 integrins differentially 
regulate LFA-1 function in K562 cells 
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Role of the ß2 cytoplasmic tail in LFA-1 function 
ABSTRACT 
The ß2 integrin LFA-1 mediates activation-dependent adhesion of lymphocytes. To 
investigate whether lymphocyte-specific elements are essential for LFA-1 function, we 
expressed LFA-1 into the erythroleukemic cell line K562, that expresses only the integrin 
VLA-5. We observed that K562 that expresses LFA-1 cannot bind to ICAM-1 coated 
surfaces when stimulated by PMA, whereas the LFA-1 activating antibody KIM 185 
markedly enhanced adhesion. Since the endogenously expressed ßi integrin VLA-5 is 
readily activated by PMA, we investigated the role of the cytoplasmic domain of distinct β 
subunits in regulating LFA-1 function. Transfection of chimeric LFA-1 receptors in K562 
cells reveals that replacement of the β2 cytoplasmic tail for the ßi but not for the ß7 
cytoplasmic tail completely restores PMA responsiveness of LFA-1, whereas a ß2 
cytoplasmic deletion mutant of LFA-1 is constitutively active. Both deletion of the ß2 
cytoplasmic tail or replacement by the β] cytoplasmic tail alters the localization of LFA-1 
into clusters, thereby regulating LFA-1 activation and LFA-1 mediated adhesion to ICAM-
1. These data demonstrate that distinct signaling routes activate ßi and ß2 integrins 
through the β chain and hint at the involvement of lymphocyte specific signal transduction 
elements in β2 and βγ integrin activation, that are absent in the non-lymphocytic cell line 
K562. 
INTRODUCTION 
The β2 integrin LFA-1 (lymphocyte function-associated antigen-1; CD 11 a/CD 18 or 
(*Lß2) is a lymphocyte specific adhesion receptor, that co-ordinates different adhesive and 
signaling interactions within the immune-system [1-4]. LFA-1 mediates cell-cell adhesion 
upon binding to any one of its ligands, that are intercellular adhesion molecule-1 (ICAM-1) 
[5], -2 [6] and -3 [7-10]. Integrins are heterodimeric transmembrane molecules composed of 
an α chain that is non-covalently linked to a β chain. According to differences in their β 
chain, various integrin subfamilies can be distinguished [11]. 
Besides β2 integrins, lymphocytes also express β ι and βγ integrins. Similar to the β2 
integrins, α4βγ is only expressed on lymphocytes and mediates adhesion to VCAM-1, 
MAdCAM, оц or the extracellular matrix component fibronectin [12-14]. In contrast, the ßi 
integrins 0C4ßi and α^βι are not lymphocyte specific adhesion receptors, since they are 
found on a variety of other cell types [15-17]. ot4ßi mediates, adhesion to VCAM-1, ot4 and 
the extracellular matrix component (ECM) fibronectin, whereas otsßi, predominantly binds 
to fibronectin [14,18-20]. 
LFA-l/ICAM-1 adhesion requires activation of LFA-1 through intracellular signals 
[3,21-23]. This activation process, termed 'inside-out' signaling, is common to all integrins 
including the ßi and ß7 integrins [21,22,24-28]. Activation of LFA-1 is thought to result in 
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a conformational change in the α/β heterodimer, leading to an enhanced binding affinity 
LFA-1 for its ligand ICAM-1 [29] Both affinity (active conformation) and avidity 
(clustering) changes are required to obtain strong binding of LFA-1 to ICAM-1 [30] 
Affinity/avidity changes in LFA-1 depend on an intact cytoskeleton, physiological 
temperature and on binding of divalent cations, in particular M g 2 + [31-34] Binding of 
C a 2 + to LFA-1 supports clustering (high avidity state) of LFA-1 on the cell surface, 
resulting in enhanced LFA-1 mediated adhesion [32,35] 
Alternatively, binding of certain activating anti-integnn antibodies, or the divalent 
cation M n 2 + , to the extracellular part of the integnn, can also induce an active 
conformation (high affinity state) of the (βι, β2, βγ) integnn, resulting in increased adhesion 
to the ligand [24,25,27,36] It is thought that these activating anti-integnn mAbs mimic 
ligand binding and stimulate post-ligand binding signaling ('outside-in' signaling) 'Outside­
rn' signaling generates different intracellular signals, including phosphorylation of distinct 
tyrosine kinases and other proteins [23,37,38] 
Although the cytoplasmic tail of the α and β chain of βι, β2 and β7 ïntegnns are 
relatively short (46, 45 and 51 amino-acids for the β ι , β2 and β7 cytoplasmic tail, 
respectively) and do not contain any intrinsic kinase activity, the cytoplasmic tails seem to 
be involved in transmitting 'inside-out' signals as well as 'outside-in' signals to and from the 
integnn molecule It has been demonstrated that the adhesiveness of LFA-1 is controlled 
by the cytoplasmic domain of the ß2 subunit, since truncation of the cytoplasmic β2 tail, 
but not the OCL tail, eliminates LFA-1 binding to ICAM-1 [39] In particular, mutations of a 
triplet of threonines (position 758-760) and the phenylalanine residue at position 766, in 
the β2 cytoplasmic tail profoundly reduced the adhesiveness of LFA-1 [40,41] It has been 
suggested that the altered adhesiveness due to mutation of the threonine triplet is caused 
by an altered cytoskeletal association/organization and not to an affinity change m LFA-1 
[40] Since deletion of the cytoplasmic domain of the OIL subunit does not affect binding to 
ICAM-1, it is hypothesized that the cytoplasmic tail of OCL IS predominantly involved in 
'post-ligand binding events of this integnn [39] 
Similarly truncation of the cytoplasmic domain of the β ι integnn subunit impairs 
adhesion to both fibronectin and laminin, and has been shown to be important for cell 
spreading and localization to focal contacts [42-45] Moreover, also partial removal ot the 
β7 cytoplasmic domain displayed no ligand binding activity of 0.4$-; [46] 
In this paper we investigated whether a lymphocytic environment is required to 
mediate adhesion through the β2 integnn LFA-1 and whether this depends on the 
cytoplasmic tail of the β chain Therefore, we used the erythroleukemic K562 cells to 
express either wildtypc LFA-1, LFA-1 in which the entire cytoplasmic tail of the ß2 was 
deleted (Δ724), or LFA-1 in which the cytoplasmic domain of the ß2 was exchanged for 
the cytoplasmic domains of β] or β7 We demonstrate that the cytoplasmic tail of the β 
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chain of integrins play a pivotal role in regulating ligand binding affinity (active 
conformation) and avidity (clustering) and suggest that K562 and lymphocytes use 
different signaling elements to activate integrins 
MATERIAL AND METHODS 
Monoclonal antibodies 
The monoclonal antibodies (mAbs) SPV-L7 (IgGl) and NKI-L16 (IgG2a) reactive 
with the α chain of LFA-1 were raised as described previously [24,47] The non-blocking 
mAb TS2/4 (IgGl) reactive with at was provided by Dr E Martz [48] M Ab 60 3 (IgGl), 
directed against ß2 was obtained from Dr Harlan [49] The anti-ß2 mAb KIM 185 (IgGl) 
was used to activate p2 integrins [25] and the anti-ßi mAb TS2/16 to activate ßi integrins 
[50,51] The anti-as mAb SAM-1 (IgGl) was used to block VLA-5 dependent adhesion 
[52] 
DNA constructs 
The 4 2 kb α chain of LFA-1 was cloned in the Xbal site of the pCDM8 vector, that 
directs expression of aL from the CMV AD169 immediate early promotor (pCDLl) The 3' 
end of β2 was cloned as an EcoRI-BgHI fragment in the pRc/CMV vector (containing a 
neomycin resistance gene, Invitrogen Corporation, San Diego, CA) Within this sequence is 
an unique Apal site at position 1980 The C-terminal end was rebuilt from this site using 10 
overlapping oligonucleotides and amplification by PCR to obtain the appropriate hybrids 
For the β2/βι chimeric protein, amino-acid 752 of ßi (cytoplasmic domain) was joined to 
ammo-acid 723 of ß2 and for the ß2/ß7 chimeric protein, amino-acid 747 of βγ (cytoplasmic 
domain) was joined to amino-acid 723 of β2 The deletion mutant of LFA-1 was made by 
truncation of the β2 cytoplasmic tail from amino-acid 724 (Figure 3) 
Cell culture and transfection 
Stable LFA-1 expressing K562 transfectants were established by electroporation of 
107 cells in 0 8 ml PBS at 280V and 960μΡ with either the OIL (m pCDM8) and wildtype β2 
subunit (in pRc/CMV), the OIL and β2 cytoplasmic truncated subunit (Δ724) or the а ь and 
the chimeric β2/βι or β2/β7 chain of LFA-1 K562-LFA-1 transfectants were cultured in 
RPMI 1640 medium (Life Technologies ltd, Paisley, Scotland), supplemented with 10% 
FCS (Bio Whitaker, Verviers Belgium), 1% antibiotics/antimycotics (Life Technologies, Ine , 
Grand Island, NY) After 48 hrs the neomycin analogue, geneticin (2 mg/ml, Life 
Technologies ltd, Paisley, Scotland) was added to the culture medium The different 
transfectants were sorted three times to obtain a homogeneous population of cells 
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expressing high levels of LFA-1 Positive cells were stained with directly FITC-labeled 
TS2/4 mAb Cells were sorted using the Coulter Epics Elite (Coulter, Hialeah, FL) 
Immunofluorescence analysis 
Expression of LFA-1 on the transfectants was determined by immunofluorescence 
Cells (2 χ 10 5) were incubated (30 mm, 4 °C) in PBS, containing 0 5% wt/vol BSA 
(Boehnnger, Mannheim, Germany) and 0 01% sodiumazide (10 mM, Merck, Hohenbrunn, 
Germany), with appropriate dilutions of either an anti-integnn mAb or an isotype matched 
control antibody, followed by incubation with FITC-labeled goat (Fab')2 anti-mouse IgG 
mAb (Zymed laboratories, San Francisco, CA) for 30 min at 4 °C The relative fluorescence 
intensity was measured by FACScan analysis (Becton Dickinson & Co , Oxnard, CA) 
Adhesion assay 
Binding of LFA-1 positive cells to ICAM-1 was performed using 1CAM-1 tusion 
proteins consisting of the five Ig-like domains of ICAM-1 fused to a human IgGl Fc 
fragment (ICAM-1 Fc) ICAM-1 Fc was generated by transfecting mouse L cells with the 
vector pICAM-1-IgGl by СагРС^ precipitation (Calcium phosphate transfection system, 
BRL Life Technologies, Ine Gaithersburg, MD) using a standard protocol [8] Culture 
supernatant was purified by protein A chromatography and eluted by 3 5 M MgCl2 and 
10% glycerol 
96-wells flat bottom plates (MaxiSorp, Nunc, Roskilde, Denmark) pre-coated with 50 
μΐ of goat-anti-human Fc specific F(ab')2 (4 μg/ml, Jackson Immuno Research Laboratories, 
Ine , Westgrove, PA) for 1 hr 37 °C and blocked with 1% BSA in TSM (20 mM Tris HCl pH 
8, 150 mM NaCl, 1 mM СаС12 2 mM MgCl2) for 30 mm at 37 °C, were coated with 0 2 
μg/ml ICAM-1 Fc proteins overnight (o/n) at 4 °C Stable transfected CD1 la/CD18 K562 
cells were labeled with Na2S 'Cr04 (Amersham International, Buckinghamshire, UK) for 45 
mm at 37 °C Radiolabeled cells were washed and pre-incubated for 15 mm at RT with 
different stimuli (50 nM PMA Calbiochem, La Jolla, CA, 5 μg/ml KIM 185 or 5 μg/ml 
TS2/16) and/or blocking mAbs (10 μg/ml) Cells were allowed to adhere for 45-60 mm at 37 
°C Unbound cells were removed by washing with TSM, supplemented with 0 5% w/v 
BSA The adherent cells were lysed with 100 μΐ of 2% Triton X-100 and radioactivity was 
quantified in a gamma counter Results are expressed as the mean percentage of cells 
binding from triplicate wells Values are depicted as integrin specific adhesion Percentage 
of cells binding - percentage of cells binding in the presence of an integrin blocking mAb 
(NKI-L15orSAM 1) 
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Radiolabeling and Immunoprecipitation 
Transfectants were surface labeled by N a 1 2 5 I (Amersham International, 
Buckinghamshire, UK) For immunoprecipitation, 107 cells were solubilized for 1 hr at 4 °C 
in immunoprecipitation buffer (IPB), which contained 1% NP-40 (Sigma chemical Co, St 
Louis, MO), 50 mM tnethanolamine (Sigma chemical Co, St Louis, MO, pH 7 8), 150 mM 
NaCl, 1 mM СаСІг, 2 mM MgCl2 and as protease inhibitors (Sigma chemical Co, St Louis), 
1 mM PMSF, 0 02 mg/ml ovomucoid trypsin inhibitor, 0 02 mg/ml leupeptin and 1 mM Nd-
P-tosyl-L-lysine chloromefhyl ketone were added Nuclear debris was removed from the 
lysates by centnfugation at 13,000 g for 15 min at 4 °C Lysates were pre-cleared by 
successive incubation with mouse IgG covalently coupled to protein A-Sepharose CL-4B 
beads (Pharmacia Fine Chemicals, Piscataway, NJ) Pre-cleared cell lysates were 
immunoprecipjtated with specific mAb, directed against either LFA-1 or VLA-5, coupled to 
protein A-sepharose CL-4B for 1-2 h at 4 °C The immunoprecipitates were removed from 
the lysates by centnfugation at 13,000 g Subsequently, immunoprecipitates were washed 
extensively in IPB and were analyzed under reducing conditions, with 5% 2-ß-
mercaptoethanol in SDS sample bulfer SDS-PAGE was carried out on vertical slab gels (5-
15%) according to a modification of the Laemmli procedure [53] Kodak XAR-film was 
used in combination with intensifier screens (Cronex Lightning Plus, Dupont Chemical 
Co , Newton, CT) for autoradiography of 125I-labeled materials 
Confocal Microscopy 
Cells were fixed with 0 5% paraformaldehyde Fixed cells were stained with TS2/4 
mAb (10 μg/ml) for 30 min at 37 °C, followed by incubation with FITC-labeled goat (Fab')2 
anti-mouse IgG mAb (Zymed laboratories, San Francisco, CA) 30 min at room temperature 
(RT) Cells were attached lo poly-1-lysine coated glass slides, after which cell surface 
distribution ot integnns was determined by Confocal Laser Scanning Microscopy (CLSM) 
at 488 nm with a krypton/argon Laser (Biorad 1000, Hercules, CA) The CLSM settings 
were lens, 60x, gain, 1300, pinhole, 1 5 μπι, and magnification, 1 5x The same instrument 
settings of the CLSM were used, throughout the distinct experiments 
RESULTS 
Expression and function of wildtype LFA-1 in the erythroleukemic K562 cells 
LFA-1 (OCLP2) IÍ> an adhesion receptor which is exclusively expressed on 
lymphocytes To investigate the importance of a lymphocytic environment for the adhesive 
function of LFA-1, we transfectcd both wildtype OCL and β2 chain cDNA in 
erythroleukemic K562 cells that do not express the lymphocyte specific β2 and β7 
109 
Chapter 5 
integrins endogenously. The transfectants express high levels of the heterodimer LFA-1 on 
their cell surface as detected by staining of the cells with mAb directed against either CXL 
(SPV-L7) or ß2 (60.3; Figure 1). 
Control 
LFA-1 α 
SPV-L7 
LFA-1 β 
60.3 
1СГ 1СГ 
fluorescence intensity 
Figure 1. Expression of LFA-1 on LFA-1 transfected K562 cells. K562-aLß2 
transfectants were stained with specific antibodies directed against the α subunit (SPV-L7), 
the β subunit of LFA-1 or an isotype-matched control antibody. One out of five 
experiments is shown. 
ICAM-1 Fibronectin Offl 
Control PMA ΚΓΜ185 Control PMA TS2/16 
Figure 2. Capacity of K562-aLß2 transfectants to bind to ICAM-1 or fibronectin. K562-
aLß2 cells were pre-incubated in medium (= control), PMA (50 nM), or the activating anti-
ß2 mAb KIM185 or the activating anti-ßi mAb TS2/16 (5 μg/ml), respectively. Depicted is 
the mean percentage of either LFA-1 specific adhesion to ICAM-1 or VLA-5 specific 
adhesion to fibronectin. Integnn specific adhesion: Percentage of cells binding -
percentage of cells binding in the presence of an integrin blocking mAb (NKI-LI5 or SAM-
1). Data are representative of four experiments. 
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Chapter 5 
The capacity of LFA-1 on K562 cells to bind its ligand ICAM-1 was determined after 
activation of LFA-1 with PMA or the activating anti-ß2 mAb (KIM 185) and was compared 
with the adhesion capacity of the only endogenously expressed β ι ïntegnn, VLA-5 Figure 
2A, demonstrates that the LFA-1 transfected K562 cells express functional LFA-1 
molecules since KIM 185 readily induces LFA-1 mediated ICAM-1 binding Surprisingly, 
PMA was not able to induce LFA-1 mediated adhesion to ICAM-1 This is not due to a 
general non-responsiveness of K562 cells to PMA, since it significantly enhances VLA-5 
mediated binding to fibronectin Similar to KIM 185, the activating anti-βι TS2/16 
effectively stimulated VLA-5 mediated adhesion (Figure 2B) 
The observation that PMA could enhance ßi ïntegnn (VLA-5) mediated adhesion 
but not ß2 ïntegnn (LFA-1) mediated adhesion suggests that distinct signaling elements are 
involved in the PMA induced ß2 and ßi ïntegnn activation 
Expression of ß2-chimeric LFA-1 molecules in erythroleukemic K562 cells 
To determine whether the observed differences, between PMA responsiveness of ßi 
and ß2 integrins are due to differences in the cytoplasmic tail, we generated LFA-1 
molecules in which the cytoplasmic tail of the ß2 chain was truncated close to the 
transmembrane region at amino-acid position 724 (Κ562-^β2/Δ724), or replaced with that 
of the β ι chain or the βγ chain (K562-otLß2/ßl and K562-aLß2/ß7. respectively) Figure 3 
shows the amino-acid sequence of the different LFA-1 chimeras Asterisks mark the amino 
acid sequence homology of the cytoplasmic domain of the three distinct β chains Both β2 
and ß7 integrins are predominantly expressed by lymphocytes, whereas β ι integrins are 
widely distributed 
The chimeric β2 chains β2/βι, ß2/ß7 and β2/Δ724 were transfected together with the 
wildtype α chain ( a j j in K562 All transfectants expressed equally high levels of LFA-1 
(Figure 4A) LFA-1 was expressed as a heterodimer on the cell surface since all 
transfectants expressed equally high levels of the MHM23 epitope (data not shown) 
which has been reported to detect an α/β association dependent epitope on LFA-1 [54] 
These data demonstrate that deletion of the β2 cytoplasmic tail or replacement of the β2 
cytoplasmic tail for the β ι or ß7 cytoplasmic tail does not alter the overall conformation of 
the LFA-1 α/β heterodimer All transfectants show similar levels of the endogenously 
expressed ßi ïntegnn, VLA-5 (Figure 4A) 
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A) 
Control 
LFA-1 a 
SPV-L7 
LFA-1 β 
60 3 
VLA-5 
SAM-1 
«Lß2 
«Lß2/ßl 
«Lß2/ß7 
aLß2/A 
Ц І І Л І . , , .-, . , „ . , , , „η· , . . . . _ , . . . . _ , . , , . ·•·-, , ·• 
10" 10' ΙΟ1 105 ΙΟ4 10" 10 ' ΙΟ1 1(Г ΙΟ4 10" 10 ' 101 ΙΟ5 10"" 10" 10' 10' 
fluorescence intensity 
Figure 4. Expression and immunoprecipitation of LFA-1 and VLA-5 on the chimeric 
LFA-1 transfectants (A)K562-aLß2, K562-aLß2/ßb K562-aLß2/ß7 and aLß2/A724 
transfectants were stained with either isotype-matched control antibodies, or specific 
antibodies directed against the α subunit (SPV-L7) or the β subunit of LFA-1 or against 
VLA-5 (SAM-1) (B) K562-aLß2/ß7 (lane А, В, С and D), K562-aLß2/ßl (lane E, F and G) 
and K562-aLß2 transfectants (lane H, I, and J) were immunoprecipitated with either the 
anti-VLA-5 mAb SAM-1 (lane B, E and H), the anti-LFA-1 α m Ab (SPV-L7) (lane, С, F and 
I) or the anti LFA-1 β mAb 60 3 (lane D, G and J) As a control for aspecific precipitated 
proteins, lysates were also precipitated with normal mouse serum (lane A) (C) K562-0CLß2 
(lane Α-G) and Κ562-αι_β2/Δ724 (lane Η-N) were immunoprecipitated with the anti-LFA-
l a mAb SPV-L7 (lane В and I), NKI-L15 (lane С and J) or TS2/4 (lane D and K), the anti-
LFA-lß mAb 60 3 (lane E and L) and KIM185 (lane F and M) or the anti-VLA-5 mAb 
SAM-1 (lane G and N) As a control for aspecific precipitated proteins, cell lysates were 
also precipitated with normal mouse serum (lane A and H) 
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Role of the /?2 cytoplasmic tail in LFA-1 function 
To verify that the chimeric LFA-1 molecules, aLß2/ßl and аьрг/Р7, did not associate 
with endogenous 0:5 chain in K562, LFA-1 and VLA-5 were immunoprecipitated from all 
transfectants. Both ß2 wildtype and chimeric ß2 chains associated with OCL and not with as 
(indicated by two arrows in Figure 4B, lanes C, D, F, G, I and J as the thick bands of 185 
and 95 kD). Similarly, immunoprccipitation with an anti-ots mAb showed that VLA-5 does 
not associate with OIL or ß2 (indicated by an arrow in Figure 4B, lanes Β, E and H as one 
thick band of 130-135 kD, which is the result of approximately the same molecular weight 
of both the 0C5 and ßi chains, under reduced conditions). The same results were obtained 
for the OCLP2/A724 (Figure 4C, VLA-5 immunoprecipitate is depicted in lane N, and LFA-1 
in lanes I-M as indicated by arrows). The immunoprecipitation with anti-LFA-1 mAbs 
clearly demonstrates the lower molecular weight of the truncated β chain of abß2/A724 
(Figure 4C, the thick band of approximately 90 kD in lane I-M as indicated by an arrow), 
compared to the β chain of wildtype LFA-1 (Figure 4C, the thick band of 95 kD in lane B-
F, indicated by an arrow). 
A) « L ß 2 / ß l 
Figure 5. The cytoplasmic βι 
domain res tores PMA 
responsiveness of LFA-1 in 
K562 cells. K562-aLß2/ßl (A), 
K562-aLß2/ß7 transfectants 
(B) and K562-aLß2/A724 (С) 
were pre-incubated in medium 
(= control), PMA (50 nM) or 
the activating anti-ß2 mAb 
KIM 185 (5 μg/ml), and allowed 
to adhere for 45-60 min at 37 
°C in the absence or presence 
of the LFA-1 blocking mAb 
(NKI-L15). Depicted is the 
mean percentage of LFA-1 
specific binding to ICAM-1 of 
three independent wells. LFA-
1 specific adhesion: Percentage 
of cells binding - percentage of 
cells binding in the presence of 
a LFA-1 blocking mAb (NKI-
L15). Data are representative 
of three experiments. 
Control PMA KIM 185 
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Figure 6. PMA non-responsiveness 
of K562-otLß2 is independent of the 
concentration ICAM-1 coated. K562-
a L ß 2 ( A ) and K562-aLß2/ßl (В) 
were pre-incubated in medium (= 
control), PMA (50 nM) or the 
activating anti-ß2 m Ab KIM 185 (5 
μg/ml), and allowed to adhere to 
different concentrations of ICAM-
lFc (500 I , 300 D, 200 I , 100 Q, 50 
Ξ and 25 ng/ml H), for 45-60 min at 
37 °C in the absence or presence of 
the LFA-1 blocking mAb (NKI-L15). 
Depicted is the mean percentage of 
LFA-1 specific binding to ICAM-1 of 
three independent wells. LFA-1 
specific adhesion: Percentage of cells 
binding - percentage of cells binding 
in the presence of a LFA-1 blocking 
mAb (NKI-L15). Data are 
representative of three experiments. 
Control P M A K I M 185 
The cytoplasmic βχ domain restores PMA responsiveness of LFA-1 in K562 cells 
Next, we investigated the capacity of the cytoplasmic tail of the β ι or ß7 integrin to 
restore activation of LFA-1 by PMA. Both wildtype LFA-1 (Figure 2A) as well as the 
chimeric LFA-1 transfectants otLß2/ßl (Figure 5A) and ctLß2/ß7 (Figure 5B) showed 
increased binding when activated by the LFA-1 activating antibody, KIM 185. The 
cytoplasmic tail of ß7 in the αι_β2/β7 transfectant did not restore PMA induced binding to 
ICAM-1. In contrast, the cytoplasmic tail of β ι in the chimeric aLß2/ßl transfectant 
restored PMA responsiveness, which is not dependent on expression levels of chimeric 
ctLß2/ßl, since transfectants expressing low levels of ß2/ßi, also respond to PMA (data not 
shown). In addition, increasing the concentration of coated ICAM-1 Fc, did not alter the 
PMA non-responsiveness of wildtype LFA-1 in K562 (Figure 6A), whereas PMA 
stimulated binding of chimeric 0tLß2/ßl to ICAM-1 to a similar extent as the KIM185 
stimulated adhesion of these cells, both independent of the concentration of coated ICAM-
lFc (Figure 6B). In contrast to both the chimeric and wildtype LFA-1 transfectants, the 
0iLß2/A724 transfectant binds ICAM-1 equally well in the absence or presence of the 
activating mAb KIM 185 or PMA (Figure 5C). Adhesion was LFA-1 mediated since 
antibodies directed against LFA-1 (Figure 5) or ICAM-1 inhibited the cell binding 
completely and mock transfectants showed always less than 2% adhesion to ICAM-1 (data 
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no shown) These data indicate that the ßi, but not the ß7 cytoplasmic domain is capable 
of restoring PMA responsiveness of LFA-1 in K562 and that the cytoplasmic tail of ß2 is 
important in regulating ЬГА-1 activation The observation that PMA could still enhance ßi 
íntegrin (VLA-5) mediated adhesion to fibronectin oí all transfectants (Figure 7 and 2B), 
again suggests that distinct intracellular routes are involved in ß2 and βγ compared to ßi 
mipor in ч< t i v a t i n n 
80 
A) a L ß 2 /ß 1 
Figure 7. PMA act ivates the 
endogenously expressed β ι íntegrin 
VLA-5 in all three different K562 
transfectants K562-c<Lß2/ßl (A), 
K562-ctLß2/ß7 transfectants (B) and 
K 5 6 2 - a L p V A 7 2 4 (C) were pre-
íncubated in medium (= control), PMA 
(50 nM) or the activating anti-βι mAb 
TS2/16 (5 ц§/т1), and allowed to 
adhere for 45-60 mm at 37 °C in the 
absence or presence oí the VLA-5 
blocking mAb (SAM-1) Depicted is 
the mean percentage of VLA-5 
specific binding to fibronectin of three 
independent wells VLA-5 specific 
adhesion Percentage of cells binding -
percentage of cells binding in the 
presence of a VLA-5 blocking mAb 
(SAM-1) One out of live experiments 
is shown 
Control PMA TS2/16 
Clustering of LFA-1 on the cell surface is regulated by the β chain 
We determined whethci tiuncation of the cytoplasmic β2 domain or replacement of 
the cytoplasmic β2 domain by the corresponding β ι or β7 cytoplasmic domains affected 
the distribution of cq^2 mtegrins at the cell surface Altered distribution of intcgnns may 
affect the avidity state of the receptors, facilitating ligand binding [32,35,55] Therefore 
wildtype ((*Lß2) the deletion mutant (c<Lß2/A724) and the ß2-chimeric LFA-1 transfectants 
(c<Lß2/ßl and c<Lß2/ßl) were stained with the anti-LFA-1 antibody NKI-L16 which reports 
Ca2+ dependent clustering oí LFA-1 on the cell surlace [24,35] Figure 8 demonstrates that 
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wild-type LFA-1 transfectants express low levels of the LI6 epitope compared to 
expression of a regular anti-LFA-1 (NKI-L16 · SPV-L7 peakchannel ratio is approximately 
0.3). Similarly, 0CLß2/ß7 transfectants show low LI6 expression indicating that the 
cytoplasmic domain of ß7 does not affect LFA-1 distribution (NKI-L16 SPV-L7 
peakchannel ratio is circa 0.3) In marked contrast, (XLß2/ßl and αι.β2/Δ724 transfectants 
show high expression of the LI6 epitope, comparable to expression of the SPV-L7 epitope, 
indicating that all LFA-1 molecules express the L16 epitope (NKI-L16 : SPV-L7 
peakchannel ratio is roughly 1) 
Control 
LFA-1 α 
NKI-L16 
ε 
1) 
о 
•
_ T 1 "'J 1 " - ' Ι ' 
i n 1 i r t¿ ι η ° 
LFA-l α 
SPV-L7 
«Lß2 
«Lß2/ßl 
aLß2 /ß7 
aLß2/A 
10' 1(Г 10 10υ ю' 10¿ 10J 10ч 10u IO1 
l| І І Й І . І І І І І І
Ч
' 
1<Г ИГ IO4 
fluorescence intensity 
Figure 8. Expression of the LFA-1 clustering dependent L16 epitope K562-aLß2, K562-
aLß2^ßl. K562-aLß2/ß7 afid K562-aLß2/A724 transfectants were stained with ìsotype-
matched control antibodies, the m Ab NKI-L16, which reports LFA-1 clustering or with a 
regular mAb directed against the α subunit (SPV-L7) of LFA-1 Data are representative of 
five expenments 
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To determine whether deletion or replacement of the ß2 cytoplasmic domain for the 
ßl cytoplasmic domain directly affects the distribution of LFA-1 on the cell surface, 
confocal laser scanning microscopy studies were performed with all LFA-1 transfectants. 
Figure 9 demonstrates that LFA-1 is homogeneously distributed on the cell surface of both 
wildtype (Figure 9A, only 2 out of 7 cells show some clustering of LFA-1) and chimeric 
Γαίβ2/β7 transfectants (Figure 9C), whereas on the cell surface of all chimeric 0CLß2/ßl 
(Figure 9B) and аьРг/А724 transfected cells (Figure 9D) LFA-1 is distributed in clusters. 
Clustering was not attributed to a higher expression level of LFA-1 (Figure 4). These data 
indicate that either deletion or replacement of the ß2 cytoplasmic domain for the ßi 
cytoplasmic domain dramatically affects the distribution of LFA-1, as well as results in an 
increment in the LI6 epitope expression. Moreover VLA-5 is similarly distributed on all 
K562 transfectants (data not shown). It should be noted that despite the strong clustering 
of cxLß2/ßl receptors on the cell surface stable binding to ICAM-1 still depends on 
activation of the receptor with PMA, in contrast to the 0(Lß2/A724 transfectants that 
express constitutively active LFA-1 molecules. 
Figure 9. Surface distribution of LFA-1 as determined by Confocal Laser Scanning 
Microscopy (CLSM). Cells were fixed (0.5% paraformaldehyde) and subsequently stained 
with the anti-LFA-1 mAb TS2/4 and GAM-(Fab')2-FITC second antibodies. LFA-1 is 
localized in large clusters on K562-0CLß2/ßl (В) and K562-aLß2/A724 (D), whereas LFA-1 
is more homogeneously expressed on Κ562-αι_β2 (A), K562-aLß2/ß7 transfectants (C). 
The instrument settings of the CLSM were the same for the four different panels: Lens, 
60x; gain, 1300; pinhole, 1.5 μιη, and magnification, 1.5x One out of three experiments is 
shown. 
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DISCUSSION 
Our results demonstrate that (1) PMA cannot activate LFA-1 when expressed in 
erythroleukemic K562 cells, despite the fact that PMA readily activates endogenously 
expressed ßi integnns, (2) Expression of ß2 chimeric receptors in K562 reveals that the ßi 
cytoplasmic tail but not the βγ cytoplasmic tail restores PMA responsiveness of LFA-1, (3) 
Lymphocyte specific signal transduction elements may be involved in β2 and β7 ïntegrin 
activation, that are absent in K562 cells, (4) 'Inside-out' signaling (by PMA) is mediated by 
the β chain of integnns, (5) Replacement of the β2 cytoplasmic tail for that of ßi alters the 
surface distribution of LFA-1 into clusters and facilitates ICAM-1 binding, and (6) Deletion 
of the entire ß2 cytoplasmic domain localizes LFA-1 molecules into clusters and results in 
constitutively active receptors 
The PMA non-responsiveness of LFA-1 in K562 cells is not restricted to this integrin 
only, but holds also for the other two ß2 integnns Mac-1 and pl50,95 [56], and is not 
dependent on the concentration of the hgand presented Our finding that the cytoplasmic 
tail of the βγ integrin cannot revert the PMA non-responsiveness of LFA-1 in these cells, 
predicts that transfection of βγ integnns into K562 (these cells do not endogenously 
express βγ integnns), such as ο^βγ, will not respond to PMA This suggests that K562 cells 
lack intracellular signaling elements required to regulate adhesion through the lymphocyte 
specific β2 and βγ integnns The finding that the cytoplasmic tail of the ßi integrin 
completely restores PMA responsiveness of LFA-1 in K562 cells cannot be attributed to a 
higher expression level of the β2/βι chimeric receptors, since transfectants expressing low 
levels of ß2/ßb also respond to PMA (data not shown) Our finding that the ßi integrin 
VLA-5, that is endogenously expressed by the K562 cells, responds to PMA to bind its 
hgand fibronectin, demonstrates that the intracellular signaling elements activated by PMA 
are different tor ßi integnns compared to ß2 and ß7 integnns 
Our results demonstrate that the cytoplasmic domain of the β chain of integnns plays 
an important role in the inside-out' signaling initiated by PMA Whether PMA directly or 
indirectly activates β2 integnns via its β chain requires further study Previously, it has 
been shown that PMA leads to phosphorylation of the serine residue at position 756 in the 
ß2 cytoplasmic domain [41] However, mutation of this serine residue does not impair 
ICAM-1 binding, demonstrating that phosphorylation at this position is not crucial for 
adhesion to ICAM-1 [41] Alignment of the β ι and βγ cytoplasmic domains to the β2 
cytoplasmic domain revealed that the serine residue is conserved in both β ι and βγ (Figure 
3), indicating that this serine residue cannot explain the differences observed in the 
chimeric receptors expressed in K562 Mutations ol a triplet of threonines (amino-acids 
758-760) and a phenylalanine residue at position 766 in the β2 cytoplasmic domain has 
been shown to completely abrogate ICAM-1 adhesion Interestingly, a similar triplet of 
threonines and phenylalanine residue are present in the βγ cytoplasmic domain, and are 
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absent in the βι cytoplasmic domain Therefore, it is tempting to speculate that these 
residues may be important in the lymphocyte specific signal transduction pathway [41] To 
determine the precise residues in the βι cytoplasmic domain, involved in the PMA induced 
signaling, mutations studies have to be performed (work in progress) 
Our LFA-l deletion mutant K562-aLß2/A724, which lacks the complete ß2 
cytoplasmic tail (45 amino-acids long) was found to be constitutively active in K562 cells 
Similar observations were made when the complete cytoplasmic tail of the βγ was deleted 
(Δ747, deletion of 51 amino-acids) in 0 ^ 7 [46] or that of the ß3, in anbßß (Δ744, deletion 
of 45 amino-acids, the β-} cytoplasmic tail is 47 amino-acids long) [57] In contrast, when 
the first 28 amino-acids of the N-terminal region of the cytoplasmic tail of ß2 were deleted, 
no effect on ICAM-1 binding activity was observed [41] Similarly, mutants containing 
deletion greater than 5-15 amino-acids at the C-terminal end of the βι cytoplasmic domain 
neither promoted adhesion nor localization of βι ïntegnns in focal contacts [42-44] In 
contrast, deletion of 39 amino-acids C-terminal of the βι cytoplasmic tail (Δ759, βι 
cytoplasmic tail is 46 amino-acids long) impairs the binding capacity to both lamimn and 
fibronectin Likewise, partial removal of the C-terminal part of the β7 cytoplasmic domain 
(Δ773) of the α.$η íntegrin displayed no hgand binding activity to VCAM-1 [43,46] 
These distinct findings can be attributed to the sites where the cytoplasmic tails of the β 
chains were deleted The different β cytoplasmic tails share high homology in their 
membrane proximal region, especially the DRRE sequence is conserved between the 
different β cytoplasmic tails (Figure 3, D 7 5 9 R R E 7 6 2 of βι) Comparison of the positions at 
which the distinct β cytoplasmic tail were truncated, suggests that deletion of the 
conserved aspartic acid residue corresponding to position 731 in the β2 tail results in a 
constitutively active molecule, indicating that this residue is most important in regulating 
integrin activation In contrast, it seems that in deletion mutants in which this conserved 
aspartic acid residue is not removed, the integrin activity can still be regulated Moreover, 
amino-acid sequences more C-terminal of the β cytoplasmic tail are more likely important in 
hgand binding capacity rather than in regulation of integrin activation [39,41-44,46,57] 
The hypothesis that the conserved aspartic acid residue (Figure 3, D 7 5 9 of βι) is pivotal in 
the regulation of integrin activation, is also supported by our finding that the LFA-l 
deletion mutant Κ562-^β?/Δ724, which lacks the entire cytoplasmic β2 tail, including the 
conserved DRRE sequence, has shown to be constitutively active 
The observation, that β2/βι chimeric LFA-l receptors localize in clusters on the cell 
membrane, whereas the ß2/ß7 chimeric LFA-l and wildtype LFA-l do not, demonstrates 
that the βι cytoplasmic domain plays an important role in mobilizing LFA-l into clusters 
Others have demonstrated that the NPIY motif within the βι cytoplasmic domain is 
important for localization of the integrin into focal contacts [45,58,59] Interestingly, this 
motif is absent in the β2 and β7 cytoplasmic domain (Figure 3), which may explain the 
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absence of a clustered LFA-1 distribution on the wildtype 0iLp2 and the chimeric (XLß2/ß7 
transfectants 
It has been demonstrated that integrine can associate with cytoskeletal components 
(α-actinin, talin), particularly through the β chain and thereby regulate the cell surface 
distribution of the integrin [60,61] Deletion of the cytoplasmic tail may disconnect the 
integrin from the cytoskeleton and allows lateral movement of the integrin at the cell 
membrane, explaining the clustered distribution of LFA-1 on the aLß2/A724 transfectants 
Furthermore, it may well be that clustering of integrins on the cell surface, co-localizes 
important kinases essential for proper signal transduction [62] Not only the intracellular 
conformation or association with regulatory proteins is affected by clustering of integrins 
on the cell surface, also the extracellular conformation is altered, as evidenced by enhanced 
LI6 epitope expression when the ß2 cytoplasmic domain was deleted or replaced for the 
ßl cytoplasmic domain This may be attributed to distinct interactions with cytoplasmic 
proteins, affecting the extracellular conformations of the integrin molecule 
In summary, we have demonstrated that the cytoplasmic domain of the β chain of 
integrins is responsible for the cell surface distribution of the integrin, regulating the 
activation of the integrin and that it plays either directly or indirectly an essential role in 
PMA induced signaling Furthermore, PMA can activate β ι integrins on K562, whereas it 
failed to activate the lymphocyte specific ß2 and ß7 integrins in K562, suggesting that 
PMA activates ß2 and βγ integrins through lymphocyte specific elements, that are absent 
in the non-lymphocytic cell line K562 
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Integrins and their role in adhesion, intracellular signaling, targeting of cytoskeletal 
proteins and gene expression 
Apart from their adhesive function integrins also act as signal transducers. As 
discussed in the introduction, the affinity and/or avidity of integrins to bind ligand can be 
modulated by 'inside-out' signaling, whereas binding of ligand by integrins can result in the 
generation of a variety of intracellular signals, which are termed 'outside-in' or post-ligand 
signaling. 
Signaling through post-ligand binding of integrins results in the generation of many 
signals (see also Introduction, section III: Post-ligand signaling through adhesion 
receptors), including a rise in intracellular Ca 2 + , increase of intracellular pH, protein 
tyrosine and non-tyrosine phosphorylation, alteration in phosphoinositol metabolism, 
activation of mitogen-activated protein kinases (МАРК), and ultimately in induction of 
growth stimulation, gene expression, and inhibition of apoptosis [1-11]. Since many of the 
integrin mediated signaling events overlap with those induced by growth factor receptors, 
the distinction between, and/or integration of, these signaling events will be discussed. 
Role of Rho in intracellular signaling and FAC formation 
Common for both growth factor receptor, lysophosphatidic acid (LPA) receptor and 
integrin mediated signal transduction is the induction of focal adhesion complexes (FACs) 
[12] (Figure 1). FACs are specialized structures between cells and extracellular matrix, 
composed of actin stress fibers which are linked to integrins at the inner surface of the 
plasma membrane. Several types of FACs can exist in one cell, and in general they contain 
various structural proteins including talin, vinculin, and a-actinin, and molecules, such as 
p p l 2 5 F A K , Src and tensin that play a role in the interaction with the intracellular milieu 
[13-15]. P P 1 2 5 F A K is a protein tyrosine kinase that becomes phosphorylated after 
activation of integrins or growth factor receptors [12,16,17]. This suggests that p p l 2 5 F A K 
is a key regulatory component at one of the junctions between these two signaling 
pathways [18]. 
Lysophosphatidic acid (a serum component), platelet derived growth factor (PDGF), 
epidermal growth factor (EGF), insulin, bombesin and bradykinin [19] stimulate the 
formation of stress fibers and FACs [20]. FAC formation can also be induced by Rho (a 
member of the Rho subfamily of GTP-binding proteins; Figure 1). This suggests that 
lysophosphatidic acid, as well as different growth factors, insulin, bombesin and bradykinin 
function stimulate Rho. The link between these distinct factors and Rho activation is not 
clear, but cdc42 and Rac, two other members of the Rho subfamily (cdc42 induces 
filopodia, whereas Rac induces lamellipodia), are upstream of Rho activation and thus 
involved in FAC formation [21,22]. Furthermore, clustering of integrins in FACs is also 
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dependent on functional Rho activity, since FACs staining is lost in cells in which Rho is 
inhibited [23] This indicates that Rho must be upstream of integrin clustering Besides 
Rho activity, hgand binding of integnns is required for recruitment of talin, oc-actinin and 
vincuhn into the FACs (Figure 1 ) 
FACs are neh in proteins which have phosphorylated tyrosines, indicating a role for 
protein tyrosine kinases in FAC formation Inhibition of tyrosine phosphorylation by 
protein tyrosine kinase-inhibitors also blocks lysophosphatidic acid-induced FAC 
formation, whereas activated Rho can bypass this blockade, suggesting that tyrosine 
kinases are upstream of Rho [24] Growth factors such as PDGF and EGF can stimulate 
FAC/stress fiber assembly These receptors signal through tyrosine kinases and thereby 
activate Rho One such tyrosine kinase is phosphoinositol 3-kinase (PI3K), which 
activates Rac and thereby activates Rho Thus, Rho becomes activated either by 
lysophosphatidic acid or by growth factors, and Rho activates other signaling pathways, 
eventually resulting in recruitment of focal adhesion proteins into FACs and stress fiber 
assembly (Figure 1 ) 
Role of ppl25FAK in FAC and stress fiber formation 
Distinct tyrosine kinases are found in FACs and are implicated in stress fiber 
formation ppl25F A K is recruited into FACs, and autophosphorylated in response to 
clustering of integnns by hgand or antibodies [14,18] Also mitogens, growth factors (e g 
EGF) [12,20,25] and lysophosphatidic acid can mediate phosphorylation of ppl25FAK, 
which is inhibited when Rho is blocked, demonstrating that activation of ppl25FAK is 
downstream of Rho activation Autophosphorylation of ppl25FAK at tyrosine 397 creates 
a binding site for the Src homology (SH)2 domain of members of the sre family (c-Src, c-
Fyn, c-Yes and c-Syk) Src can be activated by protein tyrosine phosphatases (PTP), by 
dephosphorylating the negative regulatory COOH-terminal phosphotyrosine Thus far, 
CD45 and protein tyrosine phosphatase-IB are the only known protein tyrosine 
phosphatases that participate in integrin signaling [26,27] Src (e g p58/?r) further 
activates autophosphorylated ppl25F A K by phosphorylation of residues Tyr576 and 
Tyr577 [28] Physical association of Src with ppl25FAK has also been demonstrated by 
the formation of immunoprecipitable complexes of ppl25FAK and c-Src in 3T3 cells upon 
binding of integnns to fibronectin In addition, adhesion to fibronectin promotes 
association of the Ras-activating complex Grb2-mSos with Tyr925-phosphorylated 
ppl25FAK and activation of MAP kinase [29] 
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Chapter 6 
Table I. Components of integrin-mediated signaling pathways (adapted from [14]) 
Molecule Characteristics 
Kinases 
ppl25FAK 
Src 
Syk 
Csk 
PKC 
МАРК 
Tyrosine kinase that localizes to FACs through their FAT domains; FAK 
associates with Src, Csk, Grb2, PI3K, paxillin and ßi peptide. 
Tyrosine kinase with SH2 and SH3 domains; associates with p p l 2 5 F A K 
and paxillin. 
Tyrosine kinase and member of the Src subfamily; expressed in hemato-
poietic cells; activated by ßi and ß3 integrin cross-linking. 
Tyrosine kinase containing SH2 and SH3 domains; suppresses Src family 
kinase activity; associates with ppl25 F A K and paxillin. 
Serine-threonine kinase that localizes to FACs; activated by metabolites 
and calcium 
Serine-threonine kinase activated by mitogens or integrin cross-linking. 
SH2-SH3 signaling 
Crk 
Grb2 
PI3K 
PLC 
SH2-SH3-SH3-containing adapter protein that associates with paxillin 
and C3G. 
SH2-SH3-SH2-containing adapter protein that links receptors to Ras 
activation; associates with ppl25FAK^and mSOSl. 
Lipid kinase specific for phosphatidyl inositol; Integrin-dependent 
association with ppl25 F A K , Src and a-actinin; activated in vitro by Rho. 
Phospholipase that hydrolyzes inositol phospholipids such as PIP2 into 
DAG and IP3; γ isoform contains two SH2 and a SH3 domain; tyrosine-
phosphorylated after engagement of integrin and growth factor receptors. 
Small molecular weight GTPases 
Ras GTPase; activated upon integrin engagement in Τ cells. 
Rho GTPase; essential for LPA and integrin induced formation of FACs and 
stress fibers. 
Rac GTPase; upstream of Rho; induces formation of lamellipodia. 
cdc42 GTPase; upstream of Rac; induces formation of filopodia. 
mSOSl Guanine nucleotide exchange factor that binds to Crk-SH2. 
RasGAP GTPase-activating protein (GAP) for Ras that contains two SH2 and a 
SH3 domain; binds to pl90, a putative RhoGAP. 
Substrates of activated p p l 2 5 F A K or the ppl25 F A K -Src complex are paxillin [30], 
tensin [31,32] and p l 3 0 c a s [33,34]. These substrates become phosphorylated upon ligand 
binding by integrins. Paxillin, a ligand for vinculin, binds near the focal adhesion targeting 
(FAT) sequence in p p l 2 5 F A K . A phosphotyrosine on paxillin serves as binding site for the 
SH2 domain of the SH2/SH3 adapter protein Crk [30], which activates C3G, a Ras-guanine 
nucleotide exchange factor. The tyrosine kinase Csk, the negative regulator of Src kinases, 
associates with p p l 2 5 F A K indirectly, by binding of its SH2 domain to paxillin [14]. 
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Ligands for tensin, an actin nucleating and capping protein with a SH2 domain [35], are 
not known Recently it has been shown that tahn binds to the FAT sequence of pp l25 F A K 
[36], and that pp l25 F A K binds to the membrane proximal part of the cytoplasmic tail of ßi 
integrins, thus providing a direct linkage between an integnn and pp l25 F A K A new 59 
kD threonine-serine kinase has been found that associates with a peptide, covering the 
whole cytoplasmic tail of the ßi subunit [37] Specific regulation of its kinase activity, by 
adhesion to fibronectin, suggests that this integnn linked kinase (p59 ILK) is a mediator of 
integnn signaling In contrast to ppl25F A K , p591LK activity is down regulated in response 
to integnn binding to fibronectin Overexpression of this kinase results in disruption of the 
epithelial cell architecture and in inhibition of integnn mediated binding to substrates, 
whereas it promotes anchorage independent growth [37] It is tempting to speculate that 
integnn mediated signaling is regulated by a balance between p p l 2 5 F A K and integnn 
linked kinase activity Disturbance of this balance results in recruitment of distinct 
signaling molecules and thereby in different integnn mediated responses 
Hierarchy in integrin signaling 
It becomes clear that growth factor receptors and integrine share similar signaling 
pathways, both resulting in the assembly of FACs However, there is a hierarchy in 
responses mediated by integrins, as shown by distinct signals generated upon hgand 
binding, or the aggregation of integnn receptors, or both (Figure 1) Furthermore, the 
distribution of cytoskeletal proteins is differentially affected by the distinct signals 
generated upon integnn triggering In addition, many of the interactions between integrins 
and cytoplasmic proteins, and between different cytoplasmic proteins in FACs, depend on 
tyrosine-phosphorylation of these proteins 
Clustering of integrine by non-blocking anti-integrm antibodies in the absence of 
hgand results in accumulation of tensin and ppl25 F A K at integnn clustering sites (FACs), 
and tyrosine phosphorylation of pp l25 F A K [38,39] Nevertheless, integnn clustering must 
be accompanied by hgand occupancy in order to recruit more cytoskeletal proteins, such 
as tahn, α-actinin and vincuhn, into the FACs [39] Tyrosine phosphorylation is yet 
another step in integnn mediated signaling and formation of FACs For example, Grb2-sos, 
implicated in the EGF-induced signaling, is also bound to integrin-activated and 
phosphorylated p p l 2 5 F A K [14,29] Large FACs, composed of many cytoskeletal and 
signaling proteins (paxillin, filamin, F-actin, Grb2, Sos, Ras, phospholipase-Cy, JNK, МАРК 
and ERK) are obtained after both clustering and hgand binding by integrins (Figure 1) 
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Figure 2. Schematic drawing of the functioning of β2 íntegrins as adhesion receptors 
and signal transducing molecules (adapted from [14]) GFR, growth factor receptor, PLCy, 
phosphohpase-Cy, ERK, extracellular signal-regulated kinases, МАРК, mitogen-activated 
protein kinase, p58/#r, member of Src family 
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Signaling pathways implicated in leukocyte specific ß2 integrili function 
The role of the cytoplasmic domain in integrin mediated signaling of ßi and Рз 
ìntegrins has been studied in great detail Much less is known about leukocyte specific ß2 
and p7 integrin signaling elements Since the cytoplasmic tails of ßi and ß3 integnns are 
highly homologous to those of ß2 and ß7 integnns, signal transduction pathways for ßi 
and ß3 integnns can be used as templates for ß2 integrin signaling This, and information 
available from ß2 integrin studies, provides insight into ß2 integrin mediated signal 
transduction (see also Figure 3) However, it must be stressed that ßi and ß2 integnns have 
different characteristics 1) ßi integnns are expressed on many cell types, including 
adherent cells such as fibroblasts and epithelial cells, whereas ß2 are expressed on original 
non-adherent cells including leukocytes, and 2) typical FAC and stress fiber formation has 
only been observed in adherent cells 
FAC formation by ß2 integnns 
Identical to ßi integnns, α-actinin also interacts with the cytoplasmic domain of ß2 
integnns upon activation of neutrophils, suggesting that ß2 integnns can also recruit 
cytoskeletal proteins at the site of integrin clustering [40] Furthermore, in adherent 
chinese hamster ovary cells (CHO), chimeric cqibß3 integnns containing the cytoplasmic 
domains of aLß2 have been demonstrated to form FACs and stress fibers Mutation of one 
of the conserved threonines into an alanine (TTT to TAT) in the ß2 cytoplasmic domain has 
been shown to impair FAC and stress fiber formation, suggesting that similar to ßi and ß3, 
ß2 integnns can also form FAC and stress fibers when expressed in adherent cells [41] 
Recently, it became clear that peptides of the ß3 and ß2 cytoplasmic tail can also 
interact with p p l 2 5 F A K [42] The consensus sequence covering different peptides that 
show binding to pp l25 F A K is 'KLLvXIhDRRE' (less conserved amino-acids are in lower 
case, X indicates a non-conserved residue) In this motif, only aspartic acid (D) and 
glutamic acid (E) are conserved residues between all different integnns (Introduction, 
Figure 8) Amino-acid substitution studies revealed that these two conserved residues are 
essential for complex formation of integnns with p p l 2 5 F A K , indicating that the 
cytoplasmic tail of every integrin β subunit (except that of β4) is able to interact with 
ppl25pAK (Figure 3) [42] 
Role of protein tyrosine -kinases and -phosphatases in β2 mediated signaling 
Protein tyrosine kinases are involved in integrin signaling, and members of the Src 
family have been shown to bind p p l 2 5 F A K The Src family member p58/# r is activated 
upon binding of polymorphic nuclear cells (PMN) to fibrinogen Tyrosine phosphorylation 
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βj and ß2 integrins differ in their abilities to cluster in FACs 
As reported earlier (Discussion: Role of Rho in intracellular signaling and FAC 
formation), Rho is implicated in FAC and stress fiber formation. However, activation of 
Rho in the presence of the actin-polymerization inhibitor cytochalasin D still results in 
FAC formation, in the absence of stress fiber formation. On the contrary, inhibition of 
protein tyrosine kinase activity by staurosporine, inhibits FAC assembly, but thin bundles 
of actin filaments are still formed [21]. Similar observations are also described in chapter 3 
and in chapter 4, where the dual role of the actin cytoskeleton in LFA-1 mediated adhesion 
is discussed. Treatment of resting leukocytes with cytochalasin D induces clustering of 
LFA-1 on the cell surface, and LFA-1 mediated adhesion to ICAM-1. This may indicate that 
also on leukocytes ß2 integrins can form FACs and that this facilitates integrin-ligand 
binding. Additional evidence for FAC formation, independent from stress fiber assembly, 
comes from Elemer et al. [55], who demonstrate that inhibition of actin-polymerization 
permits the conformational dynamics which are required for recognition of ligand by the 
integrin. The clustering of ß2 integrins (= FACs) on resting PBL, treated with cytochalasin 
D is not observed for ßi integrins, indicating that FACs are not only different on distinct 
cell types, but that ß2 and ßi integrins may also differ in their abilities to cluster into FACs 
(chapter 2). 
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Chapter 6 
Differences in p2 and β ι ïntegnn mediated signaling and assembly of FACs is also 
demonstrated in chapter 5 of this thesis Deletion or replacement of the β2 cytoplasmic tail 
of LFA-1 by the βι or βγ cytoplasmic tail revealed that replacement of β2 cytoplasmic tail 
for the βι cytoplasmic tail (aL,ß2/ßl) facilitates FAC assembly in K562 cells In addition, 
protein kinase C-dependent activation of LFA-1 (by PMA) is defective in these cells, 
whereas endogenously expressed βι integnns are readily activated by PMA Also chimeric 
0iLß2/ßl i n K562 is activated by PMA This again demonstrates that βι and β2 integnns 
differ in their ability to cluster into FACs Furthermore, these data suggest that K562 cells 
and leukocytes use different signaling pathways to activate integnns 
Integnn-specific signaling pathways 
Recently, a novel polypeptide has been found that specifically binds to the 
cytoplasmic domain of the ß3 subunit [56] This peptide, ß3-endonexin, cannot bind to the 
cytoplasmic tails of the βι or β2 subunits ß3-endonexin binds to the cytoplasmic tail of ßß 
m Ctnbß3 and α
ν
β3 Both aiibß3 and α
ν
β3 are involved in integrin mediated signaling [57] 
Serine at position 752 in ß3 appears critical for this process in both integnns Platelets in 
which the carboxy-terminal serine residue of ß3 is mutated into a proline do not bind 
soluble fibrinogen due to defective agonist-induced conversion of otiibßl into a high 
affinity state [58] The same mutation abolishes anbßi mediated spreading of CHO cells on 
fibnnogen and α
ν
β3 clot retraction by melanoma cells [59] This mutation also inhibits β3-
endonexin binding up to 64% This suggests a specific role for ß3-endonexin in ß3 integrin 
signal transduction, and the existence of other integrin subfamily specific molecules 
implicated in β subunit mediated signaling 
Also for ß2 integnns a new intracellular protein has been identified that specifically 
binds to the cytoplasmic domain of the ß2 subunit and not to the β ι cytoplasmic domain 
[60] This protein, called cytohesin-1, shows homology to the yeast SEC7 gene product 
and has a pleckstnn homology (PH) domain Overexpression of cytohesin-1 or the SEC7 
domain induces β2 integrin-dependent binding of Jurkat Τ cells to ICAM-1 In contrast, 
expression of only the PH domain inhibits Τ cell receptor stimulated adhesion The SEC7 
domain of cytohesin-1 specifically interacts with β2, whereas no interaction of β2 could be 
detected with the PH domain It is suggested that PH domains contribute to the 
localization of proteins to the plasma membrane [61] Surprisingly, K562 cells, that are 
defective in the 'inside-out' activation of LFA-1 by PMA (Chapter 5), show low expression 
of cytohesin-1 It is tempting to speculate that low expression of cytohesin-1 is responsible 
for the 'inside-out' signaling defect of LFA-1 in K562 In conclusion, cytohesin is a first 
example of a ß2-specific linked signal transducer Further studies will reveal the signaling 
pathways to which cytohesin-1 is interconnected 
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Leukocytes are the main actors in the immune system that protect the body against 
invading micro-organisms and support wound healing In order to perform these functions, 
leukocytes must circulate as non-adherent cells in lymph and blood, and migrate as 
adherent cells throughout the tissues Therefore, adhesiveness is regulated through the 
many adhesion receptors, expressed by leukocytes, that control processes such as chrome 
inflammation, tumor growth and metastases, hematopoiesis and rejection of transplants 
One important family of adhesion receptors are the integnns Integnns are heterodimenc 
transmembrane molecules composed of an α and a β subunit Apart from their adhesive 
function integnns also act as signal transducers According to their difference in β subunit 
various subfamilies of integnns can be distinguished Leukocyte-restricted integnns are β2 
and β7 integnns, whereas β ι integnns are also expressed on various other cell types This 
thesis focuses on the role of the cytoplasmic domain and environment of the β2 integnn 
LFA-1 m regulating LFA-1 mediated adhesion to ICAM-1 
Chapter 1 outlines the different leukocyte integnns that are currently known The 
structure of LFA-1, an adhesion receptor that belongs to the ß2 integnn subfamily, is 
discussed in detail Integnns have short cytoplasmic tails and are associated with the 
cytoskeleton and with different integrin-signaling molecules that regulate adhesion Little 
is known about the regions within the cytoplasmic domains of integnns that interact with 
the cytoskeleton, and which signaling molecules, important for integnn function, associate 
with the cytoskeleton or with the integnn We have therefore investigated in detail the role 
of the cytoskeleton, integnn signaling molecules and the different regions in the α and β 
cytoplasmic tail that are implicated in integnn function 
Chapter 2 discusses the competition between two adhesion receptors, LFA-1 and 
Mac-1 (both β2 integnns), for binding to the same hgand ICAM-1 We demonstrate that 
when both adhesion receptors are expressed, LFA-1 dominates over Mac-1 for binding to 
ICAM-1 Mac-1/ICAM-1 binding could only be observed in cells that hardly express LFA-
1 on the cell surface These findings suggest that occupation of ICAM-1 by LFA-1 may 
result in the generation of intracellular signals that lead to a selective mactivation of the 
Mac-1 receptor Alternatively the two receptors may differ in their binding affinity for 
ICAM-1, suggesting that binding of LFA-1 to ICAM-1 is much stronger than binding of 
Mac-1 to ICAM-1 
Chapter 3 discusses the role of LFA-1 as a two-way signaling molecule, mediating 
signaling from inside-to-outside the cell and from outside-to-inside the cell 'Inside-out' 
signaling can activate LFA-1, by generating intracellular signals that induce an active 
conformation (high affinity state) of LFA-1, or by changing the distribution of LFA-1 into 
clusters (high avidity state) 'Outside-in' or post-hgand signaling by integnns has been 
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identified by monoclonal antibodies and immobilized hgands to cross-link specific integnn 
receptors, and includes tyrosine phosphorylation, a rise in intracellular Ca 2 + levels and pH 
The 'inside-out' and 'outside-in signaling properties of the prototype leukocyte integnn 
LFA-1 are discussed in normal and malignant Τ cells These data are integrated into a model 
that points at the role of the cytoskeleton in the regulation of LFA-1 function 
Activation of LFA-1 is necessary for achieving strong cell adhesion Activation of 
LFA-1 can be subdivided in alterations in the affinity of LFA-1 (active conformation) and 
in the avidity of LFA-1 (clustered distribution) Chapter 4 describes the dual role of the 
actin cytoskeleton in the activation process of LFA-1 Different cell types may vary in their 
LFA-1 distribution at the cell surface (clustered to more dispersed) Cells that have a 
dispersed LFA-1 distribution (low avidity) hardly bind to ICAM-1 Only the combination 
of clustered LFA-1 (high avidity) and an active state of the adhesion receptor (e g induced 
by PMA) results in strong binding to ICAM-1 On cells that show a dispersed LFA-1 
distribution, uncoupling of LFA-1 from the actin cytoskeleton results in enhanced binding 
to ICAM-1, by facilitating lateral movement of LFA-1 and cluster formation This 
multimenzation of receptors increases the avidity of LFA-1 for ICAM-1 When the affinity 
state of LFA-1 on these cells is enhanced by inducing a conformational change in the 
receptor upon PMA stimulation, binding to ICAM-1 is further increased In contrast, on 
cells that show already a clustered distribution of LFA-1, uncoupling of the integnn from 
the actin cytoskeleton results in decreased ICAM-1 binding, caused by lowering the 
ICAM-1 binding avidity (clustering) of LFA-1 This dual role of the actin cytoskeleton is 
not restricted to leukocytes, because it is also observed when LFA-1 is expressed in non-
leukocytes 
Chapter 5 focuses on the role of the cytoplasmic domain of the integnn β subunit in 
regulating LFA-1 function Therefore, chimeric LFA-1 receptors were generated of which 
the p2 cytoplasmic domain was exchanged for the β] or βγ cytoplasmic domain Both 
wildtype and chimenc LFA-1, containing the cytoplasmic domain of the leukocyte specific 
ß7 integnn, cannot be activated by PMA stimulation, when expressed in erythroleukemic 
K562 cells In contrast, chimeric K562-LFA-1 transfectants, containing the ßi cytoplasmic 
domain, can be activated by PMA to bind ICAM-1, indicating that different signaling 
routes activate ß2 and ßi integrins Furthermore, LFA-1 is constitutively active on K562-
LFA-1 transfectants that lack the cytoplasmic domain of the ß2 subunit In addition, LFA-1 
is distnbuted in clusters at the cell surface when it contains the ßi cytoplasmic domain, or 
when the ß2 cytoplasmic domain is deleted This demonstrates that the β subunit of 
integrins play a pivotal role in regulating ligand binding affinity and avidity, and suggests 
that K562 cells and leukocytes use different signaling pathways to activate integrins 
The diversity of functions of integrins is highlighted in Chapter 6 Integrins do not 
only function as adhesion molecules, but are also implicated in intracellular signaling, 
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targeting of cytoskeletal proteins and eventually, they may induce gene expression. Since 
many intracellular signaling pathways of growth factor receptors resemble that of integrins, 
we have used the growth factor receptor signaling pathway as prototype to discuss the 
integrin signaling pathways. Furthermore, the signaling, targeting of cytoskeletal proteins, 
and induction of gene expression of especially рз and ßi integrins is used to speculate 
about the function of ß2 integrins in these processes of which relatively little is known. 
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Het immuun-systeem beschermt het lichaam tegen infecties met micro-organismen en 
zorgt voor een lichamelijk herstel na verwondingen De leukocyten, onderdeel van het 
immuun-systeem, zijn de cellen die het grootste deel van deze taak op zich nemen Om 
deze functie te vervullen moeten leukocyten kunnen circuleren als niet hechtende cellen 
door de bloed- en lymfevaten en migreren als hechtende cellen door het weefsel Hiervoor 
zijn leukocyten voorzien van adhesie receptoren Een belangrijke familie van adhesie 
receptoren zijn de integrines Integnnes zijn heterodimere transmembraan eiwitten 
bestaande uit een α en een β keten Naast hun functie als adhesie receptoren nemen ze 
ook deel in de signaal transductie Op basis van het verschil in β ketens kunnen 
verschillende subfamilies onderscheiden worden Leukocyt gerestncteerde integnnes 
behoren tot de β2 of ß7 subfamilie, terwijl de ßi subfamilie van integnnes, naast 
leukocyten, ook tot expressie komt op andere cel typen De integrine adhesie moleculen, 
die voorkomen op leukocyten, waaronder LFA-1, spelen een belangrijke rol in 
transplantaat afstoting, chronische ontstekingen, tumor groei en metastasering en 
hematopoiesis Het onderzoek in dit proefschrift beschrijft de rol van de cytoplasmatische 
domeinen van de ß2 ïntegnn LFA-1, en de cytoplasmatische omgeving waarin LFA-1 zich 
bevindt, in de regulatie van LFA-1 gemedieerde adhesie aan ICAM-1 
Hoofdstuk 1 introduceert de verschillende integnnes zoals die nu bekend zijn De 
structuur van LFA-1, een adhesie receptor die tot de ß2 ïntegnn subfamilie behoort, wordt 
gedetailleerd besproken Integnnes met hun korte cytoplasmatische staarten zijn enerzijds 
geassocieerd met het cytoskelet en anderzijds met verschillende ïntegrin-signalenngs 
moleculen Beide associaties zijn van belang voor de LFA-1 gemedieerde adhesie Er is 
weinig bekend welke regionen in de cytoplasmatische domeinen van integnnes een 
associatie aangaan met het cytoskelet Ook de signalenngs moleculen, die associëren met 
het cytoskelet of met de ïntegnn en die belangrijk zijn voor de ïntegnn functie, zijn veelal 
onbekend Daarom hebben wij uitvoerig onderzoek gedaan naar de rol van het cytoskelet, 
ïntegnn signalenngs moleculen en de verschillende regionen in de α en β cytoplasmatische 
staart, in het functioneren van integrins 
In hoofdstuk 2, wordt de competitie tussen de β2 integnnes LFA-1 en Mac-1 voor 
binding aan het hgand ICAM-1 bediscussieerd In dit hoofdstuk hebben we aangetoond 
dat als beide adhesie receptoren tot expressie komen op het cel oppervlak, LFA-1 
domineert over Mac-1 voor binding aan ICAM-1 De Mac-1/1СAM-1 binding wordt alleen 
waargenomen in cellen die nauwelijks tot geen LFA-1 tot expressie brengen Deze 
resultaten impliceren dat binding van LFA-1 aan ICAM-1 leidt tot de generatie van 
intracellulaire signalen, welke resulteren in een selectieve inactivatie van de Mac-1 
receptor Een alternatieve verklaring is dat de twee receptoren verschillen in hun bindings 
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affiniteit voor ICAM-1. Dit suggereert dat binding van LFA-1 aan ICAM-1 sterker is dan 
binding van Mac-1 aan ICAM-1. 
Hoofdstuk 3 behandelt de rol van LFA-1 als een 'twee-richtings verkeer' signalerings 
molecuul. LFA-1 geeft signalen door van binnen-naar-buiten de cel ('inside-out' 
signalering) en van buiten-naar-binnen de cel ('outside-in' signalering). De 'inside-out' 
signalering kan LFA-1 activeren doordat de intracellulaire signalen een actieve conformatie 
(hoge affiniteit) van LFA-1 induceren, of doordat de distributie van LFA-1 op het cel 
oppervlak wordt veranderd (aviditeit). 'Outside-in' of post-ligand signalering door 
integrines is geïdentificeerd door gebruik te maken van monoclonale antistoffen en 
geimmobiliseerde liganden om de integrines te cross-linken en omvat onder andere tyrosine 
fosforylering, een toename in de intracellulaire calcium concentratie en een toename in pH. 
De 'inside-out' en 'outside-in' signalerings capaciteiten van het prototype leukocyt integrin 
LFA-1 wordt besproken in zowel normale als maligne Τ cellen. Deze data zijn geïntegreerd 
in een model welke doelt op de rol van het cytoskelet in de regulering van LFA-1 
gemedieerde adhesie. 
Activatie van LFA-1 is nodig voor het verkrijgen van een sterke binding van ICAM-
1, wat resulteert in cel-cel binding. Activatie van LFA-1 kan onderverdeeld worden in 
veranderingen in de bindings affiniteit van LFA-1 (een actieve conformatie) en in 
veranderingen in de LFA-1 distributie op het cel oppervlak (geclusterde distributie). 
Hoofdstuk 4 beschrijft de dubbele rol die het actine-cytoskelet speelt in het activatie 
proces van LFA-1. Verschillende cellen kunnen variëren in hun distributie van LFA-1 op 
het cel oppervlak (van geclusterd tot een meer homogene distributie). Cellen met een 
homogene LFA-1 distributie binden nauwelijks aan ICAM-1. Alleen de combinatie van 
zowel clustering als een actieve conformatie van LFA-1 (b.v. geïnduceerd door PMA) 
resulteert in een sterke binding aan ICAM-1. Op cellen, met een homogene LFA-1 cel 
oppervlakte distributie, leidt ontkoppeling van LFA-1 van het cytoskelet tot een 
verhoogde binding van LFA-1 aan ICAM-1. Dit komt doordat de ontkoppeling ervoor 
zorgt dat LFA-1 zich lateraal over het cel oppervlakte kan bewegen en kan samengaan in 
clusters, waardoor LFA-1 een grotere aviditeit krijgt. Indien nu de ligand-bindings affiniteit 
van LFA-1 wordt verhoogd, door een conformationele verandering in de receptor te 
induceren met PMA, neemt de binding aan ICAM-1 verder toe. In tegenstelling tot cellen 
met een homogene LFA-1 cel oppervlakte distributie, leidt ontkoppeling van het 
cytoskelet tot een verlaagde binding van LFA-1 aan ICAM-1 op cellen die al een 
geclusterde LFA-1 distributie hebben. Dit wordt veroorzaakt door vermindering van de 
ICAM-1 bindings aviditeit (clustering) van LFA-1. De dubbele rol van het actine 
cytoskelet is niet beperkt tot leukocyten en wordt ook gezien bij niet-leukocytaire cellen 
die getransfecteerd zijn met LFA-1. 
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Hoofdstuk 5 beschrijft de rol van verschillende β cytoplasmatische staarten in de 
regulering van LFA-1 gemedieerde adhesie. Hiervoor zijn chimere LFA-1 receptoren 
gemaakt, waarin het β2 cytoplasmatische domein is uitgewisseld voor het β] of het ß7 
cytoplasmatische domein. Zowel wildtype- als chimere- LFA-1 moleculen, die het 
cytoplasmatische domein van de leukocyt-speficieke βγ integrine bevatten, kunnen niet 
geactiveerd worden met PMA, indien tot expressie gebracht in erythroleukemische K562 
cellen. Daarentegen, de chimere K562-LFA-1 transfectanten, die het cytoplasmatisch 
domein van β ι bevatten, kunnen wel geactiveerd worden door PMA. Dit impliceert dat de 
signalerings routes voor ß2 en β ι integrines verschillend zijn. Op K562-LFA-1 
transfectanten, die het cytoplasmatisch domein van de β2 integrin missen, is LFA-1 
permanent actief. Ook kunnen we zeggen dat LFA-1 geclusterd is op het cel oppervlak als 
LFA-1 het βι cytoplasmatische domein bevat of wanneer LFA-1 haar ß2 cytoplasmatische 
domein mist. Deze gegevens tonen aan dat de β keten van integrines een belangrijke rol 
spelen in de regulatie van de ligand bindings -affiniteit en -aviditeit en suggereren dat 
K562 cellen verschillen van leukocyten in hun signalerings mechanismen om integrines te 
activeren. 
De diversiteit van de verschillende integrin functie wordt belicht in hoofdstuk 6. 
Integrines functioneren namelijk niet alleen als adhesie moleculen, maar zijn ook belangrijk 
voor de intracellulaire signalering, het samenbrengen van cytoskeletaire eiwitten en 
uiteindelijk kunnen integrines zelfs gen-expressie induceren. Omdat veel van de 
intracellulaire signalerings wegen van groei factor receptoren lijken op die van integrines, 
hebben we de signalerings route van de groei factor receptor gebruikt als prototype om de 
signalerings route van de integrines ter discussie te stellen. Tevens is de signaal transductie, 
het samenbrengen van cytoskeletaire eiwitten en inductie van gen-expressie door de β ι en 
β3 integrines als voorbeeld gebruikt om te speculeren over de functie van ß2 integrines in 
deze processen, waarover nog zo weinig bekend is. 
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Stellingen 
behorende bij het proefschrift: 'Role of the cytoplasmic domain and cytoskeleton in 
regulating LFA-1 mediated adhesion'. 
1. De cytoplasmatische domeinen van integrines zijn niet alleen belangrijk voor 
de interactie met het cytoskelet maar ook voor de signalering en de 
extracellulaire conformatie van deze integrines (dit proefschrift). 
2. Zowel een hoge affiniteit (actieve conformatie) als een hoge aviditeit 
(clustering) is noodzakelijk voor een sterke integrine-ligand interactie (dit 
proefschrift). 
3. Jarenlang werd associatie met hel cytoskelet onontbeerlijk geacht voor een 
goede integrine functie. Pas recentelijk is ontdekt dat de ontkoppeling van het 
cytoskelet noodzakelijk is voor de activatie van o.a. de integrine LFA-1 (D. F. 
Kucik et al. 1996. J. Clin. Invest. 97:2139-2144 en dit proefschrift: 
Hoofdstuk 4: Dual role of the actin cytoskeleton in regulating LFA-1 mediated 
cell adhesion, Mol. Biol. Cell, in press). 
4. Het is de vraag of lymfocytaire componenten belangrijk zijn voor het goed 
functioneren van lymphocyte function-associated antigen (LFA)-l (dit 
proefschrift). 
5. De kristalstructuur van een receptor die ligand gebonden heeft, geeft meer 
inzicht over de drie-dimensionele structuur van deze interactie (К. C. Garcia et 
al. 1996. Science 274:209-219). 
6. Presentatie van confocale laser scanning microscopie resultaten hangt af van de 
integriteit van de onderzoeker. 
7. De ß2 integrine pl50,95 is een echte adhesie receptor, het bindt aan bijna elk 
eiwit. 
8. Waar veel te doen is kun je het beste met eten beginnen (Afrikaans gezegde). 
9. Als je twijfelt aan de twijfel, blijf je twijfelen (Sartre). 
10. Je kunt verdriet inslikken, maar het verlaat nooit je lichaam (Fraterman, 
zaterdags bijvoegsel, NRC handelsblad 1996). 
11. Met doorzettingskracht bereik je niet altijd je doel. 
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